Sentence,class,file
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   203First    author (yr)Country Design SamplePrenatal maternal  distress assessmentOutcome  assessmentEffect size  (adjusted) (95% CI)Main conclusion Turcotte-Trem - blay (2014)13Canada Prospective 68 Maternal responses  to IES-R and LES Asthma: maternal  self-report at the age  of 12OR 1.09 (1.00-1.19) In girls only, higher levels of   subjective maternal distress in  pregnancy were associated with  increased lifetime risk for   wheezing, doctor-diagnosed   asthma, and inhaled corticoste - roid usage Guxens  (2014)14Netherland Prospective 4,848 Maternal response to  Brief Symptom In - ventory at 20 weeks  of gestation Wheezing: maternally  reported annually;  Asthma: physician- diagnosed at 6 yearsOR 1.60 (1.32-1.93) Prenatal maternal distress was  positively associated with   wheezing in offspring Chiu (2012)15USA Prospective 653 Maternal negative  life events during  pregnancy Wheezing: maternally  reported at 3-month  intervalOR 3.04 (1.67-5.53) Exposure-response relationship  between prenatal distress and  child wheeze  Khashan  (2012)16Sweden Retrospective  (national  register)3,200,000 Maternal bereave - ment: death of their  spouse or child up to  6 months before or  during pregnancyAsthma: hospitaliza - tion due to ICD  codes of asthma RR 1.20 (1.03-1.39) Children of exposed mothers   were at increased risk of being  hospitalized for asthma Fang (2011)17Sweden Retrospective  (national  register)426,334 (1 to  4 years old)  493,813  (7 to  12 years old)Maternal bereave - ment shortly before  and during pregnan - cyAsthma: hospital con - tact for asthma or at  least 2 dispenses of  inhaled corticoste - roids or montelukast(in boys) HR 1.55 (1.19-2.02)Exposed boys, especially those   exposed during their second   trimester, were at increased risk  of asthma Reyes (2011)18USA Prospective 279 Maternal demoraliza - tion: PERI-D scale at  3rd trimesterWheezing: maternally  reported during birth  to 5 yearsOR 1.66 (1.29-2.14) Prenatal maternal demoralization  was associated with overall,  transient, and persistent wheeze Wood (2011)19USA Prospective 560 Maternal distress:  9-distress related  questionnaire includ - ing PAS, EPDS, and  PSSNumber of wheeze  assessed every 3  months by question - naireOR EPDS 1.37  (P value < 0.01) OR PSS 1.59  (P value<0.01)Positive associations were detected  between multiple wheeze and  cotinine, maternal stress, and  maternal depression Wen (2011)20Taiwan Prospective 730 Maternal self-report - ed mental statusMaternally reported  atopic dermatitis via  telephone surveyOR 2.3 (1.1-5.3) Maternal distress during pregnancy  was associated with ever having  physician-diagnosed AD in 2  years old children Cookson  (2009)21UK Prospective 5,810 Anxiety score on the  self-reported Crown- Crisp Experiential In - dex at 18 and 32  weeks of gestationAsthma: maternal   report of doctor-di - agnosed asthma at  7½ yearsOR 1.64 (1.25-2.17) Children of mothers in the higher  anxiety scores were more likely  to have asthma, with evidence  for a dose-response Sausenthaler  (2009)22Germany Prospective 3,004 The presence of 2 or  more stress factors  of the 12 factorsMaternally reported  physician-diagnosed  atopic dermatitis   during birth to 6  yearsOR 1.48 (0.95-2.30) Maternal factors during pregnancy  were positively associated with  childhood eczema in terms of   cumulative prevalence up to the  age of 2 years, but not beyond  AD, atopic dermatitis; ATC, Anatomical Therapeutic Chemical Classification; CESD-10, the 10 item Center for Epidemiologic Studies Depression Scale; CI, confidence  interval; COCOA, the COhort for Childhood Origin of Asthma and allergic diseases; EPDS, Edinburgh Postnatal Depression Scale; HR, hazard ratio; ICD-10, Interna - tional Classification of Diseases, Tenth Edition; IES-R, Impact of Event Scale-Revised; ISAAC, International Study of Asthma and Allergies in Childhood; LES, Life Ex - periences Survey; OR, odds ratio; PAS, Pregnancy Anxiety Scale; PERI-D, psychiatric epidemiology research interview-demoralization, PSKC, Panel Study on Korean  Children; PSQ, Perceived Stress Questionnaire; PSS, Perceived Stress Scale; RR, relative risk; STAI-T, State Trait Anxiety Inventory- Trait scale.Table.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 Volume 9, Number 3, May 2017 204  http://e-aair.orgPOSSIBLE PATHWAYS LINKING PRENATAL MATERNAL  DISTRESS AND ALLERGIC DISEASES Psychological stress is known to exacerbate allergic diseases  via endocrine or immune responses.25 Considering that atopy is  related to dysregulated immunity and that exposure to any risk  factors during the critical period of development can affect the  immune system’s maturation, psychological stress during the  fetal period may play a role in the onset of allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   205ating a fetal stress response with subsequent fetal HPA axis acti - vation.32 These all may eventually alter the responsiveness of  the fetal HPA axis.,Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 Volume 9, Number 3, May 2017 206  http://e-aair.orgaxis dysregulation, and elevated oxidative stress.5 They mea - sured placental HSD2 levels directly from a subgroup of the co - hort sample and found that children without either allergic dis - eases or prenatally distressed mothers had significantly higher  placental HSD2 levels than those with prenatally distressed  mothers, regardless of their later allergic disease development.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   207thetic nervous system regulates the balance of Th1 and Th2 in  the uterus to influence the implantation and development of  embryos during early pregnancy.,Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 Volume 9, Number 3, May 2017 208  http://e-aair.orgchildhood.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   209natal distress, should be adjusted for during the analysis.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 Volume 9, Number 3, May 2017 210  http://e-aair.org25.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   21163.,Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease212  http://e-aair.orgINTRODUCTION Urticaria is one of the most common skin diseases, and pa - tients may present with a wide spectrum of symptoms, includ - ing sudden development of pruritic wheals or angioedema.1  Chronic urticaria has a significant impact on quality-of-life due  to the constant sensation of itching, regular recurrence, and un - known etiology.2 Urticaria is classified as acute or chronic form  based on the duration of illness.",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"Chronic urticaria is diagnosed  when disease has been continuously or intermittently present  for at least 6 weeks.3 The chronic and acute forms of urticaria  differ in etiology, pathophysiology, and underlying mecha - nism.3 An estimated 15% to 23% of adults have experienced at least 1  episode of acute urticaria at some time in their lives,4,5 and the  prevalence of chronic urticaria in adults is estimated at 0.5% to  5%.2,3,6 In children, previous studies reported the prevalence of  acute urticaria to be 1% to 14.5%,1,7,8 but there is little data on the prevalence of chronic urticaria in children.5,7 Chronic urti - caria is considered less prevalent in children than in adults,9  and most studies estimating its prevalence are based upon ex - trapolation from adult data,7 hospital-based results,8,10 or stud - ies of the general adult population.2 Previous studies have reported that chronic idiopathic urti - caria is associated with infection,11 pseudo-allergy to a food,12  autoimmunity,13,14 and low serum level of vitamin D.15-18 How - ever, there is little information on the relationship of chronic ur - ticaria with type of residence, overcrowding, socio-economic  status, air pollutants, exposure to secondary smoke, and other Prevalence and Risk Factors of Urticaria With a Focus on Chronic  Urticaria in Children Seung Jin Lee,1 Eun Kyo Ha,1 Hye Mi Jee,1 Kyung Suk Lee,1 Seung Won Lee,2 Mi Ae Kim,3 Dong Hyun Kim,4 Young-Ho Jung,1  Youn Ho Sheen,5 Myong Soon Sung,6 Man Yong Han1* 1Department of Pediatrics, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea 2CHA University School of Medicine, Seongnam, Korea 3Department of Allergy & Clinical Immunology, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea 4Department of Dermatology, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea 5Department of Pediatrics, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea 6Department of Pediatrics, CHA Gumi Medical Center, CHA University School of Medicine, Gumi, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
2017 May;9(3):212-219. https://doi.org/10.4168/aair.2017.9.3.212 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 AAIR http://e-aair.org   213life style factors that have established importance in other aller - gic diseases.1,2,19,20 The aims of this study were to estimate the prevalence of acute  and chronic urticaria in children and to identify their associa - tions with the demographic and epidemiological characteristics  of individuals, including family history, comorbidities, disease  severity, and environmental factors by using questionnaires.",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 Volume 9, Number 3, May 2017 214  http://e-aair.orging or ceiling, etc), distance of the residence to the main road  (<50, 50-100, 100-200, >200 m), parental education, and pa - rental income ( <$3,360 vs ≥$3,360/month).",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 AAIR http://e-aair.org   215caria, and controls were 20.5 ±5.1, 22.9 ±4.9, and 20.0 ±5.1 ng/ mL, respectively; there was no significant between-group dif - ference ( P=0.183).",OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 Volume 9, Number 3, May 2017 216  http://e-aair.orgFood was the most frequent cause of urticaria (n =236, 37.8%),  followed by changing environment (n =172, 27.6%).",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 AAIR http://e-aair.org   217urticaria was associated with living in a new house, but was not  associated with family history of allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 Volume 9, Number 3, May 2017 218  http://e-aair.orgcal practice to determine disease activity and response to treat - ment of chronic urticaria.23 For this reason, the disease severity  of our patients cannot be directly compared with that of other  studies.",Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
2017 May;9(3):212-219.  https://doi.org/10.4168/aair.2017.9.3.212 AAIR http://e-aair.org   219chronic spontaneous urticaria patients: a prospective case-control  study.,Non-OADS,/arxiv_data1/oa_pdf/7b/97/aair-9-212.PMC5352572.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease220  http://e-aair.orgINTRODUCTION Allergic rhinitis (AR) has become a global health problem that  affects a large part of the general population.1 According to pre - vious reports, the house dust mite (HDM) is regarded as the  most probable inhalant allergen.2 HDM-induced AR is also re - lated to an increased risk of asthma.3 Additionally, compared  with other kinds of aeroallergens, if people are exposed to HDM  allergens for a long time, the symptoms seem to be more  chronic and severe.4 In fact, the prototypic perennial allergen  (i.e., HDMs) have not been confirmed, although more and less  mite allergens can be found in the early autumn and winter, re - spectively.5 Symptomatic treatment remains the first treatment  choice for patients with AR.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"Remarkably, early  treatment of AR with specific immunotherapy may even pre - vent it from evolving into asthma.11,12 Sublingual immunotherapy (SLIT) is regarded as an effective  therapy, and is recommended by the World Allergy Organiza - tion (WAO) on the basis of relevant research.13 However, a later  study on AR using extracts of HDMs demonstrated that there  was no consensus on fundamental therapy parameters.14 In evidence-based medicine (EBM), data obtained from me - ta-analyses and randomized controlled trials (RCTs) are the  most convincing regarding the efficacy of an intervention.15,16 Efficacy of Sublingual Immunotherapy for House Dust Mite- Induced Allergic Rhinitis: A Meta-Analysis of Randomized  Controlled Trials Bohai Feng, Haijie Xiang, Haiyong Jin, Jinjian Gao, Saiyu Huang, Yunbin Shi, Ruru Chen, Bobei Chen* Department of Otolaryngology, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
2017 May;9(3):220-228. https://doi.org/10.4168/aair.2017.9.3.220 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 AAIR http://e-aair.org   221Both Cochrane’s studies and reported meta-analyses17-19 con - firmed the effectiveness of AR-related immunotherapy.,OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 Volume 9, Number 3, May 2017 222  http://e-aair.orgstudy drug or placebo administration ranged from 6 to 36  months.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 AAIR http://e-aair.org   223Medication scores The type of rescue medication varied across the included  studies: systemic antihistamines (available in all studies), nap - hazoline nitrate as a decongestant, topical antihistamines, topi - cal nasal corticosteroids, and systemic corticosteroids.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 Volume 9, Number 3, May 2017 224  http://e-aair.orgFig.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 AAIR http://e-aair.org   225in the present analysis: lack of effectiveness due to low dosage,  poor compliance of children, and the small numbers of pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 Volume 9, Number 3, May 2017 226  http://e-aair.orgin terms of symptom scores.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 AAIR http://e-aair.org   22714.,Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"2017 May;9(3):220-228.  https://doi.org/10.4168/aair.2017.9.3.220 Volume 9, Number 3, May 2017 228  http://e-aair.org45.",Non-OADS,/arxiv_data1/oa_pdf/48/13/aair-9-220.PMC5352573.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   229INTRODUCTION In high ventilation sports defined as “sustained periods of  high aerobic and ventilatory demand, ”1 the prevalence of air - way hyperresponsiveness (AHR), exercise-induced broncho - constriction (EIB), and exercise-induced asthma (EIA) exceeds  recreationally active populations.2 Airway dysfunction is also  the most common reported symptom in summer sport athletes  (8%), and prevalent in high ventilation sports of triathlon (25%),  cycling, and swimming (17%).2 However, the majority of cases  identified as AHR are EIB-related,3 implicating exercise in the  etiology of AHR.4 Bronchiole challenge tests used to determine EIB involve eu - capnic voluntary hyperpnea (EVH) developed by5 and evaluat - ed against other provocation tests.6 As described by Rundell et  al.3 and Anderson et al .,7 the EVH test replicates the heavy ven - tilation of a maximal exercise test6 or a race pace field test.8 The  International Olympic Committee (IOC)-Medical Commission  has designated the EVH test as the ‘gold standard’ for EIB iden - tification in athletes3,9 and has been shown to be an effective  airway challenge in well trained,10,11 elite athletes12 as well as  high ventilation sports.1 However, questions regarding the best method as well as sensitivity and specificity to determine EIB  are still ongoing.3 Regarding sensitivity, the initial work found a decrease in  FEV1 of 5% to 10% to be suggestive of AHR and a decrease of  >10% FEV1 to be diagnostic.6 Currently, a ≥10% FEV1 de - crease at 2 consecutive time points post-EVH is the most ac - cepted threshold for EIB determination.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"Michael D. Kennedy,1* Craig D. Steinback,1 Rachel Skow,1 Eric C. Parent2 1Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, Canada 2Department of Physical Therapy, University of Alberta, Edmonton, Alberta, Canada This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
2017 May;9(3):229-236. https://doi.org/10.4168/aair.2017.9.3.229 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 Volume 9, Number 3, May 2017 230  http://e-aair.orgthe minute by minute in-test performance.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 AAIR http://e-aair.org   231sufficient to use in research and those exceeding 0.90 adequate  for use in individuals.18 All statistical analysis were performed  using SPSS version 21.,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 Volume 9, Number 3, May 2017 232  http://e-aair.orgDISCUSSION EVH test performance The EVH test has been shown to be an efficacious broncho - provocation test for screening and diagnosis of AHR in high  ventilation varsity athletes1 as well as elite swimmers.12 Since  the original publications regarding EVH, the description of the  protocol has remained largely the same, and the majority of re - search evaluating the efficacy of the EVH test has focused on  sensitivity/specificity and reliability of pre- and post  -test spi - rometry.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 AAIR http://e-aair.org   233and had had many workouts and competitions which met the  ventilation requirements of the EVH test.,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 Volume 9, Number 3, May 2017 234  http://e-aair.orggraphic backgrounds) also had a wide range of performance  relative to their target ventilations, with a mean greater than  100% of target (mean of target, 106.9% ±13.9%; range, 81%- 131%) for the EVH test.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 AAIR http://e-aair.org   235dicating that from a diagnostic standpoint the reliable thresh - old for reproducibility of EIB in athletes may be 20% or greater.,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"2017 May;9(3):229-236.  https://doi.org/10.4168/aair.2017.9.3.229 Volume 9, Number 3, May 2017 236  http://e-aair.orgenough?",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/aair-9-229.PMC5352574.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   237INTRODUCTION Allergic rhinitis (AR) affects 1 billion people worldwide, with a  15%-20% prevalence that is increasing rapidly.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"IL-9, together with IL-4,  IL-5, and IL-13, is a cytokine of the type 2 immune response  that induces allergic inflammation.13 IL-9 plays multiple roles,  acting as a growth factor for T cells, enhancing immunoglobu - lin E (IgE) production, inducing mucus production by epitheli - al cells, and promoting tissue mast cell accumulation.14,15 In a  mouse model of asthma, administration of anti-IL-9 antibody  reduced allergic pathologies.16 In human studies, anti-IL-9 Anti-Interleukin-9 Antibody Increases the Effect of Allergen- Specific Immunotherapy in Murine Allergic Rhinitis Ji-Hyeon Shin, Do Hyun Kim, Boo-Young Kim, Sung Won Kim, Se Hwan Hwang, Joohyung Lee, Soo Whan Kim* Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
2017 May;9(3):237-246. https://doi.org/10.4168/aair.2017.9.3.237 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 Volume 9, Number 3, May 2017 238  http://e-aair.orgmonoclonal antibody in adults with mild to moderate asthma  showed acceptable safety profiles and promising clinical activi - ties, although it showed no improvement in symptoms in  adults with uncontrolled asthma.17,18 Based on these reports, we  hypothesized that anti-IL-9 antibody could be considered an  adjuvant in allergen immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 AAIR http://e-aair.org   239sequences were as follows: interferon (IFN)- γ forward primer,  5´-AGAGCCAGATTATCTCTTTCTACCTCAG-3´ and IFN- γ re- verse primer, 5´-CCTTTTTCGCCTTGCTGTTG-3´; T-bet for - ward primer, 5´-GCCAGGGAACCGCTTATA-3´ and T-bet re - verse primer, 5´-CCTTGTTGTTGGTGAGCTTTA-3´; IL-4 for - ward primer, 5´-TCAACCCCCAGCTAGTTGTC-3´ and IL-4 re - verse primer, 5´-AAATATGCGAAGCACCTTGG-3´; GATA3 for - ward primer, 5´-CTGGATGGCGGCAAAGC-3´ and GATA3 re - verse primer, 5´-GTGGGCGGGAAGGTGAA-3´; IL-17 forward  primer, 5´-TCCAGAAGGCCCTCAGACTA-3´ and IL-17 reverse  primer, 5´-AGCATCTTCTCGACCCTGAA-3´; ROR- γt forward  primer, 5´-AGCATCTATAGCACTGACGG-3´ and ROR- γt reverse  primer, 5´-CAGAAACTGGGAATGCAGTG-3´; PU.1 forward  primer, 5´-GCATCTGGTGGGTGGACAA-3´ and PU.1 reverse  primer, 5´-TCTTGCCGTAGTTGAG-3´; IL-10 forward primer,  5´-GCTCTTACTGACTGGCATGAG-3´ and IL-10 reverse primer,  5´-CGCAGCTCTAGGAGCATGTG-3´; TGF- β forward primer,  5´-CACCATCCATGACATGAACC-3´, and TGF- β reverse primer  5´-TCATGTTGGACAACTGCTCC-3´; Foxp3 forward primer,  5´-GAAAGCGGATACCAAATGA-3´ and Foxp3 reverse primer,  5´-CTGTGAGGACTACCGAGCC-3´; glyceraldehyde 3-phos - phate dehydrogenase (GAPDH) forward primer, 5´-GCACAGT - CAAGGCCGAGAAT-3´ and GAPDH reverse primer, 5´-  GCCTTCTCCATGGTGGTGAA-3´.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 Volume 9, Number 3, May 2017 240  http://e-aair.org Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 AAIR http://e-aair.org   241OT induction attenuates eosinophil infiltration in nasal mucosa  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 Volume 9, Number 3, May 2017 242  http://e-aair.orgtranscription factor for Th9 cells) and ROR- γt (a transcription  factor for Th17 cells).",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 AAIR http://e-aair.org   243significantly higher mRNA expression of Foxp3 ( P=0.015) and  IL-10 ( P=0.049) than the OT group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 Volume 9, Number 3, May 2017 244  http://e-aair.orging.30,31 In the present study, administration of anti-IL-9 anti - body reduced the sneezing response.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 AAIR http://e-aair.org   245ACKNOWLEDGMENTS The work was supported by the Alumni Association of the De - partment of Otolaryngology-Head and Neck Surgery, College  of Medicine, The Catholic University of Korea, and Basic Sci - ence Research Program through the National Research Foun - dation of Korea (NRF) funded by the Ministry of Education, Sci - ence, and Technology (2011-0026915).",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"2017 May;9(3):237-246.  https://doi.org/10.4168/aair.2017.9.3.237 Volume 9, Number 3, May 2017 246  http://e-aair.orgA and TGF-beta promote T(H)9 cell-mediated pulmonary allergic  pathology.",Non-OADS,/arxiv_data1/oa_pdf/7e/5d/aair-9-237.PMC5352575.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   247INTRODUCTION Asthma is a chronic respiratory disease mediated by a wide  range of environmental and genetic factors.1 It is characterized  by coughing, wheezing, bronchoconstriction, airway hyperre - sponsiveness, or airway remodelling.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"Due to its multifactorial  nature, several studies have attempted to elucidate the genetic  background of asthma pathogenesis.2-6 The Hippo pathway is highly conserved from Drosophila me - lanogaster  to mammals and regulates organ size through pro - moting apoptosis and inhibiting cell proliferation in the embry - onic stages of development.7 It is still not exactly known how  the pathway is regulated by organ size; however, it has been  proposed that FRMD6 (also known as Willin) influences the ac -tivity of the Hippo pathway by turning on the central kinase  cascade.8 The members of this signaling cascade, MST1/2 and  LATS1/2 with scaffold proteins SAV1 and MOB1, respectively,  phosphorylate one another to inhibit YAP1/TAZ, the main ef - fectors of the pathway.9 YAP1 and TAZ are transcriptional co - activators that bind to transcription factors, when active, such Investigation of the Possible Role of the Hippo/YAP1 Pathway in  Asthma and Allergy Lili E. Fodor,1 András Gézsi,1 Ildikó Ungvári,1 Ágnes F. Semsei,1 Zsófia Gál,1 Adrienne Nagy,2 Gabriella Gálffy,3 Lilla Tamási,3  András Kiss,2 Péter Antal,4 Csaba Szalai1,2* 1Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary 2Heim, Pal Children Hospital, Budapest, Hungary 3Department of Pulmonology, Semmelweis University, Budapest, Hungary 4Department of Measurement and Information Systems, University of Technology and Economics, Budapest, Hungary This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
2017 May;9(3):247-256. https://doi.org/10.4168/aair.2017.9.3.247 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 Volume 9, Number 3, May 2017 248  http://e-aair.orgas TEAD, SMAD, or TP73, to regulate the expression of anti- apoptotic ( e.g., BIRC5 ), or apoptotic genes.10-12 Recently, it has  been shown that YAP1  is also widely expressed in respiratory  epithelial cells of the embryonic and mature lung and that Hip - po/YAP1 signalling regulates epithelial cell proliferation and  differentiation, and play an important role in embryonic lung  maturation and postnatal airway homeostasis.13 Furthermore,  in mice it has been demonstrated that YAP  is dynamically regu - lated during regeneration of the airway epithelium following  lung injury, suggesting a possible role of Hippo/YAP1 signaling  in the pathogenesis of acute and chronic lung diseases.14 Previously, it has been found that genetic variations in  FRMD6, an upstream activator of the Hippo pathway, were as - sociated with asthma.15 Furthermore, genetic variations in the  BIRC5  gene (also known as survivin), which is one of the target  genes of YAP1 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 AAIR http://e-aair.org   249(PDD-301/S; Piston Inc., Budapest, Hungary) and were as - sessed for fractional exhaled nitric oxide (FENO) levels (NIOX  MINO; Aerocrine, Solna, Sweden).",OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 Volume 9, Number 3, May 2017 250  http://e-aair.orgipating in the gene association study are presented in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 AAIR http://e-aair.org   251visualized on a standard X-ray film (Kodak, Rochester, NY, USA).",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
Allele frequencies between the groups of case and con - trol subjects were estimated by allele counting and tested for  deviation from Hardy-Weinberg equilibrium (HWE) by the  software program DeFinetti (https://ihg.gsf.de/cgi-bin/hw/ hwa1.pl).,OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
Odds ratios (ORs) for haplotypes were counted by  VassarStats software (http://vassarstats.net/index.html).,OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 Volume 9, Number 3, May 2017 252  http://e-aair.orgThe statistically significant genotyping results are summarized  in Table 4.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 AAIR http://e-aair.org   253variables were calculated by BN-BMLA.,OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 Volume 9, Number 3, May 2017 254  http://e-aair.orges remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 AAIR http://e-aair.org   255pendently from one another and that the studied population  was too small to detect such interactions.,OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"2017 May;9(3):247-256.  https://doi.org/10.4168/aair.2017.9.3.247 Volume 9, Number 3, May 2017 256  http://e-aair.orgaggregation, multiple targets, redundancy and interaction.",OADS,/arxiv_data1/oa_pdf/ba/52/aair-9-247.PMC5352576.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   257INTRODUCTION The human respiratory tract is constantly exposed to harmful  microbes and air pollutants.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"Inflam - mation is a fundamental innate immune response to environ - mental factors, including air pollutants.3 Accumulating evi - dence indicates that the inflammasome plays a key role in the  pathogenesis of acute and chronic respiratory diseases.1 The in - flammasome also plays a role in chronic inflammation of the  airways of patients with asthma and chronic obstructive pul - monary disease as well as in the initiation and progression of the inflammatory process in pulmonary fibrosis.4 The inflam - masome is a multiprotein complex that regulates inflammation  by activating specific proinflammatory cytokines, resulting in  an effective host immune response.5 The innate immune sys - tem is the first line of host defense, in which the inflammasome  is essential for maintaining a delicate balance between pro-  and anti-inflammatory signals to generate an appropriate im - mune response without harming the host.5 Activation of the  multiprotein complex inflammasome by danger signals plays  diverse and sometimes conflicting suppressive or stimulatory  roles in cancer development and progression, with marked Effect of TiO 2 Nanoparticles on Inflammasome-Mediated Airway  Inflammation and Responsiveness Byeong-Gon Kim,1 Pureun-Haneul Lee,1 Sun-Hye Lee,1 Moo-Kyun Park,2 An-Soo Jang1* 1Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 2Department of Otolayngology, Seoul National Uiversity, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
2017 May;9(3):257-264. https://doi.org/10.4168/aair.2017.9.3.257 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 Volume 9, Number 3, May 2017 258  http://e-aair.orgcontext-dependency.3 The inflammasome is a major regulator  of inflammation through its activation of pro-caspase-1, which  cleaves pro-interleukin-1 β (pro-IL-1 β) into its mature form.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 AAIR http://e-aair.org   259sulfonyl fluoride (PMSF) in distilled water, centrifuged at 14,000  rpm at 4°C for 30 minutes, and the soluble material collected.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 Volume 9, Number 3, May 2017 260  http://e-aair.orgvated caspase-1 expression in the lungs was increased in TiO 2  NP-treated mice compared with saline-treated mice (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 AAIR http://e-aair.org   261nate immune cells include dendritic cells, innate lymphoid  cells, and leukocytes, such as macrophages, neutrophils, and  eosinophils.20,21 Activation of the multiprotein inflammasome  by NPs plays diverse and conflicting, suppressive and stimula -tory roles in the development, progression, and exacerbation of  respiratory disease.22 Patients with neutrophilic asthma have  augmented expression of key inflammasome components and  increased release of IL-1 β.23 In human airways, a functional  Fig.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 Volume 9, Number 3, May 2017 262  http://e-aair.orgNLRP3 inflammasome has been identified in airway epithelial  cells,24 and peripheral blood neutrophils express all compo - nents of the NLRP3 inflammasome, as well as IL-1 β.25 The  NLRP3 inflammasome is a major component of the innate im - mune system, but its mechanism of activation by a wide range  of molecules remains largely unknown.",OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 AAIR http://e-aair.org   263NLRP3 and to induce caspase-1 activation and asthma (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"2017 May;9(3):257-264.  https://doi.org/10.4168/aair.2017.9.3.257 Volume 9, Number 3, May 2017 264  http://e-aair.orglogic research.",Non-OADS,/arxiv_data1/oa_pdf/9b/b7/aair-9-257.PMC5352577.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   265Allergic rhinitis (AR) is one of the most common chronic allergic respira - tory diseases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
"The purpose of the study was to evaluate whether existing  guidelines are sufficient for AR patient management in real practice and whether development of regional guidelines to reflect regional dif -Unmet Primary Physicians’ Needs for Allergic Rhinitis Care in  Korea Hyeon-Jong Yang,1,2 Young Hyo Kim,3 Bora Lee,4 Do Youn Kong,5 Dong-Kyu Kim,6 Mi-Ae Kim,7 Bong-Seong Kim,8   Won-young Kim,9 Jeong Hee Kim,10 Yang Park,11 So Yeon Park,12 Woo Yong Bae,13 Keejae Song,14 Min Suk Yang,15   Sang Min Lee,16 Young-Mok Lee,17 Hyun Jong Lee,18 Jae-Hong Cho,19 Hye Mi Jee,20 Jeong-Hee Choi,21* Young Yoo,22,23*  Young-Il Koh,24 and Work Group for Rhinitis, the Korean Academy of Asthma, Allergy and Clinical Immunology 1Department of Pediatrics, Pediatric Allergy and Respiratory Center, Soonchunhyang University College of Medicine, Seoul, Korea 2SCH Biomedical Informatics Research Unit, Soonchunhyang University Hospital, Seoul, Korea 3Department of Otorhinolaryngology, Inha University College of Medicine, Incheon, Korea 4Department of Biostatistic Consulting, Clinical Trial Center, Soonchunhyang Medical Center, Bucheon, Korea 5MBL Children’s Hospital, Daejeon, Korea 6 Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University Chuncheon Sacred Heart Hospital and Nano-Bio Regenerative Medical  Institute, Hallym University College of Medicine, Chuncheon, Korea 7Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea 8Department of Pediatrics, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea 9Wooridul Private Internal Clinic, Gwangju, Korea 10Department of Pediatrics, Inha University Hospital, Inha University College of Medicine, Incheon, Korea 11Department of Pediatrics, Wonkwang University Sanbon Hospital, Wonkwang University College of Medicine, Gunpo, Korea 12A & A Clinic, Seongnam, Korea 13Department of Otorhinolaryngology, Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea 14Department of Otorhinolaryngology-Head & Neck Surgery, Catholic Kwandong Universtiy, International St. Mary’s Hospital, Incheon, Korea 15Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea 16Division of Pulmonology and Allergy, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea 17GF Internal Medicine Allergy Clinic, Seoul, Korea 18Lee & Hong ENT, Sleep and Cosmetic Center, Seongnam, Korea 19Cho & Park ENT Clinics, Suwon, Korea 20Derpartment of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea 21Department of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea 22Department of Pediatrics, Korea University Anam Hospital, Seoul, Korea 23Allergy Immunology Center, Korea University, Seoul, Korea 24Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
2017 May;9(3):265-271. https://doi.org/10.4168/aair.2017.9.3.265 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
"2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 Volume 9, Number 3, May 2017 266  http://e-aair.orgferences is needed in Korea.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 AAIR http://e-aair.org   267ers indicating neutral opinion and the percentage of agreement  was at least 4 times as large as that of disagreement; (2) polar - ized items were defined as >30% of responders indicating  agreement and also disagreement; and (3) neither consensus  nor controversy was defined as not included in the consensus  or the polarized items.,Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
"2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 Volume 9, Number 3, May 2017 268  http://e-aair.orgTable 1.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 AAIR http://e-aair.org   269Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
"2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 Volume 9, Number 3, May 2017 270  http://e-aair.orgtreatment.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
2017 May;9(3):265-271.  https://doi.org/10.4168/aair.2017.9.3.265 AAIR http://e-aair.org   27113.,Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
Available  from: http://www.allergy.or.kr/public/November_1999.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/41/aair-9-265.PMC5352578.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease272  http://e-aair.orgINTRODUCTION Intralymphatic immunotherapy (ILIT) was introduced re - cently as a new modality of allergen-specific immunotherapy  (AIT); in this approach, only three intralymphatic injections in - duce marked clinical improvements as early as 4 months after  the day of the first injection, and last for 3 years.1-6 Moreover,  ILIT causes fewer and milder adverse reactions.",Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
"Subjects were regarded as being sensi -A Pilot Study of Intralymphatic Immunotherapy for House Dust  Mite, Cat, and Dog Allergies Sang Pyo Lee,1 Seung Joon Choi,2 Eugene Joe,3 Sang Min Lee,1* Min Woo Lee,4 Jung Woo Shim,1 Yu Jin Kim,1   Sun Young Kyung,1 Jeong-Woong Park,1 Sung Hwan Jeong,1 Joo Hyun Jung5 1Division of Pulmonology and Allergy, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea 2Department of Radiology, Gachon University Gil Medical Center, Incheon, Korea 3Department of Radiology, Seoul Medical Center, Seoul, Korea 4Gachon University Graduate School of Medicine, Incheon, Korea  5Department of Otolaryngology-Head and Neck Surgery, Gachon University Gil Medical Center, Incheon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
2017 May;9(3):272-277. https://doi.org/10.4168/aair.2017.9.3.272 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
"2017 May;9(3):272-277.  https://doi.org/10.4168/aair.2017.9.3.272 AAIR http://e-aair.org   273tized to an allergen if, according to the SPT, the allergen/hista - mine (A/H) ratio in the wheal was ≥1 and serum level of aller - gen-specific IgE was ≥0.35 kU/L.",Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
"2017 May;9(3):272-277.  https://doi.org/10.4168/aair.2017.9.3.272 Volume 9, Number 3, May 2017 274  http://e-aair.orgactions or moderate-to-severe systemic reactions of grade 2-3  in the Mueller classification (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
2017 May;9(3):272-277.  https://doi.org/10.4168/aair.2017.9.3.272 AAIR http://e-aair.org   275creased 1 year after ILIT ( P<0.05; Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
"2017 May;9(3):272-277.  https://doi.org/10.4168/aair.2017.9.3.272 Volume 9, Number 3, May 2017 276  http://e-aair.orglergen specific IgG4 to Dp was significantly increased 1 year af - ter ILIT compared with baseline ( P<0.05).",OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
2017 May;9(3):272-277.  https://doi.org/10.4168/aair.2017.9.3.272 AAIR http://e-aair.org   277Immunol 2016;116:168-70.,Non-OADS,/arxiv_data1/oa_pdf/d2/27/aair-9-272.PMC5352579.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease278  http://e-aair.orgINTRODUCTION Levodropropizine is commonly used as an antitussive drug  for acute and chronic cough.1 It is a non-opioid agent with pe - ripheral antitussive action via the modulation of sensory neu - ropeptide levels in the respiratory tract.2 Thus, levodropropi - zine has fewer sedative effects and a more tolerable profile than  opioid antitussives.",Non-OADS,/arxiv_data1/oa_pdf/62/0e/aair-9-278.PMC5352580.pdf
"Thus, we planned oral provocation tests (OPTs) to identify Levodropropizine-Induced Anaphylaxis: Case Series and Literature  Review Jae-Won Song,1 Young-Sook Jang,1 Moon-Chan Jung,1 Joo-Hee Kim,1* Jeong-Hee Choi,2 Sunghoon Park,1 Yong Il Hwang,1   Seung Hun Jang,1 Ki-Suck Jung1 1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang, Korea 2 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University  College of Medicine, Hwaseong, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/0e/aair-9-278.PMC5352580.pdf
2017 May;9(3):278-280. https://doi.org/10.4168/aair.2017.9.3.278 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/62/0e/aair-9-278.PMC5352580.pdf
"2017 May;9(3):278-280.  https://doi.org/10.4168/aair.2017.9.3.278 AAIR http://e-aair.org   279the culprit drugs in these 2 patients, and the results of OPTs us - ing the administered drugs (acetaminophen, pseudoephed - rine, and theobromine in patient 1; amoxicillin/clavulanic acid,  mosapride, and acetaminophen in patient 2) were negative.",Non-OADS,/arxiv_data1/oa_pdf/62/0e/aair-9-278.PMC5352580.pdf
"2017 May;9(3):278-280.  https://doi.org/10.4168/aair.2017.9.3.278 Volume 9, Number 3, May 2017 280  http://e-aair.orgcause it has fewer side effects than centrally acting opioid anti - tussives.",Non-OADS,/arxiv_data1/oa_pdf/62/0e/aair-9-278.PMC5352580.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   281INTRODUCTION Lichenoid drug eruption (LDE), also known as drug-induced  lichen planus, is an uncommon form of delayed-type drug  eruption, but well characterized both clinically and histopatho - logically.1-3 LDE has the clinical features of lichen planus, such  as widely distributed symmetric skin rashes with or without  Wickham striae, typical oral lesions, and similar histopatholog - ical findings (including epidermal parakeratosis and lympho - cyte infiltration into deeper layers of the dermis), but only LDE  shows an elevated eosinophil number.2 The pathogenesis of  LDE is type IV hypersensitivity, and CD8+ cytotoxic T cells may  secrete TNF- α-triggering keratinocyte apoptosis.4 A diagnosis of  LDE is made based on the presence of the suspected causative  agent, resolution of symptoms upon discontinuing the caus - ative agent, as well as on clinical and histopathological fea - tures.3 LDE accounts for 1% of all cases of drug eruption and is  caused by many agents, including gold, quinidine, hydrochlo - rothiazide, captopril, carbamazepine, and propranolol.2,5 LDE induced by anti-tuberculosis (anti-Tb) drugs has been  reported since Frentz et al .6 first reported ethambutol (EMB)- induced LDE in 1981.",Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
"The patient had low-grade fever (37°C-38°C) A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported  by the Lymphocyte Transformation Test Jakyoung Kim,1 Shinyoung Park,2 Chul Min Jung,3 Chee Won Oh,4 Jae-Woo Kwon3,5* 1Department of Pediatrics , Kangwon National University School of Medicine, Chuncheon, Korea 2The Research Department, Kangwon Regional Cancer Center, Kangwon National University Hospital, Chuncheon, Korea 3Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea 4Department of Dermatology, Kangwon National University School of Medicine, Chuncheon, Korea 5Department of Allergy and Clinical Immunology, Kangwon National University School of Medicine, Chuncheon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
2017 May;9(3):281-284. https://doi.org/10.4168/aair.2017.9.3.281 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
"2017 May;9(3):281-284.  https://doi.org/10.4168/aair.2017.9.3.281 Volume 9, Number 3, May 2017 282  http://e-aair.organd blood hypereosinophilia (20,640/μL).",Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
2017 May;9(3):281-284.  https://doi.org/10.4168/aair.2017.9.3.281 AAIR http://e-aair.org   283medications when the skin had returned to normal.,Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
"2017 May;9(3):281-284.  https://doi.org/10.4168/aair.2017.9.3.281 Volume 9, Number 3, May 2017 284  http://e-aair.orgdrugs showed blood eosinophilia and 2 showed Wickham stri - ae.13 LDE is typically resolved simply by cessation of the caus - ative drugs, and thus LDE should be considered when patients  receiving anti-Tb treatment present with blood eosinophilia  and typical hyperkeratotic skin lesions with scales.",Non-OADS,/arxiv_data1/oa_pdf/d9/d4/aair-9-281.PMC5352581.pdf
Crystal structure analysis using the PyMol Molecular Graphics System (http://www.pymol.org) suggested that the mutation altered the protein structure of the PIP3binding site (Figure 1c).,OADS,/arxiv_data1/oa_pdf/af/59/hgv20178.PMC5352671.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/af/59/hgv20178.PMC5352671.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Novel NR5A1 mutation in dizygotic twins A Hattori et al 4 Human Genome Variation (2017) 17008 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/af/59/hgv20178.PMC5352671.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/73/main.PMC5352713.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.051 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c2/73/main.PMC5352713.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/89/main.PMC5352716.pdf
A complete listing of ADNIinvestigators can be found at http://adni.loni.usc.edu/wp-content/uploads/ how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/09/89/main.PMC5352716.pdf
E-mail address: wl23@iu.edu http://dx.doi.org/10.1016/j.dadm.2017.01.008 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/89/main.PMC5352716.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/89/main.PMC5352716.pdf
Further infor-mation can be found at http://www.adni-info.org/ and in previous reports [8–13] .,OADS,/arxiv_data1/oa_pdf/09/89/main.PMC5352716.pdf
http://dx.doi.org/10.1016/j.gore.2017.02.011 2352-5789/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
http://dx.doi.org/10.1097/IGC.0000000000000084 .,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
http://asp.salud.gob.sv/ regulacion/pdf/lineamientos/lineamientos_prevencion_cancer_cervico_uterino_y_ de_mama_v3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/dc/74/main.PMC5352717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/e4/main.PMC5352718.pdf
E-mail address: E.Vijverberg@vumc.nl http://dx.doi.org/10.1016/j.dadm.2017.01.009 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/e4/main.PMC5352718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/e4/main.PMC5352718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/60/main.PMC5352719.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.006 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/60/main.PMC5352719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 1 e6,Non-OADS,/arxiv_data1/oa_pdf/ea/60/main.PMC5352719.pdf
"EDITORIAL Hip Pelvis 29(1): 1-14, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.1 Copyright ⓒ2017 by Korean Hip Society 1Print ISSN 2287-3260 Online ISSN 2287-3279 The Evolution of Computer-Assisted Total Hip Arthroplasty and Relevant Applications Jun-Dong Chang, MD, PhD, In-Sung Kim, MD, Atul M. Bhardwaj, MD, Ramachandra N. Badami, MD Arthroplasty Center, Department of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea In total hip arthroplasty (THA), the accurate positioning of implants is the key to achieve a good clinical outcome.",Non-OADS,/arxiv_data1/oa_pdf/75/67/hp-29-1.PMC5352720.pdf
"Key Words : Hip, Arthroplasty, Computer-assisted orthopaedic surgery, Navigation, Robot Submitted: January 30, 2017  1st revision: January 31, 2017 Final acceptance: February 9, 2017 Address reprint request toJun-Dong Chang, MD, PhDArthroplasty Center, Department of Orthopedic Surgery, HallymUniversity Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil,Hwaseong 18450, KoreaTEL: +82-31-8086-2411  FAX: +82-31-8086-2429 E-mail: jdchangos@gmail.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/67/hp-29-1.PMC5352720.pdf
"REVIEW ARTICLE Hip Pelvis 29(1): 15-23, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.15 Copyright ⓒ2017 by Korean Hip Society 15Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Hip arthroscopy was first described in 1931 by Burman1) who used it to view the inside of a joint in his cadaver studies; the first clinical description was made in 1939by Takagi 2).",Non-OADS,/arxiv_data1/oa_pdf/6b/71/hp-29-15.PMC5352721.pdf
"Key Words : Hip arthroscopy, Endoscopy, Advancement, Hip joint, Review Submitted: January 23, 2017  1st revision: February 1, 2017 Final acceptance: February 1, 2017 Address reprint request toDeuk-Soo Hwang, MD, PhDDepartment of Orthopaedic Surgery, Chungnam NationalUniversity School of Medicine, 282 Munwha-ro, Jung-gu, Daejeon35015, KoreaTEL: +82-42-338-2480  FAX: +82-42-338-2482 E-mail: dshwang@cnu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/71/hp-29-15.PMC5352721.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 24-29, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.24 Copyright ⓒ2017 by Korean Hip Society 24Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION As time goes by the revisional arthroplasty of hip is increased as the primary hip arthroplasty is increased.The most common reason for revisional arthroplasty isosteolysis and loosening of implant and it is more commonin acetabular component problem than femoral component 1).",Non-OADS,/arxiv_data1/oa_pdf/be/3c/hp-29-24.PMC5352722.pdf
"Key Words : Revisional arthroplasty, Jumbo cup, Peripheral rim fixation, Cementless Submitted: October 14, 2016  1st revision: November 21, 2016 2nd revision: December 13, 2016  Final acceptance: December 20, 2016 Address reprint request toYoung-Wook Lim, MDDepartment of Orthopaedic Surgery, The Catholic University ofKorea, Seoul St. Mary’s Hospital, 222, Banpo-daero, Seocho-gu,Seoul, KoreaTEL: +82-2-2258-2838  FAX: +82-2-535-9834 E-mail: albire00@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/3c/hp-29-24.PMC5352722.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 30-34, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.30 Copyright ⓒ2017 by Korean Hip Society 30Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Periprosthetic joint infection (PJI) is one of the most serious complications that could arise after total hiparthroplasty (THA) 1,2).",Non-OADS,/arxiv_data1/oa_pdf/5e/25/hp-29-30.PMC5352723.pdf
"Key Words : Urinary tract infections, Arthroplasty, Replacement, Hip, Periprosthetic joint infection Submitted: November 23, 2016  1st revision: January 4, 2017 Final acceptance: January 23, 2017 Address reprint request toKyung-Hoi Koo, MDDepartment of Orthopedic Surgery, Seoul National UniversityBundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu,Seongnam 13620, KoreaTEL: +82-31-787-7194  FAX: +82-31-787-4095 E-mail: khkoo@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/hp-29-30.PMC5352723.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 35-43, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.35 Copyright ⓒ2017 by Korean Hip Society 35Print ISSN 2287-3260 Online ISSN 2287-3279 Acute Delayed or Late Infection of Revision Total Hip Arthroplasty Treated with Debridement/Antibiotic-loaded Cement Beads and Retention of the Prosthesis  Jun-Dong Chang, MD, PhD, In-Sung Kim, MD, Sang-Soo Lee, MD, PhD*, Je-Hyun Yoo, MD, PhD�� Department of Orthopedic Surgery, Dongtan Sacred Heart Hospital, Hwaseong, Chuncheon Sacred Heart Hospital, Chuncheon*, Hallym University Sacred Heart Hospital, Anyang��, Hallym University School of Medicine, Korea Purpose : The treatment of infected revision total hip arthroplasty (THA) is very challenging due to retained revision prosthesis, poor bone stock and soft tissue condition derived from previous revision surgeries, andcomorbidities.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/hp-29-35.PMC5352724.pdf
"Key Words : Debridement, Retention of the prosthesis, Antibiotic-loaded cement bead, Acute infection, Revision, Total hip arthroplasty Submitted: November 14, 2016  1st revision: January 30, 2017 Final acceptance: February 1, 2017 Address reprint request toJe-Hyun Yoo, MD, PhDDepartment of Orthopaedic Surgery, Hallym University SacredHeart Hospital, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu,Anyang 14068, KoreaTEL: +82-31-380-3770  FAX: +82-31-382-1814 E-mail: oships@hallym.ac.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/hp-29-35.PMC5352724.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 44-53, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.44 Copyright ⓒ2017 by Korean Hip Society 44Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION The incidence of femoral intertrochanteric fractures, in particular unstable comminuted fractures, is graduallyincreasing with the recent growth of the elderly population.Patients with this fracture have high rates of complicationsand mortality due to their higher mean age and a largenumber of underlying diseases.",Non-OADS,/arxiv_data1/oa_pdf/9e/24/hp-29-44.PMC5352725.pdf
"Key Words : Hip fractures, Hemiarthroplasty, Bone wires, Fracture fixation Submitted: July 25, 2016  1st revision: October 27, 2016 2nd revision: December 7, 2016  Final acceptance: December 19, 2016 Address reprint request toJoong-Myung Lee, MD, PhDDepartment of Orthopaedic Surgery, CHA Bundang MedialCenter, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam,Gyeonggido 13496, KoreaTEL: +82-31-780-5289  FAX: +82-31-708-3578 E-mail: drjmlee@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/24/hp-29-44.PMC5352725.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 54-61, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.54 Copyright ⓒ2017 by Korean Hip Society 54Print ISSN 2287-3260 Online ISSN 2287-3279 The Results of Proximal Femoral Nail for Intertrochanteric Fracture in Hemodialysis Patient Kyung Sub Song, MD, Sang Phil Yoon, MD, Su Keon Lee, MD, Seung Hwan Lee, MD, Bong Seok Yang, MD, Byeong Mun Park, MD, Ick Hwan Yang, MD*, Beom Seok Lee, MD, Ji Ung Yeom, MD Department of Orthopaedic Surgery, Gwangmyeong Sungae Hospital, Gwangmyeong, Korea Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea* Purpose : Hip fractures in hemodialysis patients are accompanied by high rates of complications and morbidities.",Non-OADS,/arxiv_data1/oa_pdf/d0/03/hp-29-54.PMC5352726.pdf
"Key Words : Renal dialysis, Femur, Intertrochanteric fracture, Proximal femoral nail, Internal fixation Submitted: July 14, 2016  1st revision: September 7, 2016 2nd revision: October 31, 2016  3rd revision: November 28, 2016 Final acceptance: November 29, 2016 Address reprint request toSang Phil Yoon, MDDepartment of Orthopaedic Surgery, Gwangmyeong SungaeHospital, 36 Digital-ro, Gwangmyeong 14241, KoreaTEL: +82-2-2680-7263  FAX: +82-2-2617-9039 E-mail: osdr99@daum.netThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/03/hp-29-54.PMC5352726.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 62-67, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.62 Copyright ⓒ2017 by Korean Hip Society 62Print ISSN 2287-3260 Online ISSN 2287-3279 The Fixation Method according to the Fracture Type of the Greater Trochanter in Unstable Intertrochanteric Fractures Undergoing Arthroplasty Doohoon Sun, MD, Byeong-Seop Park, MD, Gun-Il Jang, MD, Bongjoo Lee, MD Department of Orthopaedic Surgery, Daejeon Sun Hospital, Daejeon, Korea Purpose : We conducted a study on patients who underwent hip joint arthroplasty because of unstable femur intertrochanteric fractures with greater trochanter bony fragments.",Non-OADS,/arxiv_data1/oa_pdf/48/34/hp-29-62.PMC5352727.pdf
"Key Words : Intertrochanteric fracture, Hip joint arthroplasty, Greater trochanter reattatchment Submitted: July 15, 2016  1st revision: November 28, 2016 2nd revision: January 24, 2017  3rd revision: February 2, 2017 Final acceptance: February 2, 2017 Address reprint request toBongjoo Lee, MDDepartment of Orthopaedic Surgery, Daejeon Sun Hospital, 29Mokjung-ro, Jung-gu, Daejeon 34811, KoreaTEL: +82-42-220-8460  FAX: +82-42-220-8464 E-mail: bonjoolee@hanmail.netThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/34/hp-29-62.PMC5352727.pdf
"ORIGINAL ARTICLE Hip Pelvis 29(1): 68-76, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.68 Copyright ⓒ2017 by Korean Hip Society 68Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Although the intramedullary nailing of subtrochanteric fractures of the femur is the current treatment of choice,this technique is limited by technical difficulties,postoperative peritrochanteric pain, and limping due toinjury to the abductor muscles.",Non-OADS,/arxiv_data1/oa_pdf/78/3a/hp-29-68.PMC5352728.pdf
"Key Words : Biologic fixation, Subtrochanteric fracture, Locking compression plate Submitted: December 15, 2016  1st revision: February 2, 2017 Final acceptance: February 9, 2017 Address reprint request toNam Hoon Moon, MDDepartment of Orthopaedic Surgery, Biomedical ResearchInstitute, Pusan National University Hospital, 179 Gudeok-ro,Seo-gu, Busan 49241, KoreaTEL: +82-51-240-7248  FAX: +82-51-247-8395 E-mail: namhoonmoon@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/3a/hp-29-68.PMC5352728.pdf
"CASE REPORT Hip Pelvis 29(1): 77-80, 2017 http://dx.doi.org/10.5371/hp.2017.29.1.77 Copyright ⓒ2017 by Korean Hip Society 77Print ISSN 2287-3260 Online ISSN 2287-3279 Several adult femoral neck stress fracture cases have been reported.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/hp-29-77.PMC5352729.pdf
"Key Words : Femur neck, Stress fractures, Symptom Submitted: December 10, 2016  1st revision: January 31, 2017 2nd revision: February 3, 2017  Final acceptance: February 3, 2017 Address reprint request toKyung-Soon Park, MD, PhDDepartment of Orthopedic Surgery, Center for Joint Disease atChonnam National University Hwasun Hospital, 322 Seoyang-ro,Hwasun-eup, Hwasun 58128, KoreaTEL: +82-61-379-7677, 7676  FAX: +82-61-379-7681 E-mail: chiasma@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/1f/hp-29-77.PMC5352729.pdf
Legumes suffered from competition for soil S resulting in a decrease of 40% in their S content compared to the monocrop.Received: 21 November 2016 Revised: 27 January 2017 Accepted: 8 March 2017 Heliyon 3 (2017) e00261 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
"Moreover, the percentage of Article No~e00261 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
"Orus Laguerre et al., 1994 Article No~e00261 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
As our main purpose was to compare individual intercrop systems Article No~e00261 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
"Accordingly, in low N conditions, combininglegumes with rapeseed seems to be relevant for reducing the amount of N fertilizer Article No~e00261 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
Article No~e00261 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00261 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/94/main.PMC5352734.pdf
"We obtain five main results: 1) we provide a theoretical framework to explain the joint determination of human development and gender inequality; 2) we show how to use this framework to simulate the impact of exogenous shocks or policy changes; 3) we demonstrate that exogenous changeshave a direct and a multiplier effect on human development and gender inequality; 4) we find that the distribution of obesity between the female and male populations represents a useful proxy variable for measuring gender equality at the country level; 5) finally, we use these results to integrate and develop existing knowledge on the ‘ecological ’approach to the overweight and obesity pandemic.Received: 19 July 2016 Revised: 27 January 2017 Accepted: 8 March 2017 Heliyon 3 (2017) e00263 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
‘multiplier ’) effect on human development and gender Article No~e00263 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
"This function −plotted in the space ( HDI,GII) for ease of Article No~e00263 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Now the Article No~e00263 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
"Accessed: March 2, 2016 http://www.bbc.com/news/world- middle-east-35075702 .",Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
Article No~e00263 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00263 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/main.PMC5352805.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode BMJ Quality Improvement Reports 2017; 6:u220211.w7861corr1.,Non-OADS,/arxiv_data1/oa_pdf/7b/ba/bmjqir.u220211.w7861corr1.PMC5352835.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Edward Wolfgang Lee, MD, PhD,  Division of Interventional Radiology, Department of Radiology,  UCLA Medical Center, 757 Westwood Plaza, Suite 2125, Los  Angeles, CA 90095, United States.",Non-OADS,/arxiv_data1/oa_pdf/0e/93/WJG-23-1735.PMC5352913.pdf
"edwardlee@mednet.ucla.ed u Telephone:  +1-310-2678771 Fax:  +1-310-2673631 Received:  November 14, 2016 Peer-review started:  November 15, 2016 First decision:  January 10, 2017 Revised:  January 26, 2017 Accepted:  February 16, 2017REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1735 1735 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1735-1746  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/0e/93/WJG-23-1735.PMC5352913.pdf
"World  J Gastroenterol  2017; 23(10): 1735-1746  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i10/1735.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1735 INTRODUCTION The portal venous system is a unique circulatory  system which connects two systems of capillary  beds; one in the gastrointestinal tract and splenic  parenchyma, and the second in the hepatic sinusoids.",Non-OADS,/arxiv_data1/oa_pdf/0e/93/WJG-23-1735.PMC5352913.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/0e/93/WJG-23-1735.PMC5352913.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Lucia Pacifico, MD,  Policlinico Umberto  I Hospital, Sapienza University of Rome, Rome, Viale Regina  Elena, 324, 00161 Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/77/e6/WJG-23-1747.PMC5352914.pdf
"The identification of  contributors other than the classic  roles played by excess fat and insulin resistance may REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1747 1747 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1747-1757  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/77/e6/WJG-23-1747.PMC5352914.pdf
World J Gastroenterol  2017;  23(10): 1747-1757  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/77/e6/WJG-23-1747.PMC5352914.pdf
com/1007-9327/full/v23/i10/1747.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/e6/WJG-23-1747.PMC5352914.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/77/e6/WJG-23-1747.PMC5352914.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript  Correspondence to: Wei- Ming Kang, MD,  Department of  General Surgery, Peking Union Medical College Hospital,  Chinese Academy of Medical Science and Peking Union Medical  College, No.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-23-1758.PMC5352915.pdf
"kangweiming@163.co m Telephone:  +86-10-69152215 Fax:  +86-10-69152213 Received:  September 27, 2016 Peer-review started:  September 28, 2016 First decision:  October 10, 2016 Revised:  November 28, 2016 Accepted:  January 11, 2017 Article in press:  January 11, 2017 Published online: March 14, 2017MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1758 1758 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1758-1763  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-23-1758.PMC5352915.pdf
World J Gastroenterol  2017;  23(10): 1758-1763  Available from: U rL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-23-1758.PMC5352915.pdf
com/1007-9327/full/v23/i10/1758.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-23-1758.PMC5352915.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-23-1758.PMC5352915.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Fabio Marongiu, PhD,  Experimental Medicine Unit, Department of Biomedical Sciences, University  of Cagliari, Via Porcell 4, IV floor, 09124 Cagliari,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/4b/ed/WJG-23-1764.PMC5352916.pdf
"RESULTS Liver size and liver DNA content were largely recovered  10 d post-PH, as expected ( e.g., total DNA/liver/100 g  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1764 1764 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1764-1770  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Hyperplasia vs hypertrophy in tissue regeneration after  extensive liver resectionBasic Study Fabio Marongiu, Michela Marongiu, Antonella Contini, Monica Serra, Erika Cadoni, Riccardo Murgia, Ezio Laconi",Non-OADS,/arxiv_data1/oa_pdf/4b/ed/WJG-23-1764.PMC5352916.pdf
World J Gastroenterol  2017;  23(10): 1764-1770  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/4b/ed/WJG-23-1764.PMC5352916.pdf
com/1007-9327/full/v23/i10/1764.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/ed/WJG-23-1764.PMC5352916.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/4b/ed/WJG-23-1764.PMC5352916.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Bao-Chun Lu,  Department of Hepa - tobiliary Surgery, Shaoxing People’s Hospital, Shaoxing Hospital  of Zhejiang University, 568 North Zhongxing Road, Shaoxing  312000, Zhejiang Province, China.",Non-OADS,/arxiv_data1/oa_pdf/83/b5/WJG-23-1771.PMC5352917.pdf
"The survival  rates and tissue injuries in liver, lungs and kidney were  evaluated.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1771 1771 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1771-1779  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Catheterization of the gallbladder: A novel mouse model of  severe acute cholangitisBasic Study Jian-Hua Yu, Hai-Jun Tang, Wei-Guang Zhang, Zhi-Yang Zhu, Xin-Xian Ruan, Bao-Chun Lu",Non-OADS,/arxiv_data1/oa_pdf/83/b5/WJG-23-1771.PMC5352917.pdf
World J Gastroenterol  2017;  23(10): 1771-1779  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/83/b5/WJG-23-1771.PMC5352917.pdf
com/1007-9327/full/v23/i10/1771.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/b5/WJG-23-1771.PMC5352917.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/83/b5/WJG-23-1771.PMC5352917.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Jun Zeng, PhD, College of Life Sciences,  Chongqing Normal University, 37 Daxuecheng Middle Road,  Chongqing 401331, China.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/WJG-23-1780.PMC5352918.pdf
"Key words:  Colorectal cancer; Interleukin-6; Invasion Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1780 1780 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1780-1786  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Clinicopathological significance of overexpression of  interleukin-6 in colorectal cancerBasic Study Jun Zeng, Zhong-Hua Tang, Shuang Liu, Shan-Shan Guo",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/WJG-23-1780.PMC5352918.pdf
World J  Gastroenterol  2017; 23(10): 1780-1786  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i10/1780.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1780 INTRODUCTION Colorectal cancer (CRC) is one of the most common  malignancies and the fourth leading cause of cancer- related death worldwide[1-3].,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/WJG-23-1780.PMC5352918.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/WJG-23-1780.PMC5352918.pdf
"Gene  ontology analysis suggested that the differenti ally  expressed genes were relevant to different biological Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1787 1787 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1787-1795  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Integrated analysis of microRNA and mRNA expression  profiles in HBx-expressing hepatic cellsBasic Study Ruo-Chan Chen, Juan Wang, Xu-Yuan Kuang, Fang Peng, Yong-Ming Fu, Yan Huang, Ning Li, Xue-Gong Fan",Non-OADS,/arxiv_data1/oa_pdf/65/41/WJG-23-1787.PMC5352919.pdf
wjgnet.com/1007-9327/full/v23/i10/1787.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/65/41/WJG-23-1787.PMC5352919.pdf
"GO annotations were downloaded from Gene Ontology  (http://www.geneontology.org/), UniProt (http://www.",OADS,/arxiv_data1/oa_pdf/65/41/WJG-23-1787.PMC5352919.pdf
"uniprot.org/), and NCBI (http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/65/41/WJG-23-1787.PMC5352919.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/65/41/WJG-23-1787.PMC5352919.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Ju-Feng Wang, Professor, Department  of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou  University, Henan Cancer Hospital, 127 Dongming Road,  Zhengzhou 450008, Henan Province ,  China.",Non-OADS,/arxiv_data1/oa_pdf/00/01/WJG-23-1796.PMC5352920.pdf
"The inhibition rate for the combination  reached its peak (51.33%) at 96 h. The early apoptotic  rates of the control, ECRG2 alone, DDP alone, and  ECRG2 plus DDP groups were 5.71% ± 0.27%,  12.68% ± 0.61%, 14.15% ± 0.87%, and 27.96% ± Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1796 1796 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1796-1803  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE ECRG2  enhances the anti-cancer effects of cisplatin in  cisplatin-resistant esophageal cancer cells via upregulation  of p53 and downregulation of PCNABasic Study Xin-Fang Hou, Lin-Ping Xu, Hai-Yan Song, Shuai Li, Chen Wu, Ju-Feng Wang",Non-OADS,/arxiv_data1/oa_pdf/00/01/WJG-23-1796.PMC5352920.pdf
World J Gastroenterol  2017;  23(10): 1796-1803  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/00/01/WJG-23-1796.PMC5352920.pdf
com/1007-9327/full/v23/i10/1796.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/01/WJG-23-1796.PMC5352920.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/00/01/WJG-23-1796.PMC5352920.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Duan-Yong Liu, Associate Professor,  Science and Technology College, Jiangxi University of Tradi­ tional Chinese Medicine, 819 Xingwan Road, Nanchang 330004,  Jiangxi Province, China.",Non-OADS,/arxiv_data1/oa_pdf/07/49/WJG-23-1804.PMC5352921.pdf
"liuduanyong@163.com  Telephone:  +86­791­83769126  Fax:  +86­791­83769126 Received:  October 22, 2016 Peer-review started:  October 25, 2016 First decision:  December 2, 2016 Revised:  December 25, 2016 Accepted:  January 17, 2017   Article in press:  January 17, 2017 Published online: March 14, 2017Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1804 1804 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1804-1815  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Therapeutic effect of curcumin on experimental colitis  mediated by inhibiting CD8+CD11c+ cellsBasic Study Hai-Mei Zhao, Fei Han, Rong Xu, Xiao-Ying Huang, Shao-Min Cheng, Min-Fang Huang, Hai-Yang Yue, Xin Wang,  Yong Zou, Han-Lin Xu, Duan-Yong Liu",Non-OADS,/arxiv_data1/oa_pdf/07/49/WJG-23-1804.PMC5352921.pdf
World J Gastroenterol  2017; 23(10):  1804 ­1815  Available from: URL: http://www.wjgnet.com/1007 ­9327/full/v23/i10/1804.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/49/WJG-23-1804.PMC5352921.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/07/49/WJG-23-1804.PMC5352921.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Peng-Fei Qiao,  Department of  General Surgery, the Second Affiliated Hospital of Harbin  Medical University, Harbin 150086, Heilongjiang Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/af/d0/WJG-23-1816.PMC5352922.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1816 1816 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1816-1827  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE miR-34a mediates oxaliplatin resistance of colorectal  cancer cells by inhibiting macroautophagy via transforming  growth factor- β/Smad4 pathwayBasic Study Chen Sun, Fu-Jing Wang, Hao-Gang Zhang, Xun-Zheng Xu, Rui-Chun Jia, Lei Yao, Peng-Fei Qiao",Non-OADS,/arxiv_data1/oa_pdf/af/d0/WJG-23-1816.PMC5352922.pdf
World J Gastroenterol  2017; 23(10): 1816-1827   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i10/1816.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/af/d0/WJG-23-1816.PMC5352922.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/af/d0/WJG-23-1816.PMC5352922.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ma-Mu-Ti-Jiang A Ba-Bai-Ke-Re, MD,  PhD, Chief Physician, Professor,  Department of Anorectal  Surgery, First Affiliated Hospital, Xinjiang Medical University,  1 Liyushan Road, Urumqi 830011, Xinjiang Uygur Autonomous  Region, China.",Non-OADS,/arxiv_data1/oa_pdf/41/03/WJG-23-1828.PMC5352923.pdf
"RESULTS There were no significant diff erences between the  experimental group and the control group in general  1828 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comORIGINAL ARTICLE Experimental porcine model of complex fistula-in-anoBasic Study Ma-Mu-Ti-Jiang A Ba-Bai-Ke-Re, Hui Chen, Xue Liu, Yun-Hai WangSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1828World J Gastroenterol   2017 March 14; 23(10): 1828-1835 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/41/03/WJG-23-1828.PMC5352923.pdf
World J  Gastroenterol  2017; 23(10): 1828-1835  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i10/1828.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1828 INTRODUCTION Fistula-in-ano is a common disorder in general surgery.,Non-OADS,/arxiv_data1/oa_pdf/41/03/WJG-23-1828.PMC5352923.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/41/03/WJG-23-1828.PMC5352923.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Lin Chen,  Department of General  Surgery, Chinese PLA General Hospital, Fuxing Road 28, Beijing  100853, China.",Non-OADS,/arxiv_data1/oa_pdf/db/19/WJG-23-1836.PMC5352924.pdf
"RESULTS Serum HER2 ECD was significantly correlated with  tissue HER 2 status ( P < 0.001), tumor size ( P <  0.001), and intes tinal type of gastric cancer ( P =  1836 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comORIGINAL ARTICLE Serum HER2 as a predictive biomarker for tissue HER2  status and prognosis in patients with gastric cancerRetrospective Cohort Study Hong-Zhi Shi, Yu-Ning Wang, Xiao-Hui Huang, Ke-Cheng Zhang, Hong-Qing Xi, Jian-Xin Cui, Guo-Xiao Liu,  Wen-Tao Liang, Bo Wei, Lin ChenSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1836World J Gastroenterol   2017 March 14; 23(10): 1836-1842 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/db/19/WJG-23-1836.PMC5352924.pdf
World J Gastroenterol  2017; 23(10): 1836-1842   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i10/1836.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/db/19/WJG-23-1836.PMC5352924.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/db/19/WJG-23-1836.PMC5352924.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Bo Jiang, professor,  Guangdong  Provincial key laboratory of Gastroenterology, Department  of Gastroenterology, Nanfang Hospital, Southern Medical  University, No.1838, Guangzhou North Ave, Guangzhou 510515,  Guangdong Province, China.",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/WJG-23-1843.PMC5352925.pdf
"Data  regarding age, gender, presenting symptoms, tumor Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1843 1843 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1843-1850  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Endoscopic submucosal tunnel dissection of upper  gastrointestinal submucosal tumors: A comparative  study of hook knife vs hybrid knifeRetrospective Cohort Study Jie-qiong Zhou, Xiao-Wei tang, Yu- tang Ren, Zheng-Jie Wei, Si- lin Huang, qiao-ping Gao, Xiao- feng Zhang,  Jian-feng Yang, Wei Gong, Bo Jiang",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/WJG-23-1843.PMC5352925.pdf
"World J  Gastroenterol  2017; 23(10): 1843-1850  Available from: URl:  http://www.wjgnet.com/1007-9327/full/v23/i10/1843.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1843 INTRODUCTION Although most submucosal tumors (SMTs) are  benign, some of them have malignant potential.",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/WJG-23-1843.PMC5352925.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/WJG-23-1843.PMC5352925.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Zhong-Min Wang, MD, Professor , Depa rtment of Intervention, Ruijin Hospital, Shanghai Jiao Tong  University School of Medicine, Shanghai 200025,  China.",Non-OADS,/arxiv_data1/oa_pdf/47/56/WJG-23-1851.PMC5352926.pdf
"Two patients with stent blockage at 35  d and 44 d after  procedure underwent percutaneous Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1851 1851 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1851-1856  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Percutaneous intraductal radiofrequency ablation for  treatment of biliary stent occlusion: A preliminary resultClinical Trials Study Ning Xia, Ju Gong, Jian Lu, Zhi-Jin Chen, Li-Yun Zhang, Zhong-Min Wang",Non-OADS,/arxiv_data1/oa_pdf/47/56/WJG-23-1851.PMC5352926.pdf
World J Gastroenterol  2017;  23(10): 1851-1856  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/47/56/WJG-23-1851.PMC5352926.pdf
com/1007-9327/full/v23/i10/1851.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/56/WJG-23-1851.PMC5352926.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/47/56/WJG-23-1851.PMC5352926.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript   Correspondence to: Amit K Mathur, MD, MS, Assistant  Professor,  Division of Transplant Surgery, Department of  Surgery, Mayo Clinic Arizona, 5777 East Mayo Boulevard,  Phoenix, AZ 85054,  United States.",Non-OADS,/arxiv_data1/oa_pdf/bb/66/WJG-23-1857.PMC5352927.pdf
"Hospital me an cirrhosis annual case volume was 90.4 Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1857 1857 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1857-1865  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Hospital resource intensity and cirrhosis mortality in United  StatesObservational Study Amit K Mathur, Apurba K Chakrabarti, Jessica L Mellinger, Michael L Volk, Ryan Day, Andrew L Singer,  Winston R Hewitt, Kunam S Reddy, Adyr A Moss",Non-OADS,/arxiv_data1/oa_pdf/bb/66/WJG-23-1857.PMC5352927.pdf
"World J  Gastroenterol  2017; 23(10): 1857-1865  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i10/1857.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1857 INTRODUCTION Cirrhosis is the final common pathway for chronic liver  disease, which predisposes patients to life-threatening  complications.",Non-OADS,/arxiv_data1/oa_pdf/bb/66/WJG-23-1857.PMC5352927.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/bb/66/WJG-23-1857.PMC5352927.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ugo Fedeli, MD,  Epidemiological  Department, Veneto Region, Passaggio Gaudenzio 1, 35131  Padova, Italy.",Non-OADS,/arxiv_data1/oa_pdf/6b/3c/WJG-23-1866.PMC5352928.pdf
"HCV-related mortality rates were higher Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1866 1866 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1866-1871  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Mortality associated with hepatitis C and hepatitis B virus  infection: A nationwide study on multiple causes of death  dataObservational Study Ugo Fedeli, Enrico Grande, Francesco Grippo, Luisa Frova",Non-OADS,/arxiv_data1/oa_pdf/6b/3c/WJG-23-1866.PMC5352928.pdf
World J Gastroenterol  2017;  23(10): 1866-1871  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/WJG-23-1866.PMC5352928.pdf
com/1007-9327/full/v23/i10/1866.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/WJG-23-1866.PMC5352928.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/6b/3c/WJG-23-1866.PMC5352928.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Omar Abdel-Rahman,  Clinical  Oncology Department, Faculty of Medicine, Ain Shams Univer - sity, Cairo 11511, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/29/ff/WJG-23-1872.PMC5352929.pdf
"omar.abdelrhman@med.asu.edu.e g Telephone:  +2-100-8541806 Fax:  +2-100-6858397 Received:  October 9, 2016 Peer-review started:  October 11, 2016 First decision:  December 19, 2016 Revised:  December 20, 2016 Accepted:  February 7, 2017 Article in press:  February 8, 2017 Published online: March 14, 2017 Abstract AIM To evaluate the prognostic value of site-specific  metastases among patients with metastatic pancreatic Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1872 1872 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1872-1880  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Prognostic value of site-specific metastases in pancreatic  adenocarcinoma: A Surveillance Epidemiology and End  Results database analysisObservational Study Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Meinrad Mannhart, Arianeb Mehrabi, Othmar Schöb,  Anwar Giryes, Michael Decker, Omar Abdel-Rahman",Non-OADS,/arxiv_data1/oa_pdf/29/ff/WJG-23-1872.PMC5352929.pdf
World J Gastroenterol  2017; 23(10): 1872-1880   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i10/1872.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/29/ff/WJG-23-1872.PMC5352929.pdf
"Available from: URL:  http://seer.cancer.gov/about 12 Ren Y , Dai C, Zheng H, Zhou F, She Y , Jiang G, Fei K, Yang P,  Xie D, Chen C. Prognostic effect of liver metastasis in lung cancer  patients with distant metastasis.",Non-OADS,/arxiv_data1/oa_pdf/29/ff/WJG-23-1872.PMC5352929.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/29/ff/WJG-23-1872.PMC5352929.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Shira Zelber-Sagi, RD, PhD, Liver  Unit, Department of Gastroenterology, Tel-Aviv Medical Center,  Tel-Aviv 6423906, Israe.",Non-OADS,/arxiv_data1/oa_pdf/f5/71/WJG-23-1881.PMC5352930.pdf
"METHODS A cross-sectional study among 146 ultrasound diagnosed Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1881 1881 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1881-1890  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Role of illness perception and self-efficacy in lifestyle  modification among non-alcoholic fatty liver disease patientsObservational Study Shira Zelber-Sagi, Shiran Bord, Gali Dror-Lavi, Matthew Lee Smith, Samuel D Towne Jr, Assaf Buch, Muriel Webb,  Hanny Yeshua, Assy Nimer, Oren Shibolet",Non-OADS,/arxiv_data1/oa_pdf/f5/71/WJG-23-1881.PMC5352930.pdf
World J Gastroenterol  2017;  23(10): 1881-1890  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f5/71/WJG-23-1881.PMC5352930.pdf
com/1007-9327/full/v23/i10/1881.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/71/WJG-23-1881.PMC5352930.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/f5/71/WJG-23-1881.PMC5352930.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1891 1891 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1891-1898  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Validation of the chinese version of the EORTC QLQ-CR29 in  patients with colorectal cancerObservational Study Jin-bo Lin, Lei Zhang, Dong-Wen Wu, Zhou-Huan xi, xue-Jun Wang, Yun-Shou Lin, Wakana Fujiwara,  Jing-Ru Tian, Min Wang, Peng Peng, Ai Guo, Zhen Yang, Le Luo, Ling-Ya Jiang, Qia-Qia Li, xue-Ying Zhang, Yun-Feng Zhang, Hou-Wei xu, bing Yang, xun-Lin Li, Yi-xiong Lei",Non-OADS,/arxiv_data1/oa_pdf/c6/6c/WJG-23-1891.PMC5352931.pdf
World J Gastroenterol  2017;  23(10): 1891-1898  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/c6/6c/WJG-23-1891.PMC5352931.pdf
com/1007-9327/full/v23/i10/1891.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/6c/WJG-23-1891.PMC5352931.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/c6/6c/WJG-23-1891.PMC5352931.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Natalie Ertz-Archambault, MD,  Department of Internal Medicine, Mayo School of Graduate  Medical Education, Mayo Clinic Arizona, 13400 E Shea Blv d,  Scottsdale, AZ 85259, United States.",Non-OADS,/arxiv_data1/oa_pdf/51/a3/WJG-23-1899.PMC5352932.pdf
"ertz.natalie@mayo.eduSYSTEMATIC REVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1899 1899 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1899-1908  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/51/a3/WJG-23-1899.PMC5352932.pdf
"World J Gastroenterol  2017; 23(10): 1899-1908  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i10/1899.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i10.1899 INTRODUCTION A commensal microbiome, by definition maintains a  symbiotic relationship in healthy individuals, offering  protection from disease by nutritive, inflammatory- modulating activity, hormonal homeostasis, detoxifi - cation, and metabolic effects of bacterial metabolites[1-3].",Non-OADS,/arxiv_data1/oa_pdf/51/a3/WJG-23-1899.PMC5352932.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/51/a3/WJG-23-1899.PMC5352932.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Giuseppe Grosso, MD, PhD,  Integrated  Cancer Registry of Catania-Messina-Siracusa-Enna, Azienda  Ospedaliero Universitaria Policlinico Vittorio Emanuele, 95123  Catania, Italy.",Non-OADS,/arxiv_data1/oa_pdf/8c/81/WJG-23-1909.PMC5352933.pdf
"Subgroup analyses  were also performed to test for potential source of  heterogeneity.META-ANALYSISSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1909 1909 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1909-1919  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8c/81/WJG-23-1909.PMC5352933.pdf
World J  Gastroenterol  2017; 23(10): 1909-1919  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i10/1909.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i10.1909 INTRODUCTION Colorectal cancer represents one of the most common cancers diagnosed in developed countries and the  fourth leading cause of cancer-related death globally.,Non-OADS,/arxiv_data1/oa_pdf/8c/81/WJG-23-1909.PMC5352933.pdf
"Available from: URL: https://www.mendeley.com/catalog/newcastleottawa-scale-nos-assessing-quality-nonrandomized- studies-metaanalyses/ 10 Kim S , Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC,  Satia JA, Halabi S, Sandler RS.",Non-OADS,/arxiv_data1/oa_pdf/8c/81/WJG-23-1909.PMC5352933.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/8c/81/WJG-23-1909.PMC5352933.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to: Hai-Tao Zheng, PhD,  Department of  Gastrointestinal and Thyroid Surgery, Yuhuangding Hospital  Affiliated to Qingdao University, No.",Non-OADS,/arxiv_data1/oa_pdf/07/f5/WJG-23-1920.PMC5352934.pdf
"We CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i10.1920 1920 March 14, 2017 |Volume 23 |Issue 10 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 March 14; 23(10): 1920-1924  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/07/f5/WJG-23-1920.PMC5352934.pdf
wjgnet.com/1007-9327/full/v23/i10/1920.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/f5/WJG-23-1920.PMC5352934.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451  0",Non-OADS,/arxiv_data1/oa_pdf/07/f5/WJG-23-1920.PMC5352934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/2a/main.PMC5352935.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.12.003 Introduction Sustained release intravitreal dexamethasone (DEX) implant, available as Ozurdex (Allergan, Inc, Irvine, CA), isapproved for the treatment of diabetic macular edema (DME) following a randomized, masked, sham-controlled phase III clinical trial that demonstrated its efficacy andsafety.",Non-OADS,/arxiv_data1/oa_pdf/b6/2a/main.PMC5352935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/b6/main.PMC5352936.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.12.002 Introduction Canaliculocele or canaliculops, first described by Fouad AR in 19721and studied by Sacks et al.",OADS,/arxiv_data1/oa_pdf/26/b6/main.PMC5352936.pdf
http://dx.doi.org/10.1097/IOP.0000000000000120 .,OADS,/arxiv_data1/oa_pdf/26/b6/main.PMC5352936.pdf
http://dx.doi.org/10.1016/j.ajo.2013.06.,OADS,/arxiv_data1/oa_pdf/26/b6/main.PMC5352936.pdf
"http://dx.doi.org/10.1016/j.sjopt.2013.11.003 , Epub 2013 Nov 13.",OADS,/arxiv_data1/oa_pdf/26/b6/main.PMC5352936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/91/main.PMC5352937.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.12.005 Introduction Fabry disease is a hereditary, X-linked disease caused by a deficiency in lysosomal hydrolase a-galactosidase A ( a-Gal A).",Non-OADS,/arxiv_data1/oa_pdf/b9/91/main.PMC5352937.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/f0/main.PMC5352938.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.12.004 Introduction Behçet’s disease (BD) is characterized by recurrent inflam- mation of the oral and genital mucosa, uveal tract, vascula-ture, skin, and central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/main.PMC5352938.pdf
http://dx.doi.org/10.1007/s10165-011-0497-5 .,Non-OADS,/arxiv_data1/oa_pdf/09/f0/main.PMC5352938.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/de/main.PMC5352940.pdf
http://dx.doi.org/10.1016/j.sjopt.2017.01.005 Introduction Paintball is a popular game played outdoors in an open field between two teams.,Non-OADS,/arxiv_data1/oa_pdf/1d/de/main.PMC5352940.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/c0/main.PMC5352941.pdf
"http://dx.doi.org/10.1016/j.sjopt.2017.01.002 Introduction Visual impairment in children has a broad negative impact on their quality of life and of course will affect their social and educational development.1 Keratoconus is a degenerative disorder characterized by ectasia and thinning of the axial or para-axial region of the cornea resulting in irregular astigmatism, myopia and scar- ring with mild to marked impairment in the quality of vision.2 Pediatric keratoconus displays a higher ratio of keratoconus eyes being about 88%.",Non-OADS,/arxiv_data1/oa_pdf/46/c0/main.PMC5352941.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/54/main.PMC5352942.pdf
"http://dx.doi.org/10.1016/j.sjopt.2017.01.003 Introduction The term Deep Anterior Lamellar Keratoplasty (DALK) indicates a corneal surgical transplantation technique in whichthe donor’s corneal button, deprived of the endothelium and the Descemet membrane (DM), is fixed above the host’s endothelium-Descemet complex.",Non-OADS,/arxiv_data1/oa_pdf/8a/54/main.PMC5352942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/92/main.PMC5352943.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.11.007 Introduction Republic of Yemen is located in the south west part of the Arab Peninsula with an area of 555,000 square kilometers.Yemen population is around 25.3 Million distributed in 21 governorates in addition to the capital city of Sana.",Non-OADS,/arxiv_data1/oa_pdf/ef/92/main.PMC5352943.pdf
< http://www.v2020.org/page.,Non-OADS,/arxiv_data1/oa_pdf/ef/92/main.PMC5352943.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/bf/main.PMC5352944.pdf
http://dx.doi.org/10.1016/j.sjopt.2017.01.001 Introduction Diabetes mellitus constitutes a major threat on health and economy worldwide.,Non-OADS,/arxiv_data1/oa_pdf/07/bf/main.PMC5352944.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/07/bf/main.PMC5352944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/72/main.PMC5352945.pdf
http://dx.doi.org/10.1016/j.sjopt.2017.01.004 Introduction The excimer laser refractive correction procedures may be performed by surface or stromal ablation techniques.,Non-OADS,/arxiv_data1/oa_pdf/dc/72/main.PMC5352945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/92/main.PMC5352946.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.12.001 Introduction Cataract is a principal cause of blindness in the world and occurs due to the clouding of the eye’s natural lens.,Non-OADS,/arxiv_data1/oa_pdf/35/92/main.PMC5352946.pdf
http://dx.doi.org/ 10.1371/journal.pone.0002867 .,Non-OADS,/arxiv_data1/oa_pdf/35/92/main.PMC5352946.pdf
"Although the same variant has never been reported previously or registered in the Database ofCollagen Mutations (http://www.le.ac.uk/genetics/collagen/), 9,10similar splicing donor site variants were frequently identi ﬁed in OI patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/bf/hgv20177.PMC5352948.pdf
( c) The IGV (http://www.broadinstitute.org/igv/) shows the identi ﬁedCOL1A1 variant in ~ 50% of the reads.,Non-OADS,/arxiv_data1/oa_pdf/cb/bf/hgv20177.PMC5352948.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/cb/bf/hgv20177.PMC5352948.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017A novel COL1A1 mutation in a family with OI T Seto et al 3 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2017) 17007",Non-OADS,/arxiv_data1/oa_pdf/cb/bf/hgv20177.PMC5352948.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/f9/main.PMC5352956.pdf
http://dx.doi.org/10.1016/j.sjopt.2016.08.001 Introduction Glaucoma is a neuro-degenerative disorder characterized by wide-spread loss of retinal ganglion cells (RGC).,Non-OADS,/arxiv_data1/oa_pdf/77/f9/main.PMC5352956.pdf
http://dx.doi.org/10.1038/cddis.2009.3 .,OADS,/arxiv_data1/oa_pdf/77/f9/main.PMC5352956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/02/main.PMC5352957.pdf
"http://dx.doi.org/10.1016/j.sjopt.2016.11.006 Introduction In many fields of ophthalmology, the examination of ante- rior segment structures and determining the accurate mea- surement of its indexes are fundamental.",Non-OADS,/arxiv_data1/oa_pdf/0c/02/main.PMC5352957.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Mr. Mohammad Irfan Azeem,  National  Centre for Immunisation Research and Surveillance of Vaccine  Preventable Diseases, Kids Research Institute, the Children’s  Hospital at Westmead, Cnr Hawkesbury Rd and Hainsworth St., Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.102World J Clin Cases   2017 March 16; 5(3): 102-111  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/e5/21/WJCC-5-102.PMC5352958.pdf
"World J Clin Cases  2017; 5(3): 102 ­111  Available from:  URL:  http://www.wjgnet.com/ 2307 ­8960 /full/v5/i3/102.htm   DOI: http://dx.doi.org/ 10.12998 /wjcc.v5.i3.102 INTRODUCTION Hajj is one of the world’s largest annual mass gat herings,  attracting approximately 2-3 million people each year  from around the globe.",Non-OADS,/arxiv_data1/oa_pdf/e5/21/WJCC-5-102.PMC5352958.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e5/21/WJCC-5-102.PMC5352958.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Alfredo De Giorgi, MD, Department of  Medical Sciences, Clinica Medica Unit, School of Medicine,  University of Ferrara, University Hospital of Ferrara, Via Aldo  Moro 8, 44121 Ferrara, Italy.",Non-OADS,/arxiv_data1/oa_pdf/2a/0f/WJCC-5-112.PMC5352959.pdf
Core tip: We report a case of Lemierre’s syndrome (LS)  complicated by pulmonary embolism (PE) that mimicked Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.112World J Clin Cases   2017 March 16; 5(3): 112-118  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/2a/0f/WJCC-5-112.PMC5352959.pdf
World J Clin Cases  2017; 5(3):  112-118  Available from: URL:  http://www.wjgnet.com/ 2307-8960 / full/v5/i3/112.htm  DOI: http://dx.doi.org/ 10.12998 /wjcc.v5.i3.112 INTRODUCTION Lemierre’s syndrome (LS) is an uncommon condition  characterized mainly by oropharyngeal infections com­ plicated with internal jugular vein (IJV) thrombosis and  subsequently metastatic infections secondary to septic  emboli.,Non-OADS,/arxiv_data1/oa_pdf/2a/0f/WJCC-5-112.PMC5352959.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2a/0f/WJCC-5-112.PMC5352959.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Eray Eroglu, MD, Department of Internal  Medicine, Erciyes University School of Medicine, Köşk, Talas Blv.,  38039 Kayseri, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/56/12/WJCC-5-119.PMC5352960.pdf
The clinically un icentric Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.119World J Clin Cases   2017 March 16; 5(3): 119-123  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/56/12/WJCC-5-119.PMC5352960.pdf
wjgnet.com/ 2307 ­8960 /full/v5/i3/119.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/12/WJCC-5-119.PMC5352960.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/56/12/WJCC-5-119.PMC5352960.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr .,Non-OADS,/arxiv_data1/oa_pdf/1c/6d/WJCC-5-124.PMC5352961.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.124World J Clin Cases   2017 March 16; 5(3): 124-127  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/1c/6d/WJCC-5-124.PMC5352961.pdf
"World J Clin Cases  2017; 5(3): 124-127   Available from: URL:  http://www.wjgnet.com/ 2307-8960 /full/ v5/i3/124.htm  DOI: http://dx.doi.org/ 10.12998 /wjcc.v5.i3.124 INTRODUCTION Surgeries in the first years of life for imperforate anus  can lead to lifelong problems with fecal incontinence (FI)  with a great impact on quality of life[1], largely due to  the neo-anus in relation to the anal sphincter position  and integrity.",Non-OADS,/arxiv_data1/oa_pdf/1c/6d/WJCC-5-124.PMC5352961.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1c/6d/WJCC-5-124.PMC5352961.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Fabio Guerriero, MD, PhD, Department  of Internal Medicine and Therapeutics, Section of Geriatrics,  University of Pavia, via Emilia 12, 27100 Pavia,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/76/3d/WJCC-5-73.PMC5352962.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.73World J Clin Cases   2017 March 16; 5(3): 73-81  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/76/3d/WJCC-5-73.PMC5352962.pdf
World J Clin Cases   2017; 5(3): 73 ­81  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/76/3d/WJCC-5-73.PMC5352962.pdf
"com/ 2307 ­8960 /full/v5/i3/73.htm  DOI: http://dx.doi.org/ 10.12998 / wjcc.v5.i3.73 INTRODUCTION Persistent pain and opioid use in geriatrics: The thin  line between love and hate Pain is an unpleasant sensory and affective experience,  that is the complex sum of injuries and sensory stimuli  mediated by individual emotions and expectations.",Non-OADS,/arxiv_data1/oa_pdf/76/3d/WJCC-5-73.PMC5352962.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/76/3d/WJCC-5-73.PMC5352962.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dennis A Bloomfield, MD, Director  of Research, Richmond University Medical Center, 355 Bard  Avenue, Staten Island, New York, NY 10310,  United States.",Non-OADS,/arxiv_data1/oa_pdf/ea/b4/WJCC-5-82.PMC5352963.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.82World J Clin Cases   2017 March 16; 5(3): 82-92  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/ea/b4/WJCC-5-82.PMC5352963.pdf
wjgnet.com/ 2307-8960 /full/v5/i3/82.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/b4/WJCC-5-82.PMC5352963.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ea/b4/WJCC-5-82.PMC5352963.pdf
"See: http://creativecommons.org/ licenses/by ­ nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Adrià Arboix, MD, PhD,  Department of  Neurology, Hospital Universitari del Sagrat Cor, Viladomat 288, E ­ 08029 Barcelona, Catalonia, Spain.",Non-OADS,/arxiv_data1/oa_pdf/a6/f4/WJCC-5-93.PMC5352964.pdf
World J Clin Cases  2017; 5(3): Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.12998/wjcc.v5.i3.93World J Clin Cases   2017 March 16; 5(3): 93-101  ISSN 2307-8960 (online)World Journal of Clinical Cases WJCC,Non-OADS,/arxiv_data1/oa_pdf/a6/f4/WJCC-5-93.PMC5352964.pdf
Bayés syndrome and acute stroke 93­101  Available from: URL:  http://www.wjgnet.com/ 2307 ­ 8960 / full/v5/i3/93.htm  DOI: http://dx.doi.org/ 10.12998 /wjcc.v5.i3.93 INTRODUCTION Bayés syndrome is an under-recognized cardiological  condition characterized by advanced interatrial block.,Non-OADS,/arxiv_data1/oa_pdf/a6/f4/WJCC-5-93.PMC5352964.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a6/f4/WJCC-5-93.PMC5352964.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/a3/bmjdrc-2016-000357.PMC5353251.pdf
"At the time when complementaryfeeding starts, 3-day food-intake recalls will be obtained from mothers and infants and evaluated by NUTRISURVEY (http://www.nutrisurvey.de).",Non-OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
"FLG gene mutation and FADS1, FADS2 and FADS3 gene polymorphism analysisDNA will be extracted from the buffy coat of the umbil- ical artery by the Puregene DNA isolation kit (Gentra Systems, http://www.gentra.com).",Non-OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
"PLAN OF DATA PROCESSING, ANALYSIS AND PRESENTATION All data processing will be performed with SAS 9.4 or R3.2.4 (http://www.r-project.org).",Non-OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
"Allele frequency, Hardy –Weinberg equilibrium (HWE), linkage disequilib- rium (LD) and further measures will be assessed withR-package Genetics (https://cran.r-project.org/web/ packages/genetics/).",Non-OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
Haplotype analysis will be performed to evaluate for association of the genetic pro ﬁle and more than one SNP at a time with AD (https://cran.r-project.org/web/ packages/haplo.stats/index.html).,Non-OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
http://dds.bps.go.id/eng/aboutus.php?sp=0 (accessed 4 Jul 2012).,OADS,/arxiv_data1/oa_pdf/2f/bf/bmjopen-2016-012475.PMC5353254.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014364).,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
"Madrid: WorldHealth Organization, 2001. http://www.euro.who.int/__data/assets/pdf_file/0008/76508/A75328.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
"Canberra: Australia Institute of Health & Welfare, 2013. http://www.health.gov.au/internet/main/publishing.nsf/Content/male-policy 7.",Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
"Luxembourg: European Commission, 2011. http://ec.europa.eu/health/population_groups/docs/men_health_extended_en.pdf 8 Teo CH, et al.BMJ Open 2017; 7:e014364.",Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
"World Health Organization, 2011. http://apps.who.int/gho/data/view.main.690?lang=en 12.",Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2015. http://www.cdc.gov/bloodpressure/facts.htm 13.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2012. https://www.diabetes.org.uk/Documents/Reports/ Diabetes-in-the-UK-2012.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2013. http://www.cdc.gov/nchs/ data/databriefs/db133.htm 19.,OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2013. http://www.cdc.gov/diabetes/statistics/ meduse/fig4.htm 20.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2016. http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b-recommendations/ 24.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2015. http://www.nih.gov/precision-medicine-initiative-cohort-program 26.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
"US Department of Labor, 2014. http://www.bls.gov/tus/#data 33.",OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2014. http://www.skmm.gov.my/skmmgovmy/media/General/pdf/Internet-Users-Survey-2014.pdf 53.,Non-OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
2010. http://www.census.gov/hhes/computer/publications/2010.html 54.,OADS,/arxiv_data1/oa_pdf/36/d1/bmjopen-2016-014364.PMC5353258.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013941).,Non-OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
"This study used secondary data obtained from the SouthAfrican Weather Service (SA WS) through the South African Air Quality Information System (SAAQIS) website (http://www.saaqis.org.za) after the approvalfor its use was granted by the data originators, Environmental Management Services Department.",OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
http://www.epa.gov/international/air/africa.htm 4.,Non-OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
http://www.who.int/phe/air_quality_q&a.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
http://www.statssa.gov.za/ (accessed 2 Sep 2015).39.,OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
http://www.epa.gov/epaoswer/hazwaste/combust/risk.htm 43.,OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
"Exposure factors Handbook , 1997. http://www.epa.gov/ncea/expofac.htm 44.",OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
"California Environmental Protection Agency, OEHHA, 2001. http://www.oehha.org/air/acute_rels/pdf/7446095A.pdf 45.",Non-OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
"Risk assessment guidance for superfund, Vol 1: human health evaluation manual (Part A), 1989. http://www.epa.gov/superfund/programs/risk/ragsa/ 46.",Non-OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
"http://www.sourceoecd.org Morakinyo OM, et al.BMJ Open 2017; 7:e013941.",OADS,/arxiv_data1/oa_pdf/d1/37/bmjopen-2016-013941.PMC5353259.pdf
http://www.malopolska.klrwp.pl/attachments/ article/502/PMR_SCORE.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/fb/4b/bmjopen-2016-014206.PMC5353260.pdf
https:// http://www.cadth.ca/rx-change.,Non-OADS,/arxiv_data1/oa_pdf/fb/4b/bmjopen-2016-014206.PMC5353260.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
http://www.rcseng.ac.uk/publications/docs/emergency-surgery-standards-for-unscheduled-care (accessed 3 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
http://www.asgbi.org.uk/en/publications/consensus_statements.cfm (accessed 3 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
http://www.drfoster.,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
10. http://www.hicic.gov.uk/hes (accessed 14 Oct 2015).11.,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
https://www.surgeons.org/ for-health-professionals/audits-and-surgical-research/anzasm/vasm/ (accessed 9 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
http://www.nela.org.uk/reports.htm (accessed 7 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
21. http://www.oecd.org/els/health-systems/health-expenditure.htm (accessed 7 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/0c/20/bmjopen-2016-014484.PMC5353261.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013511).,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
"All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_ disclosure.pdf and declare that all have no relationships with companies thatmight have an interest in the submitted work in the previous 3 years; their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and have no non-financial interests that may be relevant to the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
2009. http://www.ncepod.org.uk/2009report1/Downloads/AKI_report.,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
http://www.ncepod.org.uk/2009report1/Downloads/AKI_report.pdf: NCEPOD.,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
http://tinyurl.com/najylbl.,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?,Non-OADS,/arxiv_data1/oa_pdf/ab/15/bmjopen-2016-013511.PMC5353262.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013432).,Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
MRI data analysis sMRI data analysis Both the cortical reconstruction and morphologicalfeature extraction will be conducted using FreeSurfer software (http://surfer.nmr.mgh.harvard.edu/) with a standard cortical automatic handling protocol.,Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
FC ana- lysis will be performed using DPARSF software (http://www.restfmri.net/forum/DPARSF).,Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
"DTI data analysis DTI data processing will be performed using software from FMRIB Software Library (FSL, http:// http://www.fmrib.ox.ac.uk/fsl) 41.",Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
The target template will be the FMRIB58_FA (http://www.fmrib.ox.ac.uk/fsl/data/ FMRIB58_FA).,Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/c8/bmjopen-2016-013432.PMC5353263.pdf
4. http://icra-audiology.org/Repository/self-report-repository/IOI-HA% 20list-of-questionnaires.,Non-OADS,/arxiv_data1/oa_pdf/5a/49/bmjopen-2016-013784.PMC5353264.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013490).,Non-OADS,/arxiv_data1/oa_pdf/12/1e/bmjopen-2016-013490.PMC5353265.pdf
2003. http://casaa.unm.,Non-OADS,/arxiv_data1/oa_pdf/12/1e/bmjopen-2016-013490.PMC5353265.pdf
"Institute for Medical Technology Assessment, Erasmus University Rotterdam, 2010. http://www.bmg.eur.nl/fileadmin/ASSETS/bmg/english/iMTA/Publications/Manuals___Questionnaires/Manual_SF-HLQ_2010.pdf 17.",Non-OADS,/arxiv_data1/oa_pdf/48/df/bmjopen-2016-012187.PMC5353266.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012822).,Non-OADS,/arxiv_data1/oa_pdf/f6/cd/bmjopen-2016-012822.PMC5353267.pdf
"Population Ageing and Health in India, 2006. http://www.cehat.org/humanrights/rajan.pdf (accessed 17 Nov 2016).",Non-OADS,/arxiv_data1/oa_pdf/70/37/bmjopen-2016-013529.PMC5353268.pdf
"3, United Nations PopulationFund (UNFPA), 2014. http://www.isec.ac.in/BKPAI-WP-III.pdf(accessed 2 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/70/37/bmjopen-2016-013529.PMC5353268.pdf
http://apps.who.int/iris/bitstream/10665/ 94384/1/9789241506236_eng.pdf (accessed 24 Dec 2015).,OADS,/arxiv_data1/oa_pdf/70/37/bmjopen-2016-013529.PMC5353268.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013502).,Non-OADS,/arxiv_data1/oa_pdf/6a/dd/bmjopen-2016-013502.PMC5353271.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.6qk05.,OADS,/arxiv_data1/oa_pdf/6a/dd/bmjopen-2016-013502.PMC5353271.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/dd/bmjopen-2016-013502.PMC5353271.pdf
"Costing statement: Medicines optimisation —Implementing the NICE guideline on medicines information (NG5), 2015. https://www.nice.",Non-OADS,/arxiv_data1/oa_pdf/ca/47/bmjopen-2016-015281.PMC5353272.pdf
"Responsible Use of Medicines Report, 2012. http://www.imshealth.com/en/thought-leadership/ims-institute/reports/responsible-use-of-medicines-report 5.",Non-OADS,/arxiv_data1/oa_pdf/ca/47/bmjopen-2016-015281.PMC5353272.pdf
"Process evaluation of complex interventions: UK Medical Research Council (MRC) guidance, 2015.https://www.mrc.ac.uk/documents/pdf/mrc-phsrn-process-evaluation-guidance-final/ (accessed 4 Mar 2017).",Non-OADS,/arxiv_data1/oa_pdf/ca/47/bmjopen-2016-015281.PMC5353272.pdf
2015. http://apps.who.int/ iris/bitstream/10665/186463/1/9789240694811_eng.pdf (accessed12 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/55/51/bmjopen-2016-013922.PMC5353275.pdf
2015. http://www.ipss.go.jp/syoushika/tohkei/Popular/P_Detail2015.asp?fname=T02-18.htm (accessed 12Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/55/51/bmjopen-2016-013922.PMC5353275.pdf
2012. http://www.ipss.,Non-OADS,/arxiv_data1/oa_pdf/55/51/bmjopen-2016-013922.PMC5353275.pdf
2016. http://www.nuffieldtrust.org.uk/our-work/projects/person-based-resource-allocation-pbra (accessed 20 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/55/51/bmjopen-2016-013922.PMC5353275.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjgast-2016-000115).,Non-OADS,/arxiv_data1/oa_pdf/84/fd/bmjgast-2016-000115.PMC5353279.pdf
Data modified from original source available at: http://www.aemet.es/documentos_d/conocermas/biblioteca/calendarios/ cm-2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/fd/bmjgast-2016-000115.PMC5353279.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/84/fd/bmjgast-2016-000115.PMC5353279.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013626).,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
http://repositorio.educacionsuperior.gob.ec/handle/28000/1408 8.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
2010. http://www.inec.gob.ec/cpv/ 10. WHO | PCT databank (cited 6 November 2015).,OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
http://www.who.int/ neglected_diseases/preventive_chemotherapy/sth/en/ 11.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
2014. http://www.ecuadorencifras.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
http://iris.paho.org/xmlui/handle/123456789/18385 31.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/bmjopen-2016-013626.PMC5353281.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013451).,Non-OADS,/arxiv_data1/oa_pdf/31/85/bmjopen-2016-013451.PMC5353282.pdf
http://www.nhs.uk/Conditions/Diabetes-type2/Pages/Complications.aspx (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/31/85/bmjopen-2016-013451.PMC5353282.pdf
"Key statistics on diabetes, April 2015. http://www.diabetes.org.uk/Documents/Reports/Diabetes-in-the-UK-2012.pdf (accessed Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/31/85/bmjopen-2016-013451.PMC5353282.pdf
17 March 2015. http://www.rcgp.org.uk/news/2015/march/pharmacists-set-to-work-in-gp-surgeries.aspx (accessedJan 2016).,Non-OADS,/arxiv_data1/oa_pdf/31/85/bmjopen-2016-013451.PMC5353282.pdf
http://www.hscic.gov.uk/qof-online (accessed Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/31/85/bmjopen-2016-013451.PMC5353282.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013219).,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
A study website is currently under development (http://www.leedsbeckett.ac.uk/cancerfertilityandme.ac.,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
http://www.cancerresearchuk.org/health-professional/cancer-statistics#heading-Zero 3.,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
http://pathways.nice.org.uk/pathways/fertility#path=view%3A/pathways/fertility/cryopreservation-to-preserve-fertility-in-people-diagnosed-with-cancer.xml&content=view-index (accessed 26 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
"https://www.breastcancercare.org.uk/about-us/media/press-releases/ 8 Jones GL, et al.BMJ Open 2017; 7:e013219.",Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
"Leicester, UK, 2001. https://www.bps.org.uk (accessed 22 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
2014. https://decisionaid.ohri.ca/cochinvent.php (accessed27 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
2000. https://decisionaid.ohri.ca/eval_stage.html(Accessed 27 Jan 2016).,OADS,/arxiv_data1/oa_pdf/6b/f9/bmjopen-2016-013219.PMC5353284.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014579).,Non-OADS,/arxiv_data1/oa_pdf/4c/1e/bmjopen-2016-014579.PMC5353285.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013159).,Non-OADS,/arxiv_data1/oa_pdf/8c/fc/bmjopen-2016-013159.PMC5353286.pdf
2010. http://www.cdc.gov/flu/weekly/overview.htm 16.,Non-OADS,/arxiv_data1/oa_pdf/8c/fc/bmjopen-2016-013159.PMC5353286.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012982).,Non-OADS,/arxiv_data1/oa_pdf/e8/40/bmjopen-2016-012982.PMC5353287.pdf
Maternity snapshot 2010: Ministry of Health; 2011. http://www.health.govt.nz/publication/ maternity-snapshot-2010-provisional-data (accessed 28 Feb 2017) 3.,Non-OADS,/arxiv_data1/oa_pdf/e8/40/bmjopen-2016-012982.PMC5353287.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-015738).,Non-OADS,/arxiv_data1/oa_pdf/a3/47/bmjopen-2016-015738.PMC5353288.pdf
Toview please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/47/bmjopen-2016-015738.PMC5353288.pdf
http://www.cobas.com/home/product/ clinical-and-immunochemistry-testing/cobas-integra-400-plus.html(accessed 5 Dec 2016).,Non-OADS,/arxiv_data1/oa_pdf/a3/47/bmjopen-2016-015738.PMC5353288.pdf
ATC/ DDD Index 2016. http://www.whocc.no/atc_ddd_index/ (accessed Dec 2016).,OADS,/arxiv_data1/oa_pdf/a3/47/bmjopen-2016-015738.PMC5353288.pdf
https://www.nice.org.uk/guidance/cg192 (accessed Jan2017).,Non-OADS,/arxiv_data1/oa_pdf/a3/47/bmjopen-2016-015738.PMC5353288.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014565).,Non-OADS,/arxiv_data1/oa_pdf/3f/13/bmjopen-2016-014565.PMC5353289.pdf
2013; 22. http://urn.fi/URN:ISBN:978-952-302-054-2 (accessed 30 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/3f/13/bmjopen-2016-014565.PMC5353289.pdf
2012. http://urn.fi/URN: ISBN:978-952-245-792-9 (accessed 30 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/3f/13/bmjopen-2016-014565.PMC5353289.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/73/fb/bmjopen-2016-014957.PMC5353292.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012987).,Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
"All patients were asked to com- plete the ﬁve-level version of the EuroQoL-5D (EQ-5D) questionnaire at baseline, 6 months and 12 months inTable 1 STEMS pilot trial questionnaire measures Baseline 2 months 6 months 12 months Likely primary outcome measure for main trial Physical function SF-36v2 Physical Component Summary13http:// www.sf-36.org/(the higher the score the better the physicalhealth)✓ ✓✓✓ Secondary outcome measures Overall change in condition Global Assessment of Change since baseline — single question✗ ✓✓✓ Mental health SF-36v2 Mental Component Summary 13http:// www.sf-36.org/(the higher the score the better the mentalhealth)✓ ✓✓✓ Quality of life EuroQol EQ-5D-5L http://www.euroqol.org 14 (the higher the score the better the quality of life)✓ ✓✓✓ Self-efficacy Pain Self-Efficacy Questionnaire15 (10-item scale: 0=not at all confident, 60=completely confident despite pain)✓ ✓✓✓ Understanding of condition General Practice Assessment Questionnaire enablement subscale16 (very well, unsure, not very well)✓ ✓✓✗ Experience of consultations General Practice Assessment Questionnaire communication16 (Based on 5 items represented as a percentageof the maximum possible score 100)✓ ✓✓✗ Convenience of services Single question (0–10 Numerical Rating Scale: 0=not at all convenient, 10=very convenient)✓ ✓✓✗ Satisfaction with services Single question (0–10 Numerical Rating Scale: 0=not satisfied, 10=very satisfied)✓ ✓✓✗ Baseline measures Demographics Gender, date of birth, ethnicity, education, health literacy, employment status, socioeconomicstatus (recent paid job title, housing)✓ ✗✗✗ Baseline risk of persistent problemsSTarT Musc tool (draft tool developed at Keele University to identify patients ’risk of persistent pain and disability)✓ ✗✗✗ Pain location Body manikin ✓ ✗✗✗ Pain duration Single question about duration of pain ✓ ✗✗✗ Comorbidities Single question ✓ ✗✗✗ Economic outcomes Further healthcare usage Consultations, investigations, procedures, admissions, over-the-counter medications✗✗ ✓ ✓ Work absence Single question (number of days) ✓ ✓✓✓ Presenteeism Single work performance question (0–10 Numerical Rating Scale: 0=not at all affected, 10=unable to do my job)✓ ✓✓✓ SF-36, 36-item Short Form Health Survey.",Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
"Department of Health, 2008 http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089516.",Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
"2007, costs updated in accordance with Department of Health 2011. https://www.evidence.nhs.uk/qipp (accessed 10 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
2015. http://www.hee.nhs.uk 12.,Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
http://www.sf-36.org/14.,Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
Salisbury C. http://ukpolicymatters.thelancet.com/making-the-most- of-evaluation-to-ensure-health-policy-reform-is-evidence-based/2011.,Non-OADS,/arxiv_data1/oa_pdf/ba/9c/bmjopen-2016-012987.PMC5353299.pdf
2015 http://www.cprd.com/ home/ 15.,Non-OADS,/arxiv_data1/oa_pdf/e1/75/bmjopen-2016-012546.PMC5353300.pdf
"Deaths Registered in England and Wales (Series DR), 2014 2015 http://www.ons.gov.uk/ons/dcp171778_422395.pdf 23.",Non-OADS,/arxiv_data1/oa_pdf/e1/75/bmjopen-2016-012546.PMC5353300.pdf
Reference costs 2012-13 2013. http://www.gov.uk/ government/publications/nhs-reference-costs-2012-to-2013 25.,Non-OADS,/arxiv_data1/oa_pdf/e1/75/bmjopen-2016-012546.PMC5353300.pdf
"National Statistics Prescription Cost Analysis, England —2013 2014 http://www.hscic.",Non-OADS,/arxiv_data1/oa_pdf/e1/75/bmjopen-2016-012546.PMC5353300.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013195).,Non-OADS,/arxiv_data1/oa_pdf/9e/86/bmjopen-2016-013195.PMC5353301.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2016- 000324).,Non-OADS,/arxiv_data1/oa_pdf/78/83/rmdopen-2016-000324.PMC5353304.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/83/rmdopen-2016-000324.PMC5353304.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2017; 7:e007295corr1.,Non-OADS,/arxiv_data1/oa_pdf/b1/7c/bmjopen-2014-007295corr1.PMC5353305.pdf
"2012. http://www.who.int/pmnch/media/news/2012/preterm_birth_report/en/?utm_source=LifeSiteNews.com+Daily 8 Hägi-Pedersen M-B, et al.BMJ Open 2017; 7:e013024.",Non-OADS,/arxiv_data1/oa_pdf/27/12/bmjopen-2016-013024.PMC5353306.pdf
http://www.surveyxact.dk/38.,Non-OADS,/arxiv_data1/oa_pdf/27/12/bmjopen-2016-013024.PMC5353306.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014828).,Non-OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/query?url=https%3A%2F%2Fwww.ge.ch%2Flegislation%2Frsg%2Ff%2Fs%2Frsg_F3_20.html&date=2016-09-25 8.,OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/ query?url=http%3A%2F%2Fwww.prevention.ch%2Falcopops.htm&date=2016-09-25 9.,Non-OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/query?url=https%3A%2F%2Fwww.admin.ch%2Fopc%2Ffr%2Fclassified-compilation%2F20020101%2F&date=2016-09-25 10.,Non-OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/query?url=http%3A%2F%2Fwww.stop-alcool.ch%2Fla-legislation-sur-l-alcool%2Fla-limite-de-05-a-ameliore-la-securite-routiere&date=2016-09-25 11.,Non-OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/query?url=https%3A%2F%2Fwww.geneve.ch%2Flegislation%2Frsg%2Ff%2Fs%2Frsg_I2_24.html&date=2016-09-25 12.,OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
http://www.webcitation.org/query?url=http%3A%2F%2Fwww.,OADS,/arxiv_data1/oa_pdf/d3/21/bmjopen-2016-014828.PMC5353307.pdf
"For longitudinal analyses, participants who reported on the baseline questionnaire that they hadbeen treated for depression/anxiety in the previous month (n=3796), and/or taking antidepressant medica- tion for most of the past 4 weeks (n=700), and/or withhigh/very high levels of psychological distress (n=3030; deﬁned as having a Kessler Psychological Distress Scale (K10) score ≥22 24were excluded (n=6067), leaving a ﬁnal sample of 54 345 participants.Measurement The 45 and Up Study and SEEF Study questionnairesinclude questions on sociodemographic characteristics, personal and medical history, and lifestyle risk factors (available from http://www.saxinstitute.org.au/our-work/45-up-study/questionnaires/).",Non-OADS,/arxiv_data1/oa_pdf/62/ed/bmjopen-2016-014201.PMC5353310.pdf
Acknowledgements This research was completed using data collected through the 45 and Up Study (http://www.saxinstitute.org.au).,OADS,/arxiv_data1/oa_pdf/62/ed/bmjopen-2016-014201.PMC5353310.pdf
2016. http://www.who.int/mediacentre/events/2016/mental-health-meeting/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/62/ed/bmjopen-2016-014201.PMC5353310.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014433).,Non-OADS,/arxiv_data1/oa_pdf/ec/29/bmjopen-2016-014433.PMC5353311.pdf
All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Anhui Traditional Chinese Medical College 2002. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/811/CN-00716811/frame.html 75.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
[Assessment on life quality of patients with rheumatoid arthritis and efficacy of tripterygium wilfordii hook].Journal of Traditional Chinese Medicine University of Hunan [huNan Zhong Yi Xue Yuan Xue Bao] 2006. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
[Clinical observation of treating rheumatoid arthritis using compound tripterygium wilfordii wine].Hebei Journal of Traditional Chinese Medicine [he Bei Zhong Yi]2003. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/302/CN-00975302/frame.html 77.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Guangzhou University of Traditional Chinese Medicine [guang ZhouZhong Yi Yao da Xue Xue Bao] 2005. http://onlinelibrary.wiley.com/ o/cochrane/clcentral/articles/005/CN-00976005/frame.html 78.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Journal of Gerontology [zhong Guo Lao Nian Xue za Zhi] 2005. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/015/CN-00976015/frame.html 79.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Clinical Journal of Traditional Chinese Medicine [zhong Yi Yao Lin Chuang za Zhi] 2008. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/783/CN-00976783/frame.html 80.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Xue] 2007. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/391/CN-00976391/frame.html 81.,OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Journal of Traditional Medical Traumatology & Orthopedics [zhong Guo Zhong Yi Gu Shang] 2003. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/316/CN-00975316/frame.html 82.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Modern Rehabilitation [xian Dai Kang Fu] 2000. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/089/CN-00975089/frame.html 83.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Emergency in Traditional Chinese Medicine [zhong Guo Zhong YiJi Zheng] 2007. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/372/CN-00976372/frame.html 86.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Sichuan of Traditional Chinese Medicine[si Chuan Zhong Yi] 2006. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/208/CN-00976208/frame.html 87.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Journal of Convalescent Medicine [zhong Guo Liao Yang Yi Xue] 2002. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/093/CN-00975093/frame.html 88.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Jiangxi Journal of Traditinal Chinese Medicine 2004. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/789/CN-00975789/frame.html 89.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Acta Chinese Medicine and Pharmacology [Zhong Yi Yao Xue Bao] 2000. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/076/CN-00975076/frame.html 90.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Yunnan Journal of Traditional Chinese Medicine and Materia Medica [yunNan Zhong Yi Zhong Yao za Zhi] 2000. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Community Doctors [zhong Guo She Qu Yi Shi] 2002. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/092/CN-00975092/frame.html 92.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Anhui Clinical Journal of Traditional Chinese Medicine [an Hui Zhong Yi Lin Chuang za Zhi] 2000. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Hubei Journal of Traditional Chinese Medicine [hu Bei Zhong Yi za Zhi] 2005. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/998/CN-00975998/frame.html 94.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Anhui Traditional Chinese Medicine College [an Hui Zhong Yi Xue Yuan Xue Bao]2005. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/018/CN-00976018/frame.html 95.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Emergency in Traditional Chinese Medicine [zhong Guo Zhong YiJi Zheng] 2007. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/380/CN-00976380/frame.html97.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Tianjin Journal of Traditional Chinese Medicine [tian Jin Zhong Yi Yao] 2006. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/207/CN-00976207/frame.html 99.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Hubei Journal of Traditional Chinese Medicine [hu Bei Zhong Yi za Zhi] 2005. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/011/CN-00976011/frame.html 101.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Zhengzhou University(medical Sciences) [zhen Zhou da Xue XueBao (yi Xue Ban)] 2006. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/186/CN-00976186/frame.html 102.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Shaanxi Jornal of Traditional Chinese Medicine [shan Xi Zhong Yi] 2007. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
[Observation of rheumatoid arthritic treated by integration of traditional Chinese medicine and western medicine].Hebei Journal of Traditional Chinese Medicine [he Bei Zhong Yi]2001. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/088/ CN-00975088/frame.html 104.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Hebei Journal of Traditional Chinese Medicine [he Bei Zhong Yi] 2002. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Shandong Medical Journal [shan Dong Yi Yao] 2001. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Sichuan of Traditional Chinese Medicine[si Chuan Zhong Yi] 2003. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/319/CN-00975319/frame.html 108.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Zhejiang Journal of Integrated Traditional Chinese and Western Medicine [zhe JiangZhong Xi Yi Jie He za Zhi] 2005. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/007/CN-00976007/frame.html 109.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Lishizhen Medicine and Materia Medica Research [shi Zhen Guo Yi Guo Yao] 2000. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/082/CN-00975082/frame.html 110.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
China Science and Technology Information [zhong Guo Ke Ji Xin Xe] 2005. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/009/CN-00976009/frame.html 111.,OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Journal of Information on TCM 2006. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/980/CN-00796980/frame.html 112.,OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Community Doctors [zhong Guo She Qu Yi Shi] 2007. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
"Gansu Journal of Traditional Chinese Medicine 2006. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/190/CN-00976190/frame.html Pan X, et al.BMJ Open 2017; 7:e013242.",Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine[shiYong Zhong Xi Yi Jie He Lin Chuang] 2004. http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Modern Journal of Integrated Traditional Chinese and Western Medicine [xian Dai Zhong Xi YiJie He za Zhi] 2003. http://onlinelibrary.wiley.com/o/cochrane/ clcentral/articles/297/CN-00975297/frame.html 116.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Shaanxi Journal of Traditional Chinese Medicine [shan Xi Zhong Yi] 2008. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/770/CN-00976770/frame.html 117.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Anhui Traditional Chinese Medical College [An Hui Zhong Yi Xue Yuan Xue Bao]2004. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/583/ CN-00676583/frame.html 121.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Chinese Community Doctors [zhong Guo She Qu Yi Shi]2007. http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/386/CN-00976386/frame.html 122.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
[Treatment of rheumatoid arthritis with Yanghe Decoction combined with tripterygium glycosides in 60 cases].Shaanxi Journal of Traditional Chinese Medicine [shan Xi ZhongYi]2008. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/ 780/CN-00976780/frame.html 123.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
[Treatment of rheumatoid arthritis with Yishen Juanbi Decoction combined with MTX in 40 cases].Traditional Chinese Medicine Research [zhong Yi Yan Jiu] 2006. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/205/ CN-00976205/frame.html 124.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
Journal of Henan University of Chinese Medicine[he Nan Zhong Yi Xue Yuan Xue Bao] 2004. http://onlinelibrary.wiley.com/o/ cochrane/clcentral/articles/794/CN-00975794/frame.html 125.,Non-OADS,/arxiv_data1/oa_pdf/df/98/bmjopen-2016-013242.PMC5353312.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 015339).,Non-OADS,/arxiv_data1/oa_pdf/d3/e3/bmjopen-2016-015339.PMC5353313.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/e3/bmjopen-2016-015339.PMC5353313.pdf
http://www.cric.nu/ aid-icu-protocol-cohort-study-draft-only/ (accessed 18 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/d3/e3/bmjopen-2016-015339.PMC5353313.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012789).,Non-OADS,/arxiv_data1/oa_pdf/cf/8d/bmjopen-2016-012789.PMC5353317.pdf
http://www.nhs.,Non-OADS,/arxiv_data1/oa_pdf/d7/a1/bmjopen-2016-013648.PMC5353318.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013706).,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bmjopen-2016-013706.PMC5353320.pdf
2014. http://www.emdat.be/ 2.,Non-OADS,/arxiv_data1/oa_pdf/b1/f8/bmjopen-2016-013706.PMC5353320.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2016-000369).,Non-OADS,/arxiv_data1/oa_pdf/87/48/bmjdrc-2016-000369.PMC5353321.pdf
2015. https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations (accessed 12 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/87/48/bmjdrc-2016-000369.PMC5353321.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012943).,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/bmjopen-2016-012943.PMC5353323.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/bmjopen-2016-012943.PMC5353323.pdf
http://hakir.se/rapporter/ (accessed 3 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/bmjopen-2016-012943.PMC5353323.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014497).,Non-OADS,/arxiv_data1/oa_pdf/40/90/bmjopen-2016-014497.PMC5353324.pdf
2013. http://health.gov.ie/wp-content/uploads/2015/01/ ncec_guideline_development_manual_january13.pdf (accessed 20 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/90/bmjopen-2016-014497.PMC5353324.pdf
http://www.ahrq.gov/professionals/quality-patient-safety/ patient-safety-resources/resources/advances-in-patient-safety-2/ vol3/advances-hueckel_27.pdf (accessed 20 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/90/bmjopen-2016-014497.PMC5353324.pdf
http://www.crd.york.ac.uk/ PROSPERO/display_record.asp?ID=CRD42015015326 (accessed 3Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/40/90/bmjopen-2016-014497.PMC5353324.pdf
http://www.nets.nihr.ac.uk/projects/hsdr/1217817(accessed 10 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/40/90/bmjopen-2016-014497.PMC5353324.pdf
"The Cochrane Collaboration, 2011. http://handbook.cochrane.org.",OADS,/arxiv_data1/oa_pdf/cd/fb/bmjopen-2016-014096.PMC5353325.pdf
"The Cochrane Collaboration, 2010. http://methods.cochrane.org/ sdt/handbook-dta-reviews/ 25.",OADS,/arxiv_data1/oa_pdf/cd/fb/bmjopen-2016-014096.PMC5353325.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014609).,Non-OADS,/arxiv_data1/oa_pdf/7e/03/bmjopen-2016-014609.PMC5353326.pdf
2016. http://who.int/maternal_ child_adolescent/topics/adolescence/dev/en (accessed 6 Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/7e/03/bmjopen-2016-014609.PMC5353326.pdf
2015. http://www.stata.com/ (accessed 18 Dec 2015).,OADS,/arxiv_data1/oa_pdf/7e/03/bmjopen-2016-014609.PMC5353326.pdf
To view these files pleasevisit the journal (http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/c2/rmdopen-2016-000416.PMC5353328.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/66/c2/rmdopen-2016-000416.PMC5353328.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010807).,Non-OADS,/arxiv_data1/oa_pdf/96/ed/bmjopen-2015-010807.PMC5353329.pdf
Available from: http://www.hscic.gov.uk/catalogue/PUB16722 (accessed 25 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/96/ed/bmjopen-2015-010807.PMC5353329.pdf
http://bma.org.uk/news-views-analysis/news/2014/february/patient-and-doctor-partnership-comes-of-age(accessed 28 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/96/ed/bmjopen-2015-010807.PMC5353329.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014496).,Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
http://www.who.int/surgery/publications/QuickSitAnalysisEESCsurvey.pdf (accessed 18 Nov2016).,Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
http://www.who.int/healthinfo/systems/sara_introduction/en/ (accessed 18 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
"World health Organization, Geneva, July 2015 http://apps.who.int/iris/bitstream/10665/149025/1/WHO_HIS_HSI_2014.5_eng.pdf?ua=1 (accessed 18 Nov 2016).",Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
Available at http://www.who.int/healthinfo/systems/sara_reports/en/ (accessed 18 Nov 2016).,OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
http://www.who.int/healthinfo/systems/samintro/en/ (accessed18 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
https://www.hfgproject.org/wp-content/ uploads/2015/02/HSAA_Manual_Version_2_Sept_20121.pdf(accessed 18 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/be/9f/bmjopen-2016-014496.PMC5353330.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012666).,Non-OADS,/arxiv_data1/oa_pdf/00/e6/bmjopen-2016-012666.PMC5353332.pdf
Secondary Polio this week as of 13 January 2016 13 Jan 2016 2016. http://reliefweb.int/report/world/polio-week-13-january-2016 2.,Non-OADS,/arxiv_data1/oa_pdf/85/25/bmjopen-2016-013853.PMC5353333.pdf
"Secondary Updates on CDC ’s Polio Eradication Efforts January 27, 2016 2016. http://www.cdc.gov/polio/updates/2016/2016 –0129.htm 3.",Non-OADS,/arxiv_data1/oa_pdf/85/25/bmjopen-2016-013853.PMC5353333.pdf
2013. http://www.nips.org.pk/abstract_files/Priliminary%20Report% 20Final.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/85/25/bmjopen-2016-013853.PMC5353333.pdf
2010. http://www.searo.who.int/nepal/mediacentre/2010_increasing_access_to_health_workers_in_remote_and_rural_areas.pdf (accessed May2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
2013. http://www.cdc.gov/drugresistance/threat-report-2013/ (accessedNov 2014).,OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
2013. https://www.gov.uk/government/publications/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018 (accessedFeb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
2013. http://www.egazette.nic.in/WriteReadData/2013/E_441_2013_024.pdf (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
2010. http://www.pci.nic.in/RulesRegulations/EducationRegulations1991/Chapter2.aspx (accessed Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
2015. https://www.fip.org/files/fip/news/DOTS_TB_projectIndia.pdf (accessed May 2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/e1/bmjopen-2016-013190.PMC5353334.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013053).,Non-OADS,/arxiv_data1/oa_pdf/06/15/bmjopen-2016-013053.PMC5353336.pdf
2011. http://www.Cochrane-handbook.Org.,OADS,/arxiv_data1/oa_pdf/06/15/bmjopen-2016-013053.PMC5353336.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013909).,Non-OADS,/arxiv_data1/oa_pdf/0f/07/bmjopen-2016-013909.PMC5353337.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/07/bmjopen-2016-013909.PMC5353337.pdf
http://www.ohsu.edu/polst 5.,Non-OADS,/arxiv_data1/oa_pdf/0f/07/bmjopen-2016-013909.PMC5353337.pdf
40. http://www.spirit-statement.org/publications-downloads/ (accessed 8 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/07/bmjopen-2016-013909.PMC5353337.pdf
41. https://www.caresearch.com.au/Caresearch/tabid/2583/Default.aspx (accessed 14 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/07/bmjopen-2016-013909.PMC5353337.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014305).,Non-OADS,/arxiv_data1/oa_pdf/e9/0d/bmjopen-2016-014305.PMC5353338.pdf
"METHODS AND ANALYSIS ProtocolThis study will follow the recommendations on conduct- ing and reporting systematic reviews and meta-analyses set forth by the Preferred Reporting Items for SystematicReviews and Meta-Analyses (PRISMA) statement, 20–22 the Meta-Analysis of Observational Studies in Epidemiology proposal,23and the Cochrane Diagnostic T est Accuracy Working Group.24The protocol has been registered in PROSPERO, an International Prospective Register of Systematic Reviews (http://www.crd.york.ac.uk/PROSPERO/; Registration No.",OADS,/arxiv_data1/oa_pdf/e9/0d/bmjopen-2016-014305.PMC5353338.pdf
Brochure updated in 2016. http://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/Brochure-What-Is-MS.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/43/12/bmjopen-2016-013430.PMC5353339.pdf
"Fingolimod, 0.5mg, hard capsules (Gilenya ®) SMC No (992/14), 2014. https://www.scottishmedicines.",Non-OADS,/arxiv_data1/oa_pdf/43/12/bmjopen-2016-013430.PMC5353339.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014313).,Non-OADS,/arxiv_data1/oa_pdf/60/ce/bmjopen-2016-014313.PMC5353341.pdf
http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4817.0.55.001Chapter92007-08 (accessed10 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/60/ce/bmjopen-2016-014313.PMC5353341.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1269.02011?OpenDocument(accessed 10 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/60/ce/bmjopen-2016-014313.PMC5353341.pdf
"Humanitarian Settlement Services (HSS) [updated June 16, 2016. https://www.dss.gov.au/our-responsibilities/settlement-and-multicultural-affairs/programs-policy/settlement-services/humanitarian-settlement-services-hss (accessed July,24 2016).",Non-OADS,/arxiv_data1/oa_pdf/60/ce/bmjopen-2016-014313.PMC5353341.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/63/e6/bmjopen-2016-013353.PMC5353342.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013809).,Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
"21 and 33Guideline databases:National Guideline Clearinghouse (http://www.guideline.gov),Guidelines International Network (http://www.g-i-n.net), NationalInstitute for Clinical Excellence (http://www.nice.org.uk)Scottish Intercollegiate Guidelines Network (http://www.sign.ac.uk), New Zealand Guidelines Group (http://www.nzgg.org.nz)Canadian Medical Association —CMA Infobase: Clinical Practice Guidelines (http://www.cma.ca/cpgs/)Other databases:CareSearch (http://www.caresearch.com.au/Caresearch/Default.aspx),Centre for Effective Practice (http://www.effectivepractice.org)Delirium associations:European Delirium Association (http://www.europeandeliriumassociation.com), American Delirium Society (http://www.americandeliriumsociety.org) Bush SH, et al.BMJ Open 2017; 7:e013809.",Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
"We envision that by using the recently published AGREE Reporting Checklist (avail-able on the AGREE Enterprise website as a free and open access resource (http://www.agreetrust.org)), guideline development groups will improve the compre-hensiveness and completeness of new guidelines across all AGREE II domains.",Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
http://www.g-i-n.net/working-groups/ adaptation/history 32.,Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
http://www.guideline.gov 36.,Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
"London: National Clinical Guideline Centre (NCGC) —Acute and Chronic Conditions, 2010. http://www.nice.org.uk/CG103 39.",Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
http://rnao.ca/bpg/resources/toolkit-implementation-best-practice-guidelines-second-edition.,Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
http://www.ccsmh.ca 89.,Non-OADS,/arxiv_data1/oa_pdf/02/ad/bmjopen-2016-013809.PMC5353343.pdf
// http://www.oecd.org/els/health-systems/35987490.pdf (accessed 24 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/d8/ae/bmjopen-2016-012794.PMC5353345.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011637).,Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
http://www.snlg-iss.it/lgn_ malattia_renale 4.,Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
Available from: http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp 7.,Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 Trotta F, et al.BMJ Open 2017; 7:e011637.",Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2015/01/WC500180219.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
"Rome, 2015:522. http://www.agenziafarmaco.gov.it/it/content/rapporti-osmed-luso-dei-farmaci-italia 14.",Non-OADS,/arxiv_data1/oa_pdf/71/1e/bmjopen-2016-011637.PMC5353346.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014388).,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
http://dx.doi.org/ 10.1038/bjc.2011.486 7.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
2014. http://www.cancerresearchuk.org/sites/default/files/sun_protection_trends_-_cruk.pdf (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
http://dx.doi.org/10.1111/bjd.14800 23.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
2015. http://www.birmingham.ac.uk/university/fact/who.aspx(accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
http://eprints.ncrm.ac.uk/2273/4/how_many_interviews.pdf (accessed Nov2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
Primary prevention of skin cancer: a review of sun protection in Australia and internationally.Health Promot Int 2004;19:369 –78 doi: 10.1093/heapro/dah310 http://dx.doi.org/10.1093/heapro/dah310 51.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
https://www.nice.org.uk/guidance/ph32/documents/expert-paper-6-the-impact-of-role-models-on-sun-protection-behaviours2(accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/bmjopen-2016-014388.PMC5353347.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013796).,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://www.health.gov.au/internet/main/publishing.nsf/content/health-pbs-general-pubs-manual-content.htm 45.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
Canberra: Australian Government.http://www.health.gov.au/internet/main/publishing.nsf/content/health-casemix-data-collections-NHCDCReports 46.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
"Canberra: Australian Government, 2012. http://phiac.gov.au/wp-content/uploads/2012/11/Gap-Sep12.pdf 47.",Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://www.health.gov.au/internet/main/publishing.nsf/Content/Quarterly-Medicare-Statistics 48.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://www.mbsonline.gov.au/ 49.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://www.pbs.gov.au/pbs 50.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://phiac.gov.au/industry/industry-statistics 51.,OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
http://www.abs.gov.au/austats 52.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/bmjopen-2016-013796.PMC5353349.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014262).,Non-OADS,/arxiv_data1/oa_pdf/23/49/bmjopen-2016-014262.PMC5353350.pdf
2011. http://www.internationalmidwives.org/assets/uploads/documents/Definition%20of%20the%20Midwife %20-%202011.pdf (accessed 21 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/23/49/bmjopen-2016-014262.PMC5353350.pdf
2015. https://www2.health.vic.gov.au/~/media/health/files/collections/research%20and%20reports/e/djerriwarrh%20-%20wallace%20report%20-%20executive%20summary.pdf 75.,Non-OADS,/arxiv_data1/oa_pdf/23/49/bmjopen-2016-014262.PMC5353350.pdf
2016 https://www2.health.vic.gov.au/hospitals-and-health-services/quality-safety-service/hospital-safety-and-quality-review 76.,Non-OADS,/arxiv_data1/oa_pdf/23/49/bmjopen-2016-014262.PMC5353350.pdf
"METHODS This review protocol has been registered in PROSPERO,an International Prospective Register of Systematic Reviews at the National Institute for Health Research and Center for Reviews and Dissemination (CRD) atthe University of York (http://www.crd.york.ac.uk/ PROSPERO/; Registration No.",Non-OADS,/arxiv_data1/oa_pdf/79/ad/bmjopen-2016-013828.PMC5353352.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014047).,Non-OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
The Australian Early Development Census 2015. https://www.aedc.gov.au/ (accessed 22 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
"The Australian Statistical Geography Standard (ASGS), 2013. http://www.abs.gov.au/websitedbs/ D3310114.nsf/home/Australian+Statistical+Geography+Standard+(ASGS) (accessed 09 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
Socio-Economic Indexes for Areas (SEIFA) 2013. http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa?opendocument&navpos=260 (accessed 27 Jul 2016).,OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
"2033.0.55.001 —Census of Population and Housing: Socio-Economic Indexes for Areas(SEIFA), Australia, 2011 2011 [updated 24 September 2013. http://www.abs.gov.au/ausstats/abs@.nsf/mf/2033.0.55.001 (accessed27 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/99/e4/bmjopen-2016-014047.PMC5353361.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing Interests: The authors declare no competing financial interests.How to cite this article: Wang, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/48/srep44466.PMC5353552.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/e1/48/srep44466.PMC5353552.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/39/main.PMC5353681.pdf
http://dx.doi.org/10.1016/j.hrcr.2016.11.006,OADS,/arxiv_data1/oa_pdf/33/39/main.PMC5353681.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives Lice nse ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is pro perly cited, and is not altered, transformed, or built upon  in any way.",Non-OADS,/arxiv_data1/oa_pdf/3e/60/ypch-36-118.PMC5353737.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/84/ehw526.PMC5353752.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2017OPEN",Non-OADS,/arxiv_data1/oa_pdf/95/ec/srep42985.PMC5353760.pdf
"International Journal of Preventive Medicine 2017, 8:12 http://www.ijpvmjournal.net/content/8/1/12INTRODUCTION Low birth weight (LBW) as a significant public health  indicator is defined as weight at birth fewer than 2500 g  by the World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/19/73/IJPVM-8-12.PMC5353762.pdf
"International Journal of Preventive Medicine 2017, 8:12 http://www.ijpvmjournal.net/content/8/1/12Preterm labor, neonate female sex, pregnancy age  <18 and >35 years old, delivery by cesarean section,  maternal medical risk factors in current pregnancy,  lower maternal education level, living in the rural  area, consanguineous, delivery by obstetrician, birth  in hospital, non‑Iranian maternal nationality, and  uninsured were more frequent in LBW than NBW .",Non-OADS,/arxiv_data1/oa_pdf/19/73/IJPVM-8-12.PMC5353762.pdf
"International Journal of Preventive Medicine 2017, 8:12 http://www.ijpvmjournal.net/content/8/1/12study showed that the prevalence of LBW is between 5%  and 12% in Iran.",Non-OADS,/arxiv_data1/oa_pdf/19/73/IJPVM-8-12.PMC5353762.pdf
"International Journal of Preventive Medicine 2017, 8:12 http://www.ijpvmjournal.net/content/8/1/12nutritional factors.",Non-OADS,/arxiv_data1/oa_pdf/19/73/IJPVM-8-12.PMC5353762.pdf
"International Journal of Preventive Medicine 2017, 8:15 http://www.ijpvmjournal.net/content/8/1/15Conflicts of interest There are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/ff/c9/IJPVM-8-15.PMC5353766.pdf
Available from: http://www.wcd.nic.in/ issnip/National_Fact%20sheet_RSOC%20_02‑07‑2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/c9/IJPVM-8-15.PMC5353766.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/13able to provide primary nursing care by themselves, and  more advanced care direct RN supervision.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/13lasted from 40 to 45 min.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/13participated to decrease probable risks.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/13mix is proper combination of health care personnel who  provide care in an especial level of quality with the lowest  cost.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/13The importance of conformity of nursing estimation  model with social, cultural, economic and background  condition of each country as one of the required features  in designing a model, was observed in this study.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:13 http://www.ijpvmjournal.net/content/8/1/1322.",Non-OADS,/arxiv_data1/oa_pdf/15/75/IJPVM-8-13.PMC5353769.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11INTRODUCTION Women are considered one of the most important  population groups, who play a key role in the social and  economic development of any country.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11samples of the population size in each district within  each province.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11between 0 (perfect equality) and 1 (maximum amount of  inequality) [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11It should be asserted that life satisfaction level for women  aged 15–24 years (in geopolitical environment/welfare  category) had a Likert scale (1 = most to 5 = least  satisfaction level).",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11showed an unsatisfactory situation of overall rate and  distribution of health knowledge among Iranian women.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11are regional disparities in access to at least one type of  mass media and computers or internet among women  15–24 years of age.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11for assessing inequality in women’s health at the regional  level, particularly for developing countries.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
Available from:  https://www.sabteahval.ir/en/.,Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
Available from: http://www.salnameh.sci.org.ir/AllUser/ DirectoryTreeComplete.aspx.,OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:11 http://www.ijpvmjournal.net/content/8/1/11Switzerland: World Health Organization; 2014.",Non-OADS,/arxiv_data1/oa_pdf/8f/d9/IJPVM-8-11.PMC5353772.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14INTRODUCTION Musculoskeletal disorders are among the major causes of  disability and dysfunction in Iran and worldwide.",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14response scale) giving a total score of 0 to 210.",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14Psychometric evaluation A total of 106 patients with LBP participated in this  study.",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14with acute and subacute LBP and Cronbach’ alpha was  0.80.",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14CONCLUSIONS The ÖMPSQ‑P is a reliable and valid measure that  can be used for psychosocial screening of patients with  LBP .",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
"International Journal of Preventive Medicine 2017, 8:14 http://www.ijpvmjournal.net/content/8/1/14Cross‑validation of item selection and scoring for the SF‑12 health survey  in nine countries: Results from the IQOLA project.",Non-OADS,/arxiv_data1/oa_pdf/96/b5/IJPVM-8-14.PMC5353775.pdf
Available  from: http://www.nhstimeline.nuffieldtrust.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/17/9e/JFMPC-5-745.PMC5353806.pdf
Available from:  http://www.dciindia.org/search.aspx.,OADS,/arxiv_data1/oa_pdf/5c/51/JFMPC-5-747.PMC5353807.pdf
Available from:  http://www.whoindia.org/EN/Section20/Section251686.,Non-OADS,/arxiv_data1/oa_pdf/5c/51/JFMPC-5-747.PMC5353807.pdf
Available from: http://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/5c/51/JFMPC-5-747.PMC5353807.pdf
Available from:  http://www.who.int/reproductivehealth/topics/family_ planning/unmet_need_fp/en/.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available from: http://www.jhpiego.org/files/IUD_ Manual_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available from: http://www.rajswasthya.nic.in/ Safe%20Motherhood%20 day%2011.04.12/PPIUCD%20 Training%20Package‑cg/PPIUCD%20Reference%20Manual/ PPIUCD%20Reference%20Manual‑Feb%202011‑final.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available from: http://www.nrhmtn.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available  from: https://www.apha.confex.com/apha/142am/ webprogram/Paper310318.html.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available from: http://www.ijrcog.org/?mno=44335.,Non-OADS,/arxiv_data1/oa_pdf/db/81/JFMPC-5-770.PMC5353811.pdf
Available from: http://www.searo.who.,Non-OADS,/arxiv_data1/oa_pdf/ad/66/JFMPC-5-777.PMC5353812.pdf
Available from:  http://www.topalbertadoctors.org/ cpgs/?sid=18 and cpg.cats=79.,OADS,/arxiv_data1/oa_pdf/60/29/JFMPC-5-780.PMC5353813.pdf
Available from: http://www.who.int/oral_health/strategies/ cont/en/print.html.,Non-OADS,/arxiv_data1/oa_pdf/57/e9/JFMPC-5-785.PMC5353814.pdf
Available from: http://www.aehti.eu/ Advances_vol_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: http://www.slideshare.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: http://www.who.int/goe/publications/ goe_telemedicine_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: http://www.medind.nic.in/ice/t13/i1/ icet13i1p1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: https://www.scss.tcd.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: http://www.slideshare.net/ManishaS2/ telemedicine‑in‑india‑design‑research?related=1.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from:  http://www.egov.eletsonline.com/2007/05/ telemedicine‑adoption‑in‑india‑the‑new‑drivers/.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/JFMPC-5-798.PMC5353817.pdf
Available from: http://www.apps.who.int/iris/bitstream/10 665/85761/2/9789240690837eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available from: http://www.mohfw.nic.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available  from: http://www.pib.nic.in/newsite/PrintRelease.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available  from: http://www.econ.worldbank.org.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available  from: http://www.thehindu.com/news/national/aadhaar‑notmandatory‑sc‑reiterates/article6999924.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available from: http://www.health.bih.nic.in/ Docs/Guidelines/Guidelines‑PHC‑2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available from: http://countryoffice.unfpa.org/ india/drive/JSYConcurrentAssessment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available from:  http://www.chsj.org/uploads/1/0/2/1/10215849/ has_janani_suraksha_yojana_stimulated_institutional__ delivery_‑_a_study_in_una_district_of_himachal_pradesh_‑_ deepak_kumar_manisha_and_archana_dwivedi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available  from: http://www.microsave.net/files/pdf/130213_ MicroSave_Case_Study_AEDBT_East_Godavari.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/33/JFMPC-5-817.PMC5353820.pdf
Available from:  http://www.ftp://ftp.fao.org/docrep/fao/009/a0442e/ a0442e00.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/fa/JFMPC-5-825.PMC5353822.pdf
Available from:  http://www.unicef.org/nutrition/training/2.5/9.html.,Non-OADS,/arxiv_data1/oa_pdf/1c/d0/JFMPC-5-834.PMC5353824.pdf
Available from: http://www.who.int/childgrowth/ standards/technical_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/1c/d0/JFMPC-5-834.PMC5353824.pdf
Available  from: http://www.who.int/dietphysicalactivity/publications/ fruit_vegetables_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3e/c6/JFMPC-5-847.PMC5353826.pdf
Available  from: http://www.who.int/whr/2008/en/.,OADS,/arxiv_data1/oa_pdf/02/90/JFMPC-5-853.PMC5353827.pdf
Available from: http://www.primaryimmune.org/ about‑primary‑immunodeficiencies/specific‑disease‑types/ hyper‑ige‑syndrome/.,Non-OADS,/arxiv_data1/oa_pdf/34/11/JFMPC-5-871.PMC5353833.pdf
"Published with license by Taylor & Francis Group, LLC © Andreas Kirschner, Melanie Thiede, Thomas G. P. Gr €unewald, Rebeca Alba Rubio, G €unther H. S. Richter, Thomas Kirchner, Dirk H. Busch, Stefan Burdach, and Uwe Thiel.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
"2, e1273301 (11 pages)http://dx.doi.org/10.1080/2162402X.2016.1273301",Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
ORCID Thomas G. P. Gr €unewald http://orcid.org/0000-0003-0920-7377 References 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Nat Rev Clin Oncol 2016;PMID:27502359; http://dx.doi.org/0.1038/nrclinonc.2016.120 2.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cancer Cell 2015; 28(4):500-14; PMID:26461094; http://dx.doi.org/10.1016/j.ccell.2015.09.003 4.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Am J ObstetGynecol 1974; 118(2):223-36; PMID:4129188; http://dx.doi.org/ 10.1016/0002-9378(74)90553-5 5.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
JPathol 2014; 233(4):344-56; PMID:24931331; http://dx.doi.org/10.1002/path.4393 8.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Am J Med Sci 2009; 337(4):241-4; PMID:19365167;http://dx.doi.org/10.1097/MAJ.0b013e31818967a3 9 .,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Genome Biol 2012; 13(12): R115; PMID:23237666; http://dx.do i.org/10.1186/gb-2012-13-12-r115 10.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Oncotarget 2013; 4(8):1172-84; PMID:23896451; http://dx.doi.org/10.18632/oncotarget.1126 11.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cancer Res 2004; 64(22):8213-21; PMID:15548687; http://dx.doi.org/10.1158/0008-5472.CAN-03-4059 12.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Endocrinol Metab 1999; 84(12):4742-5; PMID:10599745; http://dx.doi.org/10.1210/jcem.84.12.6342 13.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Ann Endocrinol (Paris) 2016; 77(2):90-6; PMID:27155776; http://dx.doi.org/10.1016/j.ando.2016.04.015 14.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Biol Chem 2002; 277(49):47225-34; PMID:12370176; http://dx.doi.org/10.1074/jbc.M209155200 15.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Biochem J 2002; 367(Pt 1):31-40; PMID:12241545; http://dx.doi.org/10.1042/bj20020831 16.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Endocrinology 1993; 133(1):33-8; PMID:8319580; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Invest 1995; 96(2):767-74; PMID:7635970; http://dx.doi.org/10.1172/JCI118121 18.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Biol Chem 1995; 270(35):20424-31; PMID:7544787; http://dx.doi.org/10.1074/jbc.270.35.20424 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Development 2004; 131(5):1187-94;PMID:14973274; http://dx.doi.org/10.1242/dev.00997 20.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Clin Cancer Res 2012; 18(1):40-50; PMID:22215905; http://dx.do i.org/10.1158/1078-0432.CCR-11-0998 21.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Oncol 2011; 29(34):4541-7; PMID:22025149; http://dx.doi.org/ 10.1200/JCO.2010.34.0000 22.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cancer 2001; 92(11):2941-7; PMID:11753970;http://dx.doi.org/10.1002/1097-0142(20011201)92:11%3c2941::AID- CNCR10072%3e3.0.CO;2-C 24.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Br J Cancer 2009; 101(1):80-90; PMID:19491900; http://dx.doi.org/10.1038/sj.bjc.6605104 25.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Mol Cell Biol 2004; 24(16):7275-83; PMID:15282325; http://dx.doi.org/10.1128/MCB.24.16.7275-7283.2004 26.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
PLoS One 2008; 3(7):e2634; PMID:18648544; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Oncogene 2011; 30(24):2730-40;PMID:21278796; http://dx.doi.org/10.1038/onc.2010.640 28.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Biol Chem 1997; 272(49):30822-7; PMID:9388225; http://dx.doi.org/10.1074/jbc.272.49.30822 29.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cell 2012; 149(2):274-93; PMID:22500797; http://dx.doi.org/ 10.1016/j.cell.2012.03.017 31.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Proceedings of the New York Pathological Society 1921; CA Cancer J Clin 1972; 22(2):95-8; PMID:4622125; http://dx.doi.org/10.3322/canjclin.22.2.95 32.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Proc Natl Acad Sci U S A 2009;106(13):5324-9; PMID:19289832; http://dx.doi.org/10.1073/ pnas.0810759106 33.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
"Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing ’s sarcoma family of tumors: current management.Oncologist 2006; 11(5):503-19; PMID:16720851; http://dx.doi.org/ 10.1634/theoncologist.11-5-503 34.",Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Oncotarget 2016; 7(43):70959-68; PMID:27486822; http://dx.doi.org/10.18632/oncotarget.10938 35.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Oncol 2011; 29(7):917-24; PMID:21282551; http://dx.doi.org/10.1200/JCO.2010.32.2537 36.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Sci Transl Med 2013; 5(197):197ra103; PMID:23926201; http://dx.doi.org/10.1126/scitranslmed.3006034 37.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Blood 2013; 122(6):863-71;PMID:23770775; http://dx.doi.org/10.1182/blood-2013-03-490565 38.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Immunother 2013; 36(2):133-51; PMID:23377668;http://dx.doi.org/10.1097/CJI.0b013e3182829903 39.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
FrontOncol 2013; 3:100; PMID:23653891; http://dx.doi.org/10.3389/ fonc.2013.00100 40.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
"Stem-Cell Transplant Programs at Dusseldorf UniversityMedical Center, Germany and St. Anna Kinderspital, Vienna, Austria.Ann Oncol 2000; 11(11):1451-62; PMID:11142486; http://dx.doi.org/ 10.1023/A:1026539908115 41.",Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Oncol 2005; 23(1):242-4; PMID:15625381; http://dx.doi.org/10.1200/JCO.2005.05.940 42.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Pediatr Blood Cancer 2008;51(1):142-4; PMID:18266223; http://dx.doi.org/10.1002/pbc.21503 43.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Br J Cancer 2011; 104(6):948-56; PMID:21407224; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Nat Med 2002; 8(6):631-7; PMID:12042816; http://dx.doi.org/10.1038/nm0602-631e1273301-10 A. KIRSCHNER ET AL.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Immunol 2010; 184(11):6223-31; PMID:20483785; http://dx.doi.org/10.4049/jimmunol.0902055 50.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Nat Rev Cancer 2012; 12(3):159-69;PMID:22337149; http://dx.doi.org/10.1038/nrc3215 51.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Expert Opin Investig Drugs 2011; 20 (5):605-21; PMID:21446886; http://dx.doi.org/10.1517/13543784.2011.558501 52.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Expert OpinTher Targets 2012; 16(1):33-48; PMID:22239439; http://dx.doi.org/10.1517/14728222.2011.638626 53.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Med Oncol 2014; 31(1):805; PMID:24338270; http://dx.doi.org/10.1007/s12032-013-0805-3 54.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cancer Treat Rev2014; 40(9):1096-105; PMID:25123819; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Endocrinology 2006; 147(12):5653-61; PMID:16946002; http://dx.doi.org/10.1210/ en.2006-1055 56.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Nature 2011; 480(7378):480-9; PMID:22193102; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?J Immunother 2012; 35(9):651-60; PMID:23090074; http://dx.doi.org/ 10.1097/CJI.0b013e31827806e6 59.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
J Clin Invest 2005; 115(6):1616-26; PMID:15931392; http://dx.doi.org/10.1172/ JCI24480 60.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cancer Lett 2014; 344(1):13-9; PMID:24513265; http://dx.doi.org/10.1016/j.canlet.2013.10.015 62.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Ann Oncol 2011; 22(7):1614-21; PMID:21245159; http://dx.doi.org/10.1093/annonc/mdq703 63.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Nat Rev Cancer 2013; 13(8):525-41; PMID:23880905;http://dx.doi.org/10.1038/nrc3565 64.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Mol Cancer Ther 2015; 14(4):973-81;PMID:25695953; http://dx.doi.org/10.1158/1535-7163.MCT-14-0880 65.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Cold Spring Harb Per-spect Biol 2010; 2(10):a002311; PMID:20843980; http://dx.doi.org/ 10.1101/cshperspect.a002311 66.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Trends Immunol 2015; 36(8):494-502; PMID:26169254; http://dx.doi.org/10.1016/j.it.2015.06.004 67.,OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Sci Transl Med 2014; 6(224):224ra25; PMID:24553386; http://dx.doi.org/10.1126/scitranslmed.3008226 68.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
Blood 2014; 124(2):188-95;PMID:24876563; http://dx.doi.org/10.1182/blood-2014-05-552729 69.,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/koni-06-02-1273301.PMC5353903.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:39-47 https://doi.org/10.14 701/ahbps.2017.21.1.39 How-I-Do-It An intuitive method of duct-to-mucosa pancreaticojejunostomy  after pancreaticoduodenectomy: use of one-step circumferential  interrupted sutures Moonwhan Kim, Woo Young Shin, Keon-Young Lee, and Seung-Ik Ahn Department of Surgery, Inha Universi ty School of Medicine, Incheon, Korea Pancreaticoenteric anast omosis is the origin of post operative pancreatic fistula (POPF) .",Non-OADS,/arxiv_data1/oa_pdf/8b/e3/ahbps-21-39.PMC5353904.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:1-10 https://doi.org/10.14 701/ahbps.2017.21.1.1 Original Article Oral glucose tolerance test for preoperative assessment of  liver function in liver resection Saravanan Manickam Neethirajan1, and Raghavendra Rao Rachapoodivenkata2 1Department of Gastrointestinal Surgery, Govind Ballabh Pant Institute of Postgraduate Medical Education and  Research, New Delhi, 2National Institute of Gastroenterology and Liver Diseases, Hyderabad, India Backgrounds/Aims:  We intended to determine the role of the Oral gluc ose tolerance test (OGTT), in addition to volume- try, in preoperative assessment of  patients undergoing liver resection.",Non-OADS,/arxiv_data1/oa_pdf/33/3f/ahbps-21-1.PMC5353905.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:57-60 https://doi.org/10.14 701/ahbps.2017.21.1.57 Case Report Biliary metastasis in colorectal  cancer confers a poor prognosis:  case study of 5 consecutive patients Frederick Hong-Xiang Koh1,2, Wang Shi3, and Ker-Kan Tan1,2 1Division of Colorectal Surgery, University Surgical Cluster, National University Health System,  2Department of Surgery, Yong Loo Lin School of Me dicine, National University of Singapore,  3Department of Pathology, Yong Loo Lin School of Medici ne, National University of Singapore, Singapore The biliary duct is an extremely rare site for colon canc er metastasis.",Non-OADS,/arxiv_data1/oa_pdf/eb/f2/ahbps-21-57.PMC5353906.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:17-20 https://doi.org/10.14 701/ahbps.2017.21.1.17 Original Article Importance of critical view of safety in laparoscopic  cholecystectomy: a survey of 120 serial patients,  with no incidence of complications Bulent Kaya, Mehmet Mahir Fersahoglu, Fatih Kilic, Ender Onur, and Kemal Memisoglu Department of General Surgery, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey Backgrounds/Aims:  To determine the importance of cr itical view of safety techniques  in laparoscopic cholecystectomy.",Non-OADS,/arxiv_data1/oa_pdf/f8/d6/ahbps-21-17.PMC5353907.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:61-65 https://doi.org/10.14 701/ahbps.2017.21.1.61 Case Report ACTH-producing neuroendocrine tumor of the pancreas:  a case report and literature review Justin Byun1, Sung Hyun Kim2,3, Hyang Sook Jeong4, Yumie Rhee5,  Woo Jung Lee2,3, and Chang Moo Kang2,3 1Medical Course, Yonsei University College of Medicine, 2Division of Hepatobiliary and Pancreatic Surgery,  Department of Surgery, Yonsei University College of Medicine, 3Pancreaticobiliary Cancer Clinic, Yonsei Cancer  Center, Severance Hospital, Departments of 4Pathology and 5Endocrinology, Yonsei University College of Medicine,  Seoul, Korea Tumors that arise from the endocrine pancreas, or the islets of pancreas, are called pancreatic neuroendocrine tumors  (NETs).",Non-OADS,/arxiv_data1/oa_pdf/22/6b/ahbps-21-61.PMC5353908.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:21-29 https://doi.org/10.14 701/ahbps.2017.21.1.21 Original Article Impact of scheduled la paroscopic cholecystectomy  in patients with  acute cholecystitis, following percutaneous transhepatic  gallbladder drainage Bo-Hyun Jung, and Jeong-Ik Park Department of Surgery, Inje University Haeundae Paik Ho spital, Inje University College of Medicine, Busan, Korea Backgrounds/Aims:  Frequently encountered in practice, the first-line treatment for acute ch olecystitis is early or urgent  cholecystectomy, with laparoscopic cholecystectomy (LC) being the preferred method.",Non-OADS,/arxiv_data1/oa_pdf/c9/1e/ahbps-21-21.PMC5353909.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:48-51 https://doi.org/10.14 701/ahbps.2017.21.1.48 Case Report Fibrolamellar variant of hepatoce llular carcinoma presenting during pregnancy: management dilemmas Nagalapuram Vishnu1, Aditya V Kulkarni2, Sreenivasan Vidhyalakshmi3, Swaminathan Sambandam1,  Prerna Garg4, Venkatakrishnan LeelaKrishnan2, Krishnaveni Janarthan2, Gursharan Singh1,  Maninder Kaur5, TV Chitra6, and Biku Joseph John1 Departments of 1HPB and Liver Transplantation, 2Gastroenterology, 3Pathology, 4Radiology, 5Anaesthesiology and  Critical Care, and 6Obstetrics and Gynaecology, PSG Institute of Me dical Sciences and Research, Avinashi Road,  Coimbatore, India The Fibrolamellar variant of Hepatocellu lar Carcinoma (FLHCC) is a rare form of liver cancer that presents in the  3rd decade of life, is rarely associated with cirrhosis or chronic Hepatitis B/C virus infection, and usually presents with  normal serum alpha-fetoprotein (AFP) le vels.",Non-OADS,/arxiv_data1/oa_pdf/2e/b2/ahbps-21-48.PMC5353910.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:52-56 https://doi.org/10.14 701/ahbps.2017.21.1.52 Case Report A rare case of choledochal c yst with pancreas divisum:  case presentation and literature review Adrián Ransom-Rodríguez1,2, Ruben Blachman-Braun3, Emilio Sánchez-García Ramos1,2,  Jesús Varela-Prieto1, Erick Rosas-Lezama1, and Miguel Ángel Mercado1 1Department of Hepatopancreatobiliary Surgery, Institut o Nacional de Ciencias Médicas y Nutrición Salvador  Zubirán, Mexico City, 2Facultad Mexicana de Medicina de la Universidad La Salle, Mexico City, 3Facultad de  Ciencias de la Salud, Universidad Anáhuac México Norte, Edo.",Non-OADS,/arxiv_data1/oa_pdf/32/02/ahbps-21-52.PMC5353911.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:11-16 https://doi.org/10.14 701/ahbps.2017.21.1.11 Original Article Intra-individual variability of  mycophenolic acid concentration  according to renal function in li ver transplant recipients receiving  mycophenolate monotherapy Shin Hwang, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn,  Deok-Bog Moon, Tae-Yong Ha, Ki-Hun Kim, and Sung-Gyu Lee Division of Hepatobiliary Surgery and Liver Transplant ation, Department of Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  Mycophenolate mofetil (MMF) has wide inter- and intra-individual variability of mycophenolic acid  (MPA) after liver transplantation (LT).",Non-OADS,/arxiv_data1/oa_pdf/20/43/ahbps-21-11.PMC5353912.pdf
Ann Hepatobiliary Pancreat Surg 2017;21:30-38 https://doi.org/10.14 701/ahbps.2017.21.1.30 Original Article IL-8 gene polymorphism in acute biliary and non biliary  pancreatitis: probable cause of high level parameters?,Non-OADS,/arxiv_data1/oa_pdf/97/47/ahbps-21-30.PMC5353913.pdf
"2, e1260215 (12 pages)http://dx.doi.org/10.1080/2162402X.2016.1260215",Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
ORCID Daniela Ortner http://orcid.org/0000-0002-9433-5367 Sandrine Dubrac http://orcid.org/0000-0002-2936-8488 Bernhard Zelger http://orcid.org/0000-0003-0763-0614 Wolfgang Doppler http://orcid.org/0000-0001-6590-6063 Piotr Z. Tymoszuk http://orcid.org/0000-0002-0398-6034 Louis Boon http://orcid.org/0000-0002-0937-9171 Bj€orn E. Clausen http://orcid.org/0000-0002-2484-7842 Patrizia Stoitzner http://orcid.org/0000-0002-8488-6704 References 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
N Engl J Med 2001; 344:975-83; PMID:11274625; http://dx.doi.org/10.1056/NEJM200103293441306 2.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Dermatol Sci 1998; 17:1-7; PMID:9651822; http://dx.doi.org/10.1016/S0923-1811(97)00071-6 3.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Immunity 2000; 12:721-7; PMID:10894171; http://dx.doi.org/10.1016/S1074-7613(00)80222-8 5.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Rev Immunol 2009; 9:568-80; PMID:19629084; http://dx.doi.org/10.1038/nri2604 6.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nature2001; 413:165-71; PMID:11557981; http://dx.doi.org/10.1038/ 350931097.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Science 2001; 294:605-9;PMID:11567106; http://dx.doi.org/10.1126/science.1063916 8.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Immunol 2008; 9:146-54; PMID:18176566; http://dx.doi.org/10.1038/ni1556 9.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Commun 2011; 2:576;PMID:22146395; http://dx.doi.org/10.1038/ncomms1585 10.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Front Immunol 2015; 6:534; PMID:26557117; http://dx.doi.org/10.3389/ ﬁmmu.2015.00534 12.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Science 2012; 335:104-8; PMID:22223807; http://dx.doi.org/10.1126/science.1211600 14.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
"J InvestDermatol 2015; 135:1405-14; PMID:25233073; http://dx.doi.org/ 10.1038/jid.2014.411 1 5 .G a z i tR ,G r u d aR ,E l b o i mM ,A r n o nT I ,K a t zG ,A c h d o u tH , H a n n aJ ,Q i m r o nU ,L a n d a uG ,G r e e n b a u mEe ta l .L e t h a li n ﬂu- enza infection in the absence of the natural killer cell receptor gene Ncr1.",Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Cell Biol 2005; 169:569-76; PMID:15897263; http://dx.doi.org/10.1083/jcb.200501071 17.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Invest Dermatol 2010; 130:2752-9;PMID:20703247; http://dx.doi.org/10.1038/jid.2010.223 18.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Carcinogenesis 2004; 25:1771-8; PMID:15105299; http://dx.doi.org/10.1093/carcin/bgh170 19.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Toxicol Appl Phar-macol 2007; 224:308-12; PMID:17258781; http://dx.doi.org/10.1016/j.taap.2006.12.009 20.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Cancer Biol Ther 2003; 2:233-5;PMID:12878854; http://dx.doi.org/10.4161/cbt.2.3.373 21.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
”Blood 2005; 106:2252- 8; PMID:15933055; http://dx.doi.org/10.1182/blood-2005-03-1154 22.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Immunity 2014; 41:354-65; PMID:25238093; http://dx.doi.org/10.1016/j.immuni.2014.09.005 23.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Med 1999; 5:405-11; PMID:10202929; http://dx.doi.org/10.1038/7403ONCOIMMUNOLOGY e1260215-11,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Blood 2007; 109:3333-41;PMID:17164346; http://dx.doi.org/10.1182/blood-2006-06-026385 25.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Front Immunol 2014; 5:159;PMID:24782864; http://dx.doi.org/10.3389/ ﬁmmu.2014.00159 26.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Semin Cancer Biol 2005; 15:460-73;PMID:16039870; http://dx.doi.org/10.1016/j.semcancer.2005.06.003 27.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nature 2005; 436:1186-90; PMID:15995699; http://dx.doi.org/10.1038/nature03884 28.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
eLife 2014; 3:e01888; PMID:24843010; http://dx.doi.org/10.7554/eLife.01888 29.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Immunol 2000; 1:119-26;PMID:11248803; http://dx.doi.org/10.1038/77793 30.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Proc Natl Acad SciUSA 2001; 98:11521-6; PMID:11562472; http://dx.doi.org/10.1073/ pnas.201238598 31.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Exp Med 2003; 198:747-55; PMID:12953094; http://dx.doi.org/10.1084/jem.20021282 32.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Immunol 2006; 176:1517-24; PMID:16424180; http://dx.doi.org/10.4049/jimmunol.176.3.1517 33.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat immunol 2009; 10:75-82;PMID:19029904; http://dx.doi.org/10.1038/ni.1681 34.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Eur J Immunol 2006; 36:118-28; PMID:16323244; http://dx.doi.org/10.1002/eji.200535243 36.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Immunol 2010; 184:1102-10;PMID:20008290; http://dx.doi.org/10.4049/jimmunol.0902518 37.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Int Immunol 2001; 13:459-63; PMID:11282985; http://dx.doi.org/ 10.1093/intimm/13.4.459 38.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Chem Biol Inter-act 2004; 149:69-79; PMID:15501429; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
ImmunolRev 2010; 234:120-41; PMID:20193016; http://dx.doi.org/10.1111/j.0105-2896.2009.00886.x 40.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Trends Immunol 2007; 28:525-31; PMID:17964853; http://dx.doi.org/10.1016/j.it.2007.08.011 41.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Blood 2005;105:266-73; PMID:15331446; http://dx.doi.org/10.1182/blood-2004- 06-2492 42.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Eur J Immunol 1996; 26:659-68; PMID:8605935; http://dx.doi.org/10.1002/eji.1830260323 43.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Eur J Immu- nol 1998; 28:3231-9; PMID:9808192; http://dx.doi.org/10.1002/ (SICI)1521-4141(199810)28:10%3c3231::AID-IMMU3231%3e3.0.CO;2-Q 44.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Blood 2012; 119:5182-90; PMID:22510877; http://dx.doi.org/10.1182/blood-2011-09-382200 45.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
Nat Immunol 2003; 4:175-81; PMID:12496964; http://dx.doi.org/10.1038/ni880 46.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Leukoc Biol 2005; 77:408-13; PMID:15604121; http://dx.doi.org/10.1189/jlb.1104675 48.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Exp Med 1998; 188:1611-9;PMID:9802973; http://dx.doi.org/10.1084/jem.188.9.1611 51.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J Immunol 2005; 174:5047-56; PMID:15814736; http://dx.doi.org/10.4049/jimmunol.174.8.5047 52.,Non-OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
J ExpMed 2013; 210:2057-69; PMID:24043758; http://dx.doi.org/10.1084/ jem.20130783e1260215-12 D. ORTNER ET AL.,OADS,/arxiv_data1/oa_pdf/c0/61/koni-06-02-1260215.PMC5353916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
"2, e1265721 (3 pages)http://dx.doi.org/10.1080/2162402X.2016.1265721",Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
"al., Nature Communications 20 16; 7:12878; http://dx.doi.org/10.1038/ ncomms12878.e1265721-2 E. LAZEAR ET AL.",OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
have ﬁled a patent on data described in this manuscript with technology licensed to Courier Therapeutics ( http://www.courierthera peutics.com ).,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
ORCID Eric Lazear http://orcid.org/0000-0001-6173-8904 References 1.,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Ann Surg 1998; 228:307-19; PMID:9742914; http://dx.doi.org/ 10.1097/00000658-199809000-000042.,OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Blood 2006; 107:2409-14; PMID:16304057; http://dx.doi.org/10.1182/blood-2005-06-2399 3.,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Curr Opin Chem Biol 2014; 23:39-46; PMID:25271022; http://dx.doi.org/10.1016/j.cbpa.2014.09.006 5.,OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Nature 2012; 484:529-33; PMID:22446627; http://dx.doi.org/10.1038/nature10975 6.,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Science 2006; 311:1924-7; PMID:16484453; http://dx.doi.org/ 10.1126/science.1122927 7.,OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Cancer 1995; 76:687-94; PMID:8625167; http://dx.doi.org/10.1002/1097-0142(19950815)76:4%3c687::AID-CNCR2820760424%3e3.0.CO;2-M 8.,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
Nat Commun 2016; 7:12878; PMID:27650575; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
J Exp Med 2007; 204:1311-7; PMID:17548517; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
2013 Jan;87(2):840-50; PMID:23115291; http://dx.doi.org/10.1128/JVI.01948- 12.,OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
J Mol Biol 2008; 384:1143-56; PMID:18809410; http://dx.doi.org/10.1016/j.jmb.2008.09.008ONCOIMMUNOLOGY e1265721-3,Non-OADS,/arxiv_data1/oa_pdf/50/72/koni-06-02-1265721.PMC5353927.pdf
"Published with license by Taylor & Francis Group, LLC © Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, Fran ¸cois Bertucci, Pascal Finetti, Giuseppe Curigliano, Barbara Seliger, Luigi Cerulo, Sara Tomei, Lucia Gemma Delogu, Cristina Maccalli, Ena Wang, Lance D. Miller, Francesco M. Marincola, Michele Ceccarelli, and Davide B edognetti This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
"2, e1253654 (19 pages)http://dx.doi.org/10.1080/2162402X.2016.1253654",Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
The MAPK-mut score was calculated as follows: ﬁrst the Z-score of the differentially upregulated and downregulated genes between MAP3K1/MAP2K4 Luminal mutant vs Luminal wt sam- ples belonging to the MAPK pathway (as for KEGG http://www.genome.jp/kegg/) is calculated separately.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
"For the generation of the ideogram plot, we made use of NCBI ’s Genome Decoration Page (GDP, source: http://www.ncbi.nlm.nih.gov/genome/tools/gdp).",OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
ORCID Wouter Hendrickx http://orcid.org/0000-0002-7649-5092 Barbara Seliger http://orcid.org/0000-0002-5544-4958 Ena Wang http://orcid.org/0000-0001-6606-6510 Francesco M. Marincola http://orcid.org/0000-0001-6423-391X Davide Bedognetti http://orcid.org/0000-0002-5857-773X References 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat RevCancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/ 10.1038/nrc3245 2.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2014; 32:2959-66; PMID:25071121; http://dx.doi.org/10.1200/JCO.2013.55.0491 4.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2013; 31:860-7; PMID:23341518; http://dx.doi.org/10.1200/JCO.2011.41.0902 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Ann Oncol 2014; 25:1544-50;PMID:24608200; http://dx.doi.org/10.1093/annonc/mdu112 6.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Ann Oncol 2015; 26:259-71; PMID:25214542; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2010;28:105-13; PMID:19917869; http://dx.doi.org/10.1200/JCO.2009.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2015; 33:983-91; PMID:2553437; http://dx.doi.org/10.1200/JCO.2014.58.1967 9.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Expert Rev Vaccines 2010; 9:555-65; PMID:20518712; http://dx.doi.org/10.1586/erv.10.55 10.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Int J Cancer 2012; 131:387-95; PMID:21964766; http://dx.doi.org/10.1002/ijc.26471 11.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Genome Biol 2002; 3:RESEARCH0035; PMID:12184809; http://dx.doi.org/10.1186/gb- 2002-3-7-research0035 12.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Genome Biol 2007; 8:R8; PMID:17222352; http://dx.doi.org/10.1186/gb-2007-8-1-r8 13.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Clin Can-cer Res 2011; 17:7440-50; PMID:21976537; http://dx.doi.org/10.1158/1078-0432.CCR-11-1650 15.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Breast Cancer Res Treat 2012; 131:871-80; PMID:21479927; http://dx.doi.org/10.1007/s10549-011-1470-x 16.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139 17.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Immunity 2013; 39:11-26; PMID:23890060; http://dx.doi.org/10.1016/j.immuni.2013.07.008 18.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
CancerRes 2011; 71:1263-71; PMID:21303976; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-2907 19.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Br J Cancer 2013; 109:2412-23;PMID:24129241; http://dx.doi.org/10.1038/bjc.2013.557 20.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2013; 31:2388-95; PMID:23715562; http://dx.doi.org/10.1200/JCO.2012.44.3762 21.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2013;31:2369-71; PMID:23715576; http://dx.doi.org/10.1200/JCO.2013.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cancer Immunol Immunother 2011; 61:1019-31;PMID:22146893; http://dx.doi.org/10.1007/s00262-011-1172-6 24.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Science 2015; 350:207-11; PMID:26359337; http://dx.doi.org/ 10.1126/science.aad0095 26.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Blood 2009; 113:3620-30; PMID:19168793; http://dx.doi.org/10.1182/blood-2008-07-168351 27.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Transpl Int 2009; 22:293-302; PMID:19017305; http://dx.doi.org/10.1111/j.1432- 2277.2008.00790.x 28.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Transl Med 2011;9:174; PMID:21992116; http://dx.doi.org/10.1186/1479-5876-9-174 29.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Scand J Rheumatol 2012; 41:170-9; PMID:22401175; http://dx.doi.org/10.3109/03009742.2011.623137 30.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Curr Opin Immunol 2016; 39:150-8;PMID:26967649; http://dx.doi.org/10.1016/j.coi.2016.02.001 31.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Lancet Lond Engl 2008; 371:771-83; PMID:18275997; http://dx.doi.org/10.1016/S0140-6736(08)60241-X 32.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Trends Immunol 2008; 29:256-62; PMID:18457994; http://dx.doi.org/10.1016/j.it.2008.03.002 33.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Sci TranslMed 2013; 5:200ra116; PMID:23986400; http://dx.doi.org/10.1126/ scitranslmed.3006504 34.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Curr Opin Pharmacol 2015; 23:32-8; PMID:26047524; http://dx.doi.org/10.1016/j.coph.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Transl Med 2013; 11:145;PMID:23758773; http://dx.doi.org/10.1186/1479-5876-11-145 36.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
OncoImmunology 2014; 3:e28727; PMID:25340012; http://dx.doi.org/10.4161/onci.28727 37.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Ann Oncol 2014; 25:358-65; PMID:24299959; http://dx.doi.org/ 10.1093/annonc/mdt496 38.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Clin Cancer Res 2015;21:1688-98; PMID:25208879; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Clin Cancer Res 2008; 14:5158-65; PMID:18698033; http://dx.doi.org/10.1158/1078-0432.CCR-07-4756 40.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Invest 2013; 123:2873-92; PMID:23778140; http://dx.doi.org/10.1172/JCI67428 41.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2012; 30:1996-2004; PMID:22508827; http://dx.doi.org/10.1200/JCO.2011.39.5624 42.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Breast Cancer Res Treat 2015; 151:619-27; PMID:26006068; http://dx.doi.org/10.1007/s10549-015-3438-8 43.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol2015; 33:701-8; PMID:25605861; http://dx.doi.org/10.1200/ JCO.2014.57.6298 45.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
OncoImmunology 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884ONCOIMMUNOLOGY e1253654-17,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Curr OpinOncol 2015; 27:433-44; PMID:26418235; http://dx.doi.org/10.1097/CCO.0000000000000234 48.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
BreastCare (Basel) 2016; 11:108-15; PMID:27239172; http://dx.doi.org/ 10.1159/000445335 49.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cancer Res 2015; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cancer Res 2015; http://dx.doi.org/ 10.1158/1538-7445 51.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2015; 523:231-5; PMID:25970248; http://dx.doi.org/10.1038/nature14404 52.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2000; 406:536-40; PMID:10952317; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
BMCGenomics 2012; 13:156; PMID:22537248; http://dx.doi.org/10.1186/ 1471-2164-13-156 54.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Sci- ence 2015; 348:124-8; PMID:25765070; http://dx.doi.org/10.1126/science.aaa1348 55.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
N Engl J Med2014; 371:2189-99; PMID:25409260; http://dx.doi.org/10.1056/NEJMoa1406498 56.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Science 2016; 352:227- 31; PMID:26966191; http://dx.doi.org/10.1126/science.aac9935 57.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cancer Discov 2016; 6:202-16; PMID:26645196; http://dx.doi.org/10.1158/2159-8290.CD- 15-0283 58.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2009; 462:108-12; PMID:19847166; http://dx.doi.org/10.1038/nature08460 59.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Immunity 2013; 39:782-95; PMID:24138885; http://dx.doi.org/10.1016/j.immuni.2013.10.003 60.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2012; 490:61-70; PMID:23000897;http://dx.doi.org/10.1038/nature11412 61.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Int J Breast Cancer 2011; 2012:e217185; PMID:22295242; http://dx.doi.org/10.1155/2012/217185 62.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2013; 499:214-8; PMID:23770567; http://dx.doi.org/10.1038/nature12213 63.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature 2007; 446:153-8;PMID:17344846; http://dx.doi.org/10.1038/nature05610 64.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nature2012; 486:353-60; PMID:22722193; http://dx.doi.org/10.1038/ nature11143 65.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cell Immu-nol 2006; 244:87-9; PMID:17434156; http://dx.doi.org/10.1016/j.cellimm.2007.01.012 67.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat Med 2015; 21:938-45; PMID:26193342; http://dx.doi.org/10.1038/ nm.3909 68.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
JAK-STAT 2012; 1:65-72; PMID:24058752; http://dx.doi.org/10.4161/jkst.20045 69.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
JAK-STAT 2013; 2:e23353; PMID:24058806; http://dx.doi.org/10.4161/jkst.23353 70.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
BMC Med 2015; 13:177; PMID:26234940; http://dx.doi.org/10.1186/s12916-015-0416-2 71.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat Rev Cancer 2009; 9:798-809; PMID:19851315; http://dx.doi.org/10.1038/nrc2734 72.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cancer Res 2012; 72:6325-32; PMID:23222302; http://dx.doi.org/10.1158/0008-5472.CAN-12-2027 74.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cell 2015; 160:48-61; PMID:25594174; http://dx.doi.org/10.1016/j.cell.2014.12.033 75.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
OncoImmunology 2013; 2:e24720; PMID:24073365; http://dx.doi.org/10.4161/onci.24720 76.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Histo- pathology 2013; 62:963-5; PMID:23551496; http://dx.doi.org/10.1111/his.12085 77.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Cell Biochem 2012; 113:433-9; PMID:22006292; http://dx.doi.org/10.1002/jcb.23400 78.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Oncotarget 2014; 5:9952-65; PMID:25296970; http://dx.doi.org/10.18632/oncotarget.2481 79.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Mol Cancer Res 2015; 13:493-501;PMID:25351767; http://dx.doi.org/10.1158/1541-7786.MCR-14-0387 80.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cell Signal 2004; 16:1345-54; PMID:15381250; http://dx.doi.org/10.1016/j.cellsig.2004.05.004 81.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Biochim Biophys Acta –Mol Cell Res 2007; 1773:1213-26; PMID:17112607; http://dx.doi.org/10.1016/j.bbamcr.2006.10.005 82.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
PLoS One 2014; 9:e102289;PMID:25019290; http://dx.doi.org/10.1371/journal.pone.0102289 83.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Genes Cancer 2013; (11-12):419-26; PMID:24386504; http://dx.doi.org/ 10.1177/1947601913513950 84.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat Rev Immunol 2007; 7:202-12; PMID:17318231; http://dx.doi.org/10.1038/nri2035 85.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat Rev Immunol 2013; 13:679-92; PMID:23954936; http://dx.doi.org/10.1038/nri3495 86.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Eur CytokineNetw 2010; 21:319-28; PMID:21112826; http://dx.doi.org/10.1684/ ecn.2010.0219 88.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Front Microbiol 2016; 24;7:183; PMID:26941717; http://dx.doi.org/10.3389/fmicb.2016.00183 89.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Clin Cancer Res 2013; 19:1225-31; PMID:23307859; http://dx.doi.org/10.1158/1078-0432.CCR-12-1630 9 0 .,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Mol Oncol 2015; 9:93-104;PMID:25174651; http://dx.doi.org/10.1016/j.molonc.2014.07.014 91.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Sci Transl Med 2015; 7:279ra41-279ra41; PMID:25787767; http://dx.doi.org/10.1126/ scitranslmed.aaa4691 92.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
J Clin Oncol 2014; 32:2935-7; PMID:25071115; http://dx.doi.org/10.1200/ JCO.2014.56.7677 93.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cell 2016; 164:550-63;PMID:26824661; http://dx.doi.org/10.1016/j.cell.2015.12.028 94.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nucleic Acids Res 2016; 44:e71; PMID:26704973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Cell 2015;163:506-19; PMID:26451490; http://dx.doi.org/10.1016/j.cell.2015.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Genome Biol 2013; 14:R34; PMID:23618380;http://dx.doi.org/10.1186/gb-2013-14-4-r34 97.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Bioconductor: open soft- ware development for computational biology and bioinformatics.Genome Biol 2004; 5:R80; PMID:15461798; http://dx.doi.org/10.1186/gb-2004-5-10-r80 98.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Biostatistics2007; 8:118-27; PMID:16632515; http://dx.doi.org/10.1093/biostatistics/kxj037 99.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
BMC Genomics 2006; 7:96; PMID:16643655; http://dx.doi.org/10.1186/1471-2164-7- 96 100.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
N Engl J Med 2006; 355:560-9; PMID:16899776; http://dx.doi.org/10.1056/NEJMoa052933 101.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Breast Cancer Res 2010; 12:R68; PMID:20813035; http://dx.doi.org/10.1186/bcr2635 102.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Bioinformatics 2010; 26:1572-3; PMID:20427518; http://dx.doi.org/10.1093/ bioinformatics/btq170 103.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Stat Bandit Available from: https://statbandit.wordpress.com/2011/03/08/an-enhanced- kaplan-meier-plot/ 104.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Bioinformatics 2010; 26:139-40; PMID:19910308; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Proc Natl Acad Sci USA 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/ pnas.0506580102 106.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
PLoS One 2010; 5:e13984; PMID:21085593; http://dx.doi.org/10.1371/journal.pone.0013984 107.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
PLoS One 2007; 2:e796; PMID:17726526; http://dx.doi.org/10.1371/journal.pone.0000796 108.,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Nat Biotechnol 2015; 33:1152-8; PMID:26372948; http://dx.doi.org/10.1038/nbt.3344 109.,OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
Genome Biol 2011; 12:R41; PMID:21527027; http://dx.doi.org/ 10.1186/gb-2011-12-4-r41ONCOIMMUNOLOGY e1253654-19,Non-OADS,/arxiv_data1/oa_pdf/f3/6a/koni-06-02-1253654.PMC5353940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/bc/ftw115.PMC5353995.pdf
"Doubling time was calculated using the doubling-time calculator (Roth V. 2006 Doubling Time Computing, Availabl ef r o m http://www.doubling-time.com/compute.php ).",OADS,/arxiv_data1/oa_pdf/bf/bc/ftw115.PMC5353995.pdf
"http://www.jstatsoft.org/v61/i08/ fMASS: Venables, W. N. & Ripley, B. D. (2002) Modern Applied Statistics with S. Fourth Edition.",Non-OADS,/arxiv_data1/oa_pdf/52/f0/JVIM-31-582.PMC5354005.pdf
"7881. http://rocr.bioinf.mpi-sb.mpg.deAcknowledgments The authors are grateful for the support and help received throughout the study by the veterinarians, stu- dents, and staﬀ at Moore Equine.",Non-OADS,/arxiv_data1/oa_pdf/52/f0/JVIM-31-582.PMC5354005.pdf
"Footnotes ahttp://www.iris-kidney.com bAdvia 120, Siemens, Tarrytown, NJ cKansas State Veterinary Diagnostic laboratory.",Non-OADS,/arxiv_data1/oa_pdf/d2/8d/JVIM-31-457.PMC5354007.pdf
Available at: http://folk.ntnu.no/stoylen/strainrate/.,Non-OADS,/arxiv_data1/oa_pdf/95/73/JVIM-31-556.PMC5354014.pdf
"Ninelibraries from other cat samples from the 99 Lives pro- ject (http://felinegenetics.missouri.edu/99lives) 3,4were pooled together in equal molar ratios, based on theconcentration determined by qPCR and run across a HiSeq X ﬂow cell to generate ~1 Tb of data as 29150 bp paired-end reads.",OADS,/arxiv_data1/oa_pdf/ae/d5/JVIM-31-539.PMC5354023.pdf
"However, as pre- sented in Orphanet (http://www.orpha.net/consor/cgi- bin/index.php?lng=EN), the mutations in NPC1 occur in 95% of the families with NPC type disease and morethan 230 mutations have been identiﬁed.",Non-OADS,/arxiv_data1/oa_pdf/ae/d5/JVIM-31-539.PMC5354023.pdf
"31The clinical descriptions and phenotypes of each of these diseases and traits have been curated atthe Online Mendelian Inheritance in Animals (OMIA) website (http://omia.angis.org.au/home/), which is an invaluable resource comparison of the phenotypesacross 2216 animal species.",OADS,/arxiv_data1/oa_pdf/ae/d5/JVIM-31-539.PMC5354023.pdf
"Available at: http://omia.angis.org.au/ Accessed March10, 2016.33.",Non-OADS,/arxiv_data1/oa_pdf/ae/d5/JVIM-31-539.PMC5354023.pdf
"[Online] Available from: https://www.sealedenvelope.com/power/binary-superiority/ [Accessed Apr 26 2016] bSynbiotic D-C, Protexin Veterinary, Probiotics International Ltd., Lopen Head, Somerset, UK cWilkinson Associates, Medical Statistics, Radnage, Bucks, UK dSAS Software release 9.3, SAS Institute Inc., Cary, NC eSealed Envelope Ltd. 2012.",Non-OADS,/arxiv_data1/oa_pdf/42/8f/JVIM-31-377.PMC5354029.pdf
[Online] Available from: https://www.sealedenvelope.com/power/binary-superiority/ [Accessed Dec 10 2013] fSocial Science Statistics.,OADS,/arxiv_data1/oa_pdf/42/8f/JVIM-31-377.PMC5354029.pdf
[Online] Available from: http://www.socscistatistics.com/tests/ma nnwhitney/Default2.aspx [Accessed Nov 24 2016] gGraphPad Software Inc. 2016.,Non-OADS,/arxiv_data1/oa_pdf/42/8f/JVIM-31-377.PMC5354029.pdf
[Online] Availablefrom: https://www.graphpad.com/quickcalcs/ [Accessed Nov 24 2016] hNestle Purina Feces Scoring System.,Non-OADS,/arxiv_data1/oa_pdf/42/8f/JVIM-31-377.PMC5354029.pdf
"Primer 3 software17was used to design the primers, and the Canis lupus familiaris POMC gene transcript (Transcript: POMC-201 ENSCAFT00000006656) was downloaded from Ensembl at http://www.ensembl.org/Canis_fa- miliaris/Info/Index for this purpose.",OADS,/arxiv_data1/oa_pdf/34/18/JVIM-31-343.PMC5354034.pdf
(B) illustrates potential impact of the 14-base-pair deletion on the amino acid sequence of wild-type Labrador retriever POMC (WT-LAB) and delta-exon 3 POMC (DEL-LAB) compared to the published UNIPROT sequence (http://www.uniprot.org/uniprot/E2RQ39.fasta).,Non-OADS,/arxiv_data1/oa_pdf/34/18/JVIM-31-343.PMC5354034.pdf
Sequence alignments were per- formed at http://www.bioinformatics.org/sms2/ and functionalevaluation of the deletion at http://www.uniprot.org/uniprot/E2RQ39.,OADS,/arxiv_data1/oa_pdf/34/18/JVIM-31-343.PMC5354034.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/34/18/JVIM-31-343.PMC5354034.pdf
Available at: https://www.mercodia.se/assets/upload/files/DfU/Equine/Insulin%20Equine%20version%204_0.,Non-OADS,/arxiv_data1/oa_pdf/11/9a/JVIM-31-568.PMC5354037.pdf
Available at:http://www.fecava.org/sites/defa ult/ﬁles/ﬁles/DSAVA_Antibiotic Guidelines%20-%20v1-1_3(1).p df.,Non-OADS,/arxiv_data1/oa_pdf/55/93/JVIM-31-279.PMC5354050.pdf
"Footnotes aViraCHEK/C210/FeLV Feline Leukemia Virus (FeLV) Antigen Test Kit, Zoetis, Inc., Florham Park, NJ bPetChek/C210FeLV 15 ELISA, IDEXX Laboratories, Inc., West- brook, ME cSNAP/C210Combo FeLV Ag/FIV Ab Test, IDEXX Laboratories, Inc., Westbrook, Maine dWITNESS/C210FeLV-FIV Test Kit, Zoetis, Inc., Florham Park, NJ eAnigen/C210Rapid FIV Ab/FeLV Ag Test Kit, Bionote, Inc., Hwa- seong-shi, South Korea fVetScan/C210Feline FeLV/FIV Rapid Test, Abaxis, Inc., Union City, CA gMedCalc for Windows, MedCalc Software, Ostend, Belgium hVassarStats http://vassarstats.net/, accessed June 1, 2016 iEpi Info, version 7.0.9.34, Centers for Disease Control and Prevention, Atlanta, Georgia jLitster A, Leutenegger CM, Estrada M, et al.",Non-OADS,/arxiv_data1/oa_pdf/93/f6/JVIM-31-521.PMC5354053.pdf
"Accessed February 20, 2014 chttp://www.iris-kidney.com/pdf/grading-of-acute-kidney-injury.pdf dhydroxyethyl starch 130/0.4; Voluven/C210, Voluven balanced/C210, Fre- senius Kabi, Switzerland ehttp://apps.who.int/classifications/icd10/browse/2016/en fIBM SPSS v.21 for Mac OS X; IBM Corporation, New York, NY gStataCorp, Data Analysis and Statistical Software, College Sta-tion, Texas Acknowledgment Conﬂict of Interest Declaration: Authors declare no conﬂict of interest.",Non-OADS,/arxiv_data1/oa_pdf/2a/a0/JVIM-31-434.PMC5354072.pdf
"Development of NASA-TLX (Task  Load Index): results of empirical and theoretical research: Ames Research Center, 1988, https://archive.org/details/nasa_  techdoc_20000004342  28.",OADS,/arxiv_data1/oa_pdf/0d/07/10.1177_2050312116682254.PMC5354177.pdf
"Turk CKT, Petrik A and Sarica K. Guidelines on urolithiasis 2013, http://www.uroweb.org/publications/eau-guidelines  6.",Non-OADS,/arxiv_data1/oa_pdf/e4/b4/10.1177_2050312116685180.PMC5354178.pdf
"J Gen Intern Med 2009; 24: 614–619, http://www.ncbi.nlm.nih.gov/pubmed/19308334  3.",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"J Telemed Telecare, 2015, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"J Telemed Telecare,  2015, http://www.ncbi.nlm.nih.gov/pubmed/25712108  10.",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"J Telemed Telecare 2014; 20: 221–229, http://www.ncbi.nlm.nih.gov/pubmed/24803274  11.",OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"Am Fam Physician 2007; 75: 231–236, http://www.ncbi.nlm.nih.gov/pubmed/17263218  16.",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"Am J Med 2012; 125: e1–e7, http://www.ncbi.nlm.nih.gov/pubmed/22269625  17.",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"Med Decis Making 2015;  35: 745–757, http://www.ncbi.nlm.nih.gov/pubmed/25398622",Non-OADS,/arxiv_data1/oa_pdf/86/72/10.1177_2050312116682127.PMC5354179.pdf
"Bethesda, MD: National Cancer Institute, 2014, http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm (accessed 12 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/3c/36/10.1177_2050312116682128.PMC5354180.pdf
Trial registration The research project can be accessed on Clinical Trials site (https://clinicaltrials.gov) with the following no.,Non-OADS,/arxiv_data1/oa_pdf/f6/21/10.1177_2050312116682256.PMC5354181.pdf
"American Psychiatric  Association practice guideline for the treatment of patients  with panic disorder, 2nd edition, 2009, http://psychiatryon-line.org/pb/assets/raw/sitewide/practice_guidelines/guide-lines/panicdisorder.pdf  17.",Non-OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"ASCVD risk estimator, 2014, http://tools.acc.org/ ASCVD-Risk-Estimator/  24.",OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"Medical Expenditure Panel Survey, 2009, http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp, 2016  25.",Non-OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"Statistics about diabetes,  2016, http://www.diabetes.org/diabetes-basics/statistics/2016  31.",Non-OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"Smoking and Tobacco Use, 2013, http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/  32.",OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"Mental health financing in the United States: a  primer, 2013, https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8182.pdf  39.",Non-OADS,/arxiv_data1/oa_pdf/1a/bb/10.1177_2050312116682255.PMC5354183.pdf
"1, 46 –52 http://dx.doi.org/10.1080/19336934.2016.1222997",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Wilhelm Roux ’s Arch Dev Biol 1977; 183:85-100; http://dx.doi.org/10.1007/BF00848779 [2] Fan Y, Bergmann A. Apoptosis-induced compensatory proliferation.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Cell Death Differ 2012; 20:181; PMID:22722336; http://dx.doi.org/10.1038/cdd.2012.82 [4] Ryoo HD, Bergmann A.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Cold SpringHarb Perspect Biol 2012; 4:1-17; http://dx.doi.org/10.1101/cshperspect.a008797 [5] Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, Li CY.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Nat Med 2011; 17:860-6; PMID:21725296;http://dx.doi.org/10.1038/nm.2385 [7] Mart /C19ın FA, Per /C19ez-Garijo A, Morata G. Apoptosis in Dro- sophila: compensatory proliferation and undead cells.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Int J Dev Biol 2009; 53:1341-7; http://dx.doi.org/10.1387/ ijdb.072447fm [8] Fan Y, Wang S, Hernandez J, Yenigun VB, Hertlein G, Fogarty CE, Lindblad JL, Bergmann A.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
PLoS Genet2014; 10:e1004131; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"CurrBiol 2016; 26(5):575-84; PMID:26898463; http://dx.doi.org/10.1016/j.cub.2015.12.064 [10] Shlevkov E, Morata G. A dp53/JNK-dependant feedback ampli ﬁcation loop is essential for the apoptotic response to stress in Drosophila.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Cell Death Differ 2012; 19:451-60;PMID:21886179; http://dx.doi.org/10.1038/cdd.2011.113 [11] Thannickal VJ, Fanburg BL.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"NOX enzymes and the biology of reactive oxy- gen. Nat Rev Immunol 2004; 4:181-9; PMID:15039755; http://dx.doi.org/10.1038/nri1312 [13] Schieber M, Chandel NS.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Curr Biol 2013; 23:424-9; PMID:23394834; http://dx.doi.org/ 10.1016/j.cub.2013.01.058 [15] Santab /C19arbara-Ruiz P, L /C19opez-Santill /C19an M, Mart /C19ınez- Rodr /C19ıguez I, Binagui-Casas A, P /C19erez L, Mil /C19an M, Corominas M, Serras F. ROS-Induced JNK and p38signaling is required for unpaired cytokine activa-tion during Drosophila regeneration.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
PLoS Genet2015; 11:1-26; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Curr Opin Cell Biol 2014; 30C:1-8; http://dx.doi.org/10.1016/j.ceb.2014.04.002 [17] Cordero JB, Macagno JP, Stefanatos RK, Strathdee KE, Cagan RL, Vidal M. Oncogenic Ras diverts a host TNFtumor suppressor activity into tumor promoter.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Semin Immunopathol 2013; 35:585- 600; PMID:23657835; http://dx.doi.org/10.1007/s00281-013-0367-7 [19] Mosser DM, Edwards JP.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Nat Rev Immunol 2008; 8:958-69; PMID:19029990; http://dx.doi.org/10.1038/nri2448 [20] Sykiotis GP, Bohmann D. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in drosophila.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Antioxid Redox Signal 2014; 20:1126-67;PMID:23991888; http://dx.doi.org/10.1089/ars.2012.5149 [22] Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB, et al.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"J CellBiol 2001; 154:879-91; PMID:11514595; http://dx.doi.org/10.1083/jcb.200103132 [23] Anh NT, Nishitani M, Harada S, Yamaguchi M, Kamei K. Essential role of duox in stabilization of Drosophila wing.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"J Biol Chem 2011; 286:33244-51; PMID:21808060; http://dx.doi.org/10.1074/jbc.M111.263178 [24] Hurd TR, Liang FX, Lehmann R. Curly encodes dual oxi- dase, which acts with heme peroxidase curly su to shapethe adult Drosophila Wing.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"PLoS Genet 2015; 11:1-15;http://dx.doi.org/10.1371/journal.pgen.1005625 [25] Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. Mamma- lian thioredoxin is a direct inhibitor of apoptosis signal- regulating kinase (ASK) 1.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"EMBO J 1998; 17:2596-606;PMID:9564042; http://dx.doi.org/10.1093/emboj/17.9.2596 [26] Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J, Inoue J, Ichijo H. Recruitment of tumornecrosis factor receptor-associated factor family proteinsto apoptosis signal-regulating kinase 1 signalosome isessential for oxidative stress-induced cell death.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Science 1997; 275:90-4; PMID:8974401; http://dx.doi.org/10.1126/science.275.5296.90 [28] Noguchi T, Ishii K, Fukutomi H, Naguro I, Matsuzawa A, Takeda K, Ichijo H. Requirement of reactive oxygen spe-cies-dependent activation of ASK1-p38 MAPK pathwayfor extracellular ATP-induced apoptosis in macrophage.J Biol Chem 2008; 283:7657-65; PMID:18211888; http://dx.doi.org/10.1074/jbc.M708402200 [29] Osaka N, Takahashi T, Murakami S, Matsuzawa A, Noguchi T, Fujiwara T, Aburatani H, Moriyama K, Takeda K, Ichijo H. ASK1-dependent recruitment and activation of macrophages induce hair growth in skinFLY 51",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"J Cell Biol 2007; 176:903-9; PMID:17389227; http://dx.doi.org/10.1083/jcb.200611015 [30] Gauron C, Rampon C, Bouzaffour M, Ipendey E, Teillon J, Volovitch M, Vriz S. Sustained production of ROS trig-gers compensatory proliferation and is required forregeneration to proceed.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Sci Rep 2013; 3:2084;PMID:23803955; http://dx.doi.org/10.1038/srep02084 [31] Love NR, Chen Y, Ishibashi S, Kritsiligkou P, Lea R, K o hY ,G a l l o pJ L ,D o r e yK ,A m a y aE .A m p u t a t i o n -induced reactive oxygen species are required for suc-cessful Xenopus tadpole tail regeneration.",Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"Nat CellBiol 2013; 15:222-8; PMID:23314862; http://dx.doi.org/10.1038/ncb2659[32] Niethammer P, Grabher C, Look AT, Mitchison TJ.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
Nature 2009; 459:996-9; PMID:19494811; http://dx.doi.org/10.1038/nature08119 [33] Dvorak HF.,Non-OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"N Engl J Med 1986; 315:1650-9; PMID:3537791; http://dx.doi.org/10.1056/NEJM198612253152606 [34] Chen CC, Wang L, Plikus MV, Jiang TX, Murray PJ, Ramos R, Guerrero-Juarez CF, Hughes MW, Lee OK, Shi S,et al.",OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
Organ-Level quorum sensing directs regeneration inhair stem cell population s. Cell 2015; 161:277-90; PMID:25860610; http://dx.doi.org/10.1016/j.cell.2015.02.01652 N. DIWANJI AND A. BERGMANN,OADS,/arxiv_data1/oa_pdf/8c/f9/kfly-11-01-1222997.PMC5354222.pdf
"1, 65 –74 http://dx.doi.org/10.1080/19336934.2016.1220464",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nat Rev Mol Cell Biol 2010; 11:113-27; PMID:20094052; http://dx.doi.org/10.1038/nrm2838[2] Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Cold SpringHarb Perspect Biol 2012; 4:a013706; PMID:22751155;http://dx.doi.org/10.1101/cshperspect.a013706 [3] Christian BE, Spremulli LL.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
Biochim BiophysActa 2012; 1819:1035-54; PMID:22172991; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nat Rev Drug Discov 2015; 14:261-78;PMID:25743081; http://dx.doi.org/10.1038/nrd4505 [5] Boczonadi V, Horvath R. Mitochondria: impaired mito- chondrial translation in human disease.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
Int J BiochemCell Biol 2014; 48:77-84; PMID:24412566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Cancer Lett 2013; 340:9-21; PMID:23830805; http://dx.doi.org/10.1016/j.canlet.2013.06.019 [7] Lu J, Marygold SJ, Gharib WH, Suter B.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
Fly (Aus- tin) 2015; 9:53-61; PMID:26761199; http://dx.doi.org/ 10.1080/19336934.2015.1101196 [8] Lasko P. The Drosophila melanogaster genome: transla- tion factors and RNA binding proteins.,OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"J Cell Biol 2000;150:F51-6; PMID:10908586; http://dx.doi.org/10.1083/jcb.150.2.F51 [9] Marygold SJ, Roote J, Reuter G, Lambertsson A, Ash- burner M, Millburn GH, Harrison PM, Yu Z, KenmochiN, Kaufman TC, et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genome Biol 2007; 8:R216; PMID:17927810; http://dx.doi.org/10.1186/gb-2007-8-10-r216 [10] Attrill H, Falls K, Goodman JL, Millburn GH, Antonazzo G, Rey AJ, Marygold SJ, FlyBase Consortium.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nucleic Acids Res 2016; 44:D786-92; PMID:26467478; http://dx.doi.org/10.1093/nar/gkv1046 [11] Sasikumar AN, Perez WB, Kinzy TG.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Adv ProteinChem Struct Biol 2012; 86:45-93; PMID:22243581; http://dx.doi.org/10.1016/B978-0-12-386497-0.00002-5 [13] Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perri- mon N, Mohr SE.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"An integrative approach to ortholog pre- diction for disease-focused and other functional studies.BMC Bioinformatics 2011; 12:357; PMID:21880147; http://dx.doi.org/10.1186/1471-2105-12-357 [14] Aitken CE, Lorsch JR. A mechanistic overview of translation initiation in eukaryotes.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nat Struct Mol Biol 2012; 19:568-76; PMID:22664984; http://dx.doi.org/10.1038/nsmb.2303 [15] Myrick KV, Dearolf CR.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"244:119-25; PMID:10689194; http://dx.doi.org/10.1016/ S0378-1119(99)00568-5 [16] Krauss V, Reuter G. Two genes become one: the genes encoding heterochromatin protein Su(var)3-9 and trans-lation initiation factor subunit eIF-2gamma are joined toa dicistronic unit in holometabolic insects.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Gene 1994;140:239-42; PMID:8144032; http://dx.doi.org/10.1016/0378-1119(94)90550-9 [18] Ye X, Cavener DR.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"J Biol Chem 2001; 276:3733-42; PMID:11060303; http://dx.doi.org/10.1074/jbc.M008041200 [20] Hernandez G, Vazquez-Pianzola P, Zurbriggen A, Alt- mann M, Sierra JM, Rivera-Pomar R. Two functionallyredundant isoforms of Drosophila melanogaster eukary- otic initiation factor 4B are involved in cap-dependent translation, cell survival, and proliferation.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Eur J Biochem2004; 271:2923-36; PMID:15233788; http://dx.doi.org/10.1111/j.1432-1033.2004.04217.x [21] Carrera P, Johnstone O, Nakamura A, Casanova J, Jackle H, Lasko P. VASA mediates translation through interac-tion with a Drosophila yIF2 homolog.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Mol Cell 2000; 5:181-7; PMID:10678180; http://dx.doi.org/10.1016/ S1097-2765(00)80414-1 [22] Dorn R, Morawietz H, Reuter G, Saumweber H. Identi ﬁ- cation of an essential Drosophila gene that is homologous to the translation initiation factor eIF-4A of yeast andmouse.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Proteomics 2004; 4:316-26; PMID:14760701; http://dx.doi.org/10.1002/pmic.200300555 [24] Hernandez G, Altmann M, Sierra JM, Urlaub H, Diez del Corral R, Schwartz P, Rivera-Pomar R. Functional analy-sis of seven genes encoding eight translation initiationfactor 4E (eIF4E) isoforms in Drosophila .",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Mech Dev 2005; 122:529-43; PMID:15804566; http://dx.doi.org/ 10.1016/j.mod.2004.11.011 [25] Hernandez G, Vazquez-Pianzola P. Functional diversity of the eukaryotic translation initiation factors belonging to eIF4families.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Mech Dev 2005; 122:865-76; PMID:15922571;http://dx.doi.org/10.1016/j.mod.2005.04.002 [26] Hernandez G, Diez del Corral R, Santoyo J, Campuzano S, Sierra JM.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Mol Gen Genet 1997; 253:624-33; PMID:9065696; http://dx.doi.org/10.1007/s004380050365[27] Hernandez G, Sierra JM.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Biochim Biophys Acta 1995; 1261:427-31;PMID:7742371; http://dx.doi.org/10.1016/0167-4781(95)00039-J [28] Cho PF, Gamberi C, Cho-Park YA, Cho-Park IB, Lasko P, Sonenberg N. Cap-dependent translational inhibition estab- lishes two opposing morphogen gradients in Drosophila embryos.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Curr Biol 2006; 16:2035-41; PMID:17055983;http://dx.doi.org/10.1016/j.cub.2006.08.093 [29] Cho PF, Poulin F, Cho-Park YA, Cho-Park IB, Chicoine JD, Lasko P, Sonenberg N. A new paradigm for translationalcontrol: inhibition via 5 0-30mRNA tethering by Bicoid and the eIF4E cognate 4EHP.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Cell 2005; 121:411-23;PMID:15882623; http://dx.doi.org/10.1016/j.cell.2005.02.024 [30] Yarunin A, Harris RE, Ashe MP, Ashe HL.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"RNA Biol 2011; 8:904-12;PMID:21788736; http://dx.doi.org/10.4161/rna.8.5.16325 [31] Ghosh S, Lasko P. Loss-of-function analysis reveals distinct requirements of the translation initiation factors eIF4E,eIF4E-3, eIF4G and eIF4G2 in Drosophila spermatogenesis.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Development 2012; 139:3211-20; PMID:22833128;http://dx.doi.org/10.1242/dev.073122 [33] Brown JB, Boley N, Eisman R, May GE, Stoiber MH, Duff MO, Booth BW, Wen J, Park S, Suzuki AM, et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nature 2014; 512:393-9; PMID:24670639; http://dx.doi.org/10.1038/nature12962 [34] Chintapalli VR, Wang J, Dow JA.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Development2007; 134:2863-9; PMID:17611220; http://dx.doi.org/10.1242/dev.003764 [36] Franklin-Dumont TM, Chatterjee C, Wasserman SA, Dinardo S. A novel eIF4G homolog, Off-schedule, cou- ples translational control to meiosis and differentiation in Drosophila spermatocytes.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Development 2007; 134:2851-61; PMID:17611222; http://dx.doi.org/10.1242/dev.003517 [37] Hernandez G, del Mar Castellano M, Agudo M, Sierra JM.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genomics 2005; 85:360-71; PMID:15718103; http://dx.doi.org/10.1016/j.ygeno.2004.11.012 [39] Yoshikane N, Nakamura N, Ueda R, Ueno N, Yamanaka S, Nakamura M. Drosophila NAT1, a homolog of the verte- brate translational regulator NAT1/DAP5/p97, is requiredfor embryonic germband extension and metamorphosis.Dev Growth Differ 2007; 49:623-34; PMID:17716306; http://dx.doi.org/10.1111/j.1440-169X.2007.00956.x [40] Bradley S, Narayanan S, Rosbash M. NAT1/DAP5/p97 and atypical translational control in the Drosophila Circadian Oscillator.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genetics 2012; 192:943-57; PMID:22904033; http://dx.doi.org/10.1534/genetics.112.143248 [41] Liberman N, Marash L, Kimchi A.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Cell Cycle 2009; 8:204-9; PMID:19158497;http://dx.doi.org/10.4161/cc.8.2.7384 [42] Kim JH, Park SM, Park JH, Keum SJ, Jang SK.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Cell 2008; 135:1237-50; PMID:19109895; http://dx.doi.org/10.1016/j.cell.2008.10.037 [45] Hernandez G, Miron M, Han H, Liu N, Magescas J, Tett- weiler G, Frank F, Siddiqui N, Sonenberg N, Lasko P. Mextliis a novel eukaryotic translation initiation factor 4E-binding protein that promotes translation in Drosophila mela- nogaster .",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Mol Cell Biol 2013; 33:2854-64; PMID:23716590; http://dx.doi.org/10.1128/MCB.01354-12 [46] Lefrere V, Vincent A, Amalric F. Drosophila mela- nogaster poly(A)-binding protein: cDNA cloning reveals an unusually long 3 0-untranslated region of the mRNA, also present in other eukaryotic species.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Gene 1990;96:219-25; PMID:2125288; http://dx.doi.org/10.1016/ 0378-1119(90)90256-Q [47] Smith RW, Blee TK, Gray NK.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Poly(A)-binding proteins are required for diverse biological processes in metazoans.Biochem Soc Trans 2014; 42:1229-37; PMID:25110030;http://dx.doi.org/10.1042/BST20140111 [48] Ji Y, Shah S, Soanes K, Islam MN, Hoxter B, Biffo S, Heslip T, Byers S. Eukaryotic initiation factor 6 selec-tively regulates Wnt signaling and b-catenin protein syn- thesis.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Oncogene 2008; 27:755-62; PMID:17667944; http://dx.doi.org/10.1038/sj.onc.1210667[49] Miluzio A, Beugnet A, Volta V, Biffo S. Eukaryotic initia- tion factor 6 mediates a continuum between 60S ribo-some biogenesis and translation.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"EMBO Rep 2009;10:459-65; PMID:19373251; http://dx.doi.org/10.1038/embor.2009.70 [50] Palacios IM, Gat ﬁeld D, St Johnston D, Izaurralde E. An eIF4AIII-containing complex required for mRNA locali- zation and nonsense-mediated mRNA decay.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nature 2004; 427:753-7; PMID:14973490; http://dx.doi.org/10.1038/nature02351 [51] Frazer LN, Nancollis V, O ’Keefe RT.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Biochem Soc Trans 2008;36:551-3; PMID:18482006; http://dx.doi.org/10.1042/BST0360551 [52] Carmell MA, Xuan Z, Zhang MQ, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genes Dev 2002; 16:2733-42; PMID:12414724;http://dx.doi.org/10.1101/gad.1026102 [53] Lee S, Nahm M, Lee M, Kwon M, Kim E, Zadeh AD, Cao H, Kim HJ, Lee ZH, Oh SB, et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Development 2007; 134:1767-77; PMID:17409115; http://dx.doi.org/10.1242/dev.02842 [54] Dever TE, Gutierrez E, Shin BS.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Crit Rev Biochem Mol Biol2014; 49:413-25; PMID:25029904; http://dx.doi.org/10.3109/10409238.2014.939608 [55] Gonzalez-Flores JN, Shetty SP, Dubey A, Copeland PR.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Biomol Con- cepts 2013; 4:349-65; PMID:25436585; http://dx.doi.org/ 10.1515/bmc-2013-0007 [56] Hovemann B, Richter S, Walldorf U, Cziepluch C. Two genes encode related cytoplasmic elongation factors 1 a (EF-1 a)i n Drosophila melanogaster with continuous and stage speci ﬁc expression.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nucleic Acids Res 1988; 16:3175-94; PMID:3131735; http://dx.doi.org/10.1093/nar/16.8.3175 [57] Fan Y, Schlierf M, Gaspar AC, Dreux C, Kpebe A, Chaney L, Mathieu A, Hitte C, Gremy O, Sarot E,et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genetics2010; 184:141-54; PMID:19841092; http://dx.doi.org/10.1534/genetics.109.109553 [58] Grinblat Y, Brown NH, Kafatos FC.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
J Cell Biol 2009; 185:1181-94; PMID:19546244; http://dx.doi.org/ 10.1083/jcb.200904161FLY 73,Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"EMBO Rep 2004; 5:317-22; PMID:14978508; http://dx.doi.org/10.1038/sj.embor.7400097 [61] Graveley BR, Brooks AN, Carlson JW, Duff MO, Lando- lin JM, Yang L, Artieri CG, van Baren MJ, Boley N, Booth BW, et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nature 2011; 471:473-9; PMID:21179090; http://dx.doi.org/10.1038/nature09715 [62] Chao AT, Dierick HA, Addy TM, Bejsovec A. Mutations in eukaryotic release factors 1 and 3 act as general non-sense suppressors in Drosophila .",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Trends Biochem Sci 2013; 38:64-74; PMID:23266104; http://dx.doi.org/10.1016/j.tibs.2012.11.003 [64] Coelho CM, Kolevski B, Bunn C, Walker C, Dahanukar A, Leevers SJ.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Development 2005; 132:5411-24; PMID:16291791; http://dx.doi.org/10.1242/dev.02148 [65] Andersen DS, Leevers SJ.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"J Biol Chem 2007; 282:14752-60;PMID:17392269; http://dx.doi.org/10.1074/jbc.M701361200 [66] Schleich S, Strassburger K, Janiesch PC, Koledachkina T, Miller KK, Haneke K, Cheng YS, Kuchler K, Stoecklin G,Duncan KE, et al.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nature 2014; 512:208-12; PMID:25043021;http://dx.doi.org/10.1038/nature13401 [67] Kuzmenko A, Atkinson GC, Levitskii S, Zenkin N, Tenson T, Hauryliuk V, Kamenski P. Mitochondrial translation initi-ation machinery: conservation and diversi ﬁcation.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Biochimie 2014; 100:132-40; PMID:23954798; http://dx.doi.org/10.1016/j.biochi.2013.07.024 [68] Trivigno C, Haerry TE.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"The Drosophila mitochondrial translation elongation factor G1 contains a nuclear locali-zation signal and inhibits growth and DPP signaling.PLoS One 2011; 6:e16799; PMID:21364917; http://dx.doi.org/10.1371/journal.pone.0016799 [69] Rencus-Lazar S, Amir Y, Wu J, Chien CT, Chamovitz DA, Segal D. The proto-oncogene Int6 is essential forneddylation of Cul1 and Cul3 in Drosophila .",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"PLoS One 2008; 3:e2239; PMID:18493598; http://dx.doi.org/ 10.1371/journal.pone.0002239[70] Chew SK, Chen P, Link N, Galindo KA, Pogue K, Abrams JM.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Nature 2009; 460:123-7; PMID:19483676; http://dx.doi.org/10.1038/nature08087 [71] D ’Brot A, Chen P, Vaishnav M, Yuan S, Akey CW, Abrams JM.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genes Dev 2013; 27:1650-5; PMID:23913920; http://dx.doi.org/10.1101/gad.219287.113 [72] Serpinskaya AS, Tuphile K, Rabinow L, Gelfand VI.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"J Cell Sci 2014; 127:33-9; PMID:24163433; http://dx.doi.org/10.1242/jcs.123885 [73] Ugur B, Chen K, Bellen HJ.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Dis Model Mech 2016; 9:235- 44; PMID:26935102; http://dx.doi.org/10.1242/dmm.023762 [74] Qu S, Perlaky SE, Organ EL, Crawford D, Cavener DR. Mutations at the Ser50 residue of translation factor eIF-2alpha dominantly affect developmental rate, bodyweight, and viability of Drosophila melanogaster .",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Gene 1999; 233:241- 7; PMID:10375641; http://dx.doi.org/10.1016/S0378-1119(99)00130-4 [76] Lavoie CA, Lachance PE, Sonenberg N, Lasko P. Alterna- tively spliced transcripts from the Drosophila eIF4E gene produce two different Cap-binding proteins.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"J Biol Chem1996; 271:16393-8; PMID:8663200; http://dx.doi.org/10.1074/jbc.271.27.16393 [77] Okumura F, Zou W, Zhang DE.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Genes Dev 2007; 21:255-60;PMID:17289916; http://dx.doi.org/10.1101/gad.1521607 [78] Valzania L, Ono H, Ignesti M, Cavaliere V, Bernardi F, Gamberi C, Lasko P, Gargiulo G. Drosophila 4EHP is essential for the larval-pupal transition and required inthe prothoracic gland for ecdysone biosynthesis.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Dev Biol 2016; 410:14-23; PMID:26721418; http://dx.doi.org/ 10.1016/j.ydbio.2015.12.021 [79] Shchedrina VA, Kabil H, Vorbruggen G, Lee BC, Tura- nov AA, Hirosawa-Takamori M, Kim HY, Harshman LG, Hat ﬁeld DL, Gladyshev VN.",OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
J Biol Chem 2011; 286:29449-61; PMID:21622567; http://dx.doi.org/ 10.1074/jbc.M111.25760074 S. J. MARYGOLD ET AL.,OADS,/arxiv_data1/oa_pdf/9e/dc/kfly-11-01-1220464.PMC5354226.pdf
"Published with license by Taylo r & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"1, 10 –18 http://dx.doi.org/10.1080/19336934.2016.1222998",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Am Naturalist 2002; 160:S23-39;PMID:18707451; http://dx.doi.org/10.1086/342137 [3] Perlman SJ, Jaenike J.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Evolution 2003; 57:544-57; PMID:12703944; http://dx.doi.org/10.1111/j.0014-3820.2003.tb01546.x [4] Castrezana S, Markow TA.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"CanadianEntomologist 2001; 131:301-9; http://dx.doi.org/10.4039/ Ent133301-3[5] Polak M, Markow TA.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Evolution 1995;49:660-9; http://dx.doi.org/10.2307/2410319 [6] Heed WB.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Func- tional Ecol 1998; 12:14-21; http://dx.doi.org/10.1046/ j.1365-2435.1998.00152.x [9] Markow TA, Castrezana S. Dispersal in cactophilic Dro- sophila.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Oikos 2000; 89:378-386; http://dx.doi.org/10.1034/j.1600-0706.2000.890219.x [10] Kircher HW.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Ecol-ogy 1996; 77:1379-89; http://dx.doi.org/10.2307/2265535 [13] WoRMS.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Accessed through: World Regis- ter of Marine Species at http://www.marinespecies.org/ aphia.php?p Dtaxdetails&id D150319 2015 [14] Markow TA, O ’Grady PM.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Annual Rev Genet-ics 2005; 39:263-91; PMID:16285861; http://dx.doi.org/10.1146/annurev.genet.39.073003.112454 [15] Markow TA, Hanna G, Riesgo-Escovar JR, T /C19ellez-Garcia AA, Polihronakis Richmond M, Nazario-Yepiz NO, Ram /C19ırez Loustalot Laclette M, Carpinteyro-Ponce J, Pfeiler E. Popula-tion genetics and recent colonization history of the invasivedrosophilid Zaprionus indianus in Mexico and CentralAmerica.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Biol Invasions 2014; 16:2427-34; PMID:26190935;http://dx.doi.org/10.1007/s10530-014-0674-5 [16] Folmer O, Black M, Hoeh W, Lutz R, Vrijenhoek R. DNA primers for ampli ﬁcation of mitochondrial cytochrome c oxidase subunit I from diverse metazoan invertebrates.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Mol Marine Biol Biotechnol 1994; 3:294-9; PMID:7881515 [17] Skoracka A, Dabert M. The cereal rust mite Abacarus hystrix (Acari: Eriophyoidea) is a complex of species: evi-dence from mitochondrial and nuclear DNA sequences.Bulletin Entomolog Res 2010; 100:263-72; http://dx.doi.org/10.1017/S0007485309990216 [18] Nunney L. The colonization of oranges by the cosmopoli- tan Drosophila.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Annals Entomological Society Am 1961; 54:748; http://dx.doi.org/10.1093/aesa/54.5.748 [20] Axtell RC.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"J Economic Entomol 1963; 56:317-21; http://dx.doi.org/ 10.1093/jee/56.3.317 [21] Beresford DV, Sutcliffe SF.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Ecological Entomology 2015; 40:518-24; http://dx.doi.org/10.1111/een.12218 [23] Markow TA, Toolson EC.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Evolution 1987; 41:294-302; http://dx.doi.org/10.2307/2409139 [25] Berry JS, Holtzer TO.",Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"Exp AppliedAcarol 1990; 8:253-74; http://dx.doi.org/10.1007/BF01202136 [26] Takabayashi J, Takahashi S. Effects of host fecal pellet and synthetic airomone on host-searching and postovi-position behavior of Apanteles kariyai, a parasitoid ofPseudaletia separata.",OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Entomologia Experimentalis Et Applicata 1989; 52:221-7; http://dx.doi.org/10.1111/ j.1570-7458.1989.tb01271.x [27] Jaenike J.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
Ann Rev Ecol Systematics 1990; 21:243-73; http://dx.doi.org/10.1146/annurev.es.21.110190.00133118 A. PEREZ-LEANOS ET AL.,Non-OADS,/arxiv_data1/oa_pdf/a7/44/kfly-11-01-1222998.PMC5354228.pdf
"1, 27 –36 http://dx.doi.org/10.1080/19336934.2016.1221549",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Science 1972; 175:776-7; PMID:17836138; http://dx.doi.org/10.1126/science.175.4023.776 [2] Schilmiller AL, Howe GA.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Curr Opin Plant Biol 2005; 8:369-77;PMID:15939667; http://dx.doi.org/10.1016/j.pbi.2005.05.008 [3] Kashio S, Obata F, Zhang L, Katsuyama T, Chihara T, Miura M. Tissue nonautonomous effects of fat body methioninemetabolism on imaginal disc repair in Drosophila.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"AnnuRev Genet 2012; 46:289-310; PMID:22934642; http://dx.doi.org/10.1146/annurev-genet-110711-155637 [6] Kashio S, Obata F, Miura M. Interplay of cell prolifera- tion and cell death in Drosophila tissue regeneration.Dev Growth Differ 2014; 56:368-75; PMID:24819984;http://dx.doi.org/10.1111/dgd.12139 [7] Bellen HJ, D ’Evelyn D, Harvey M, Elledge SJ.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Development 1992; 114:787-96;PMID:1618142; http://www.ncbi.nlm.nih.gov/pubmed/ 1618142 [8] Lee JW, Cho E, Aghaian E, Aghaian E, Der J, Wisnieski BJ.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Biochemistry2005; 44:2555-65; PMID:15709768; http://dx.doi.org/10.1021/bi048317p [9] Smith-Bolton RK, Worley MI, Kanda H, Hariharan IK.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Dev Cell 2009; 16:797-809;PMID:19531351; http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Development 2010; 137:1169-79;PMID:20215351; http://dx.doi.org/10.1242/dev.045559 [11] Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phe- notypes.",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Development 1993; 118:401-15; PMID:8223268;http://www.ncbi.nlm.nih.gov/pubmed/8223268 [12] McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Science 2003; 302:1765-68; PMID:14657498;http://dx.doi.org/10.1126/science.1089035 [13] Schuster KJ, Smith-Bolton RK.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Dev Cell 2015; 34:119-28;PMID:26096735; http://dx.doi.org/10.1016/j.devcel.2015.04.017 [14] Lai SL, Lee T. Genetic mosaic with dual binary transcrip- tional systems in Drosophila.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nat Neurosci 2006; 9:703-09; PMID:16582903; http://dx.doi.org/10.1038/nn1681 [15] Potter CJ, Tasic B, Russler EV, Liang L, Luo L. The Q system: a repressible binary system for transgene expression, lineage tracing, and mosaic analysis.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Cell 2010; 141:536-48;PMID:20434990; http://dx.doi.org/10.1016/j.cell.2010.02.025 [16] Riabinina O, Luginbuhl D, Marr E, Liu S, Wu MN, Luo L, Potter CJ.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nat Methods 2015;PMID:25581800; http://dx.doi.org/10.1038/nmeth.3250 [17] Colombani J, Andersen DS, Boulan L, Boone E, Romero N, Virolle V, Texada M, Leopold P. Drosophila Lgr3 Couples O r g a nG r o w t hw i t hM a t u r a t i o na n dE n s u r e sD e v e l o p m e n t a lStability.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Curr Biol 2015; 25:2723-9; PMID:26441350; http://dx.doi.org/10.1016/j.cub.2015.09.020 [18] Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolismand glutathione synthesis by the transsulfuration pathwayand its regulation by redox changes.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Biochemistry 2000; 39:13005-11; PMID:11041866; http://dx.doi.org/doi/ 10.1021/Bi001088w [19] Eriksson S, Prigge JR, Talago EA, Arner ESJ, Schmidt EE.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nat Commun 2015; 6: PMID:25790857;http://dx.doi.org/10.1038/Ncomms7479 [20] Petrossian TC, Clarke SG.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Mol Cell Proteomics 2011; 10:M110 000976; PMID:20930037; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Physiol Rev 2012; 92:1515-42;PMID:23073625; http://dx.doi.org/10.1152/physrev.00047.2011 [22] Liu SP, Li YS, Chen YJ, Chiang EP, Li AFY, Lee YH, Tsai TF, Hsiao M, Hwang SF, Chen YMA.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"46:1413-25; PMID:17937387; http://dx.doi.org/10.1002/ hep.21863 [23] Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, Martinez N, Varela M, Luka Z, Capdevila A, Rodriguez J,Aransay AM, Matthiesen R, et al.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Hepatology 2008; 47:1191-99; PMID:18318442; http://dx.doi.org/10.1002/bep.22159 [24] Obata F, Kuranaga E, Tomioka K, Ming M, Takeishi A, Chen CH, Soga T, Miura M. Necrosis-driven sys-temic immune response alters SAM metabolismthrough the FOXO-GNMT axis.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Cell reports 2014;7:821-33; PMID:24582964; http://dx.doi.org/10.1016/j.celrep.2014.03.046 [25] Obata F, Miura M. Enhancing S-adenosy L-methionine catabolism extends Drosophila lifespan.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nat Commun 2015; 6:8332; PMID:26383889; http://dx.doi.org/10.1038/ncomms9332 [26] Huang ZZ, Mao Z, Cai J, Lu SC.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
J Biol Chem 1968; 243:707-15; PMID:5638586; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"FASEB J 2004; 18:914-6;PMID:15033934; http://dx.doi.org/10.1096/fj.03-1204fje [30] Varela-Rey M, Fernandez-Ramos D, Martinez-Lopez N, Embade N, Gomez-Santos L, Beraza N, Vazquez-Chan-tada M, Rodriguez J, Luka Z, Wagner C, et al.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Hepatology 2009; 50:443-52; PMID:19582817; http://dx.doi.org/10.1002/hep.23033 [31] Gallucci S, Matzinger P. Danger signals: SOS to the immune system.",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Curr Opin Immunol 2001; 13:114-9;PMID:11154927; http://dx.doi.org/10.1016/S0952-7915(00)00191-6 [32] Matzinger P. The danger model: a renewed sense of self.,Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Science 2002; 296:301-5; PMID:11951032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Neuron 2015; 87:47-62; PMID:26139369;http://dx.doi.org/10.1016/j.neuron.2015.05.019 [34] Coussens LM, Werb Z.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322 [35] Ming M, Obata F, Kuranaga E, Miura M. Persephone/ Spatzle Pathogen Sensors Mediate the Activation of TollReceptor Signaling in Response to Endogenous Danger Signals in Apoptosis-de ﬁcient Drosophila.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"J Biol Chem 2014; 289:7558-68; PMID:24492611; http://dx.doi.org/10.1074/jbc.M113.543884 [36] Welchman DP, Aksoy S, Jiggins F, Lemaitre B. Insect immunity: from pattern recognition to symbiont-mediated host defense.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Cell host & microbe 2009; 6:107-14; PMID:19683677; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Curr Top Dev Biol 2014;108:153-83; PMID:24512709; http://dx.doi.org/10.1016/B978-0-12-391498-9.00001-2 [38] Takeishi A, Kuranaga E, Tonoki A, Misaki K, Yonemura S, Kanuka H, Miura M. Homeostatic Epithelial Renewal in the Gut Is Required for Dampening a Fatal Systemic Wound Response in Drosophila.",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Cell Rep 2013; 3:919-30; PMID:23523355; http://dx.doi.org/10.1016/j.celrep.2013.02.022 [39] Chakrabarti S, Dudzic JP, Li X, Collas EJ, Boquete JP, Lemaitre B.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"PLoS Genet 2016;12:e1006089; PMID:27231872; http://dx.doi.org/10.1371/ journal.pgen.1006089 [40] Nam HJ, Jang IH, You H, Lee KA, Lee WJ.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Genetic evi- dence of a redox-dependent systemic wound response viaHayan Protease-Phenoloxidase system in Drosophila.Embo J 2012; 31:1253-65; PMID:22227521; http://dx.doi.org/10.1038/emboj.2011.476 [41] Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Science 2003; 302:1227-31; PMID:14551319; http://dx.doi.org/10.1126/science.1088474 [42] Pastor-Pareja JC, Wu M, Xu T. An innate immune response of blood cells to tumors and tissue damage in Drosophila.Dis Model Mech 2008; 1:144-54; discussion 153;PMID:19048077; http://dx.doi.org/10.1242/dmm.000950 [43] Parisi F, Stefanatos RK, Strathdee K, Yu Y, Vidal M. Transformed epithelia trigger non-tissue-autonomoustumor suppressor response by adipocytes via activa- tion of Toll and Eiger/TNF signaling.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Cell Rep 2014; 6:855-67; PMID; http://dx.doi.org/10.1016/j.celrep.2014.01.039 [44] Cavuoto P, Fenech MF.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Cancer Treat Rev2012; 38:726-36; PMID:22342103; http://dx.doi.org/10.1016/j.ctrv.2012.01.004 [45] Katzenberger RJ, Chtarbanova S, Rimkus SA, Fischer JA, Kaur G, Seppala JM, Swanson LC, Zajac JE, Ganetzky B,Wassarman DA.",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Elife 2015; 4: PMID:25742603; http://dx.doi.org/10.7554/eLife.04790 [46] Katzenberger RJ, Ganetzky B, Wassarman DA.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Fly 2015; 9:68-74; PMID:26291482; http://dx.doi.org/10.1080/19336934.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"FrontSyst Neurosci 2016; 10:36; PMID:27199685; http://dx.doi.org/10.3389/fnsys.2016.00036 [48] Glanville NT, Anderson GH.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Diabetologia 1984; 27:468-71; PMID:6391990; http://www.ncbi.nlm.nih.gov/ pubmed/6391990 [49] Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes.",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"J Clin Invest 2007;117:1219-22; PMID:17476353; http://dx.doi.org/10.1172/JCI32169 [50] Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, L e eJ ,L e e s o nP ,N e u b a u e rS ,R a t n a t u n g aC ,P i l l a iR ,e ta l .",Non-OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Nature 2016; 531:237-40; PMID:26934225; http://dx.doi.org/10.1038/nature16974 [53] Hasegawa T, Nakajima T, Ishida T, Kudo A, Kawakami A.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
"Dev Biol 2015; 399:80-90; PMID:25533245; http://dx.doi.org/10.1016/j.ydbio.2014.12.015 [54] Owusu-Ansah E, Perrimon N. Stress Signaling Between Organs in Metazoa.",OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
Annu Rev Cell Dev Bi 2015; 31:497-522; PMID:26393775; http://dx.doi.org/10.1146/annurev-cellbio-100814-12552336 S. KASHIO ET AL.,OADS,/arxiv_data1/oa_pdf/02/3f/kfly-11-01-1221549.PMC5354237.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 73–83Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  73 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S94059New developments in the management of  Waldenström macroglobulinemia  Jithma  P Abeykoon1  Uday Yanamandra2  Prashant Kapoor1,3 1Department of Internal Medicine,   Mayo Clinic, Rochester, MN, USA;  2Department of Hematology and  Stem Cell Transplant, Army Hospital  (Research & Referral), Delhi, India;   3Division of Hematology, Mayo Clinic,   Rochester, MN, USAAbstract:  Waldenström macroglobulinemia (WM) is a rare, immunoglobulin M  -associated  lymphoplasmacytic lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
"Epidemiology Approximately 1,500 new cases of WM are diagnosed in the US each year.4 The median  age at diagnosis is ~70 years, with an incidence rate of 3.4 per million among men and  1.7 per million among women in the US.2 Caucasians are predominantly affected.5 Although no proven inheritance patterns have been observed in WM to date, a  population-based study was remarkable for demonstrating a 20-fold increased risk of development of lymphoplasmacytic lymphoma (LPL)/WM in the first-degree relatives Correspondence: Prashant Kapoor   Division of Hematology, Mayo Clinic,   200 First Street SW, Rochester,   MN 55905, USA   Tel +1 507 538 0591   Fax +1 507 266 4972   Email kapoor.prashant@mayo.eduJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Abeykoon et alRunning head recto: Developments in the management of WMDOI: http://dx.doi.org/10.2147/CMAR.S94059",Non-OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 83 Developments in the management of WM  62.,Non-OADS,/arxiv_data1/oa_pdf/f8/d6/cmar-9-073.PMC5354523.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 299–306Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  299Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S9406 0 Clinical role of brexpiprazole in depression  and schizophrenia Nishant B Parikh Diana M Robinson Anita H Clayton Psychiatry and Neurobehavioral  Sciences, University of virginia School  of Medicine, Charlottesville, vA, USAAbstract:  Brexpiprazole, a serotonin–dopamine activity modulator, is the second D2 partial  agonist to come to market and has been approved for the treatment of schizophrenia and as an  adjunctive treatment in major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
"Current Correspondence: Anita H Clayton Psychiatry and Neurobehavioral Sciences,  University of virginia School of Medicine,  PO Box 800623, Charlottesville, vA  22908 USA email ahc8v@virginia.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Parikh et al Running head recto: Clinical role of brexpiprazole in depression and schizophrenia DOI: http://dx.doi.org/10.2147/TCRM.S94060",Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
"Available from: https://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/205422s000lbl.pd f. Accessed January 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/8d/tcrm-13-299.PMC5354524.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/b3/tcrm-13-307.PMC5354525.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 307–314Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  307ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13025 7 The risk reduction of recurrent periodontal  pathogens of local application minocycline hCl  2% gel, used as an adjunct to scaling and root  planing for chronic periodontitis treatment Y soeroso1,2 T akase3 h sunarto1,2 Y Kemal1 R salim1 M Octavia1 a Viandita1 J setiawan1 BM Bachtiar2,4 1Department of Periodontology,   Faculty of Dentistry, Universitas  indonesia, Jakarta, indonesia;   2Oral sciences Research Center,   Universitas indonesia, Jakarta,   indonesia; 3R&D, Oral Care Company,   sunstar group, Takatsuki City, Japan;   4Department of Oral Biology, Faculty  of Dentistry, Universitas indonesia,   Jakarta, indonesiaBackground:  The aim of this study was to evaluate the clinical and microbiological effects of  local application minocycline HCl 2% gel, used as an adjunct to scaling and root planing (SRP)  for treatment of chronic periodontitis (CP).",Non-OADS,/arxiv_data1/oa_pdf/46/b3/tcrm-13-307.PMC5354525.pdf
"It is well known that the immune  response to bacterial products such as lipopolysaccharide, proteolytic enzymes, and  subsequent production of proinflammatory cytokines could also evoke an inflamma - tory reaction in periodontal tissue.Correspondence: Y soeroso Department of Periodontology,  Building B, 2nd Floor, Faculty of  Dentistry, Universitas indonesia, Jln  salemba Raya no 4, Jakarta Pusat, DKi  Jakarta 10430, indonesia Tel +62 21 391 1502 Fax +62 21 391 1502 email yuniarti_22@yahoo.co.i d Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Soeroso et al Running head recto: The risk reduction of recurrent periodontal pathogens DOI: http://dx.doi.org/10.2147/TCRM.S130257",Non-OADS,/arxiv_data1/oa_pdf/46/b3/tcrm-13-307.PMC5354525.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/46/b3/tcrm-13-307.PMC5354525.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/b3/tcrm-13-307.PMC5354525.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 85–90Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 85 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S123798Antibiotic resistance among Helicobacter pylori  clinical isolates in Lima, Peru Kevin F Boehnke1 Manuel Valdivieso2 Alejandro Bussalleu3 Rachael Sexton4 Kathryn C Thompson1 Soledad Osorio5 Italo Novoa Reyes3 John J Crowley4 Laurence H Baker2 Chuanwu Xi1 1Department of Environmental Health  Sciences, School of Public Health,   2Division of Hematology Oncology,   Department of Internal Medicine,   University of Michigan, Ann Arbor, MI,  USA;  3Departamento Académico de  Clínicas Médicas, Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú;  4Cancer  Research and Biostatistics, Seattle,  WA, USA;  5Dirección General de  Salud Ambiental, Ministerio de Salud del Perú, Lima, PerúObjectives: Gastric carcinoma is the most common cancer and cause of cancer mortality in Peru.",Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
"For example, meta-analyses of European and Asian clinical data compared the standard triple therapy (amoxicillin, clarithromycin, and a proton-pump Correspondence: Chuanwu Xi Department of Environmental Health Sciences, School of Public Health, University of Michigan, 6631 SPH Tower, 1415 Washington Heights, Ann Arbor,   MI 48109, USATel +1 734 615 7594Email cxi@umich.eduJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Boehnke et alRunning head recto: Antibiotic resistance among H. pylori isolatesDOI: http://dx.doi.org/10.2147/IDR.S123798",Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
Available from: http://euro-pepmc.org/abstract/med/17211488.,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 90 Boehnke et al  23.,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
Available from: http://www.eucast.org.,Non-OADS,/arxiv_data1/oa_pdf/a8/4a/idr-10-085.PMC5354526.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/40/opth-11-503.PMC5354527.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 503–509Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  503Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12874 6 a retrospective study comparing outcomes of  primary rhegmatogenous retinal detachment  repair by scleral buckling and pars plana  vitrectomy in Finland sari sahanne1 raimo T uuminen2 Jari haukka3 sirpa loukovaara4 1Department of anesthesiology,   helsinki University Central  hospital, helsinki, 2Department  of Ophthalmology, Kymenlaakso  Central hospital, Kotka, 3hjelt  institute, Faculty of Medicine,   University of helsinki, 4Unit of  Vitreoretinal surgery, Department of  Ophthalmology, helsinki University  Central hospital, University of  helsinki, helsinki, FinlandBackground:  Rhegmatogenous retinal detachment (RRD) is the most common form of retinal  detachment and an ophthalmic emergency.",Non-OADS,/arxiv_data1/oa_pdf/8a/40/opth-11-503.PMC5354527.pdf
"Introduction RRD is a potentially sight-threatening vitreoretinal disease and ophthalmic emergency.1  PVR, first reported in 1934 by Gonin, is the most frequent and severe complication of  RRD and a major cause of failure of RRD surgery leading to a need of reoperation,  with an incidence of 4%–34% in prospective studies.2–4Correspondence: sirpa loukovaara Unit of Vitreoretinal surgery,  Department of Ophthalmology, helsinki  University Central hospital, University of  helsinki, haartmaninkatu 4 C, Fi-00290  helsinki, Finland Tel +358 50 427 1566 Fax +358 9 4717 5100 email sirpa.loukovaara@hus.fi  Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sahanne et al Running head recto: Outcomes of primary rhegmatogenous retinal detachment repair DOI: http://dx.doi.org/10.2147/OPTH.S128746",Non-OADS,/arxiv_data1/oa_pdf/8a/40/opth-11-503.PMC5354527.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8a/40/opth-11-503.PMC5354527.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/40/opth-11-503.PMC5354527.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/26/dddt-11-713.PMC5354528.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 713–723Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  713Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12686 1 Pharmacokinetics and tolerability of D a-8031, a  novel selective serotonin reuptake inhibitor for  premature ejaculation in healthy male subjects Dongseong shin1 seung hwan lee2 sojeong Yi2 seo hyun Y oon2 Joo-Y oun cho2 Mi Y oung Bahng3 in-Jin Jang2 Kyung-sang Yu2 1clinical Trials center, gachon  University gil Medical center,   incheon, 2Department of clinical  Pharmacology and Therapeutics,   seoul national University college of  Medicine and hospital, 3Department  of Product Development, Dong-a sT,   seoul, KoreaObjective:  DA-8031 is a selective serotonin reuptake inhibitor under development for the  treatment of premature ejaculation.",Non-OADS,/arxiv_data1/oa_pdf/48/26/dddt-11-713.PMC5354528.pdf
"Keywords:  DA-8031, pharmacokinetics, selective serotonin reuptake inhibitor, premature  ejaculation, first-in-human Introduction Premature ejaculation (PE) is the most common male sexual dysfunction.1,2  Approximately 20%–30% of men complained of PE, and 76.9% of males with typical  erectile function reported various degrees of PE.3–5 Psychological issues and neurogenic  conditions have been suggested as etiological factors of PE.6 Anxiety or conditioning  toward rapid ejaculation was attributed to psychological causes, and either hyposensi - tivity of 5-hydroxytryptamine 2C (5-HT2c) receptors or hypersensitivity of the 5-HT1a  receptors was associated with the neurogenic etiology.6,7 Selective serotonin reuptake  inhibitors (SSRIs) are capable of increasing the activity of serotonergic cells in the  nucleus paragigantocellularis, thereby inhibiting the expulsion phase of ejaculation  by modulating bulbospongiosus muscle activity and impairing the emission phase by  blocking the rise in seminal vesicular pressure.8,9correspondence: Kyung-sang Yu Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine and  hospital, 101 Daehak-ro Jongno-gu,  seoul 110-744, Korea Tel +82 2 2072 1920 Fax +82 2 7429 252 email ksyu@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Shin et al Running head recto: Pharmacokinetics and tolerability of DA-8031  DOI: http://dx.doi.org/10.2147/DDDT.S126861",Non-OADS,/arxiv_data1/oa_pdf/48/26/dddt-11-713.PMC5354528.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/48/26/dddt-11-713.PMC5354528.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/26/dddt-11-713.PMC5354528.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2017:11 23–30Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  23 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S123831Neutralizing activities against seasonal influenza  viruses in human intravenous immunoglobulin Hiroyuki Onodera1  Takeru Urayama2  Kazue Hirota3  Kazuhiro Maeda3  Ritsuko Kubota-Koketsu3,4  Kazuo Takahashi5  Katsuro Hagiwara6  Y oshinobu Okuno3  Kazuyoshi Ikuta3,4  Mikihiro Yunoki2,4,6 1Medical Information Department,   2Research and Development Division,   Japan Blood Products Organization,   T okyo, 3Research and Development  Division, The Research Foundation for Microbial Diseases of Osaka University, Kagawa,  4Former  Department of Virology, Research Institute for Microbial Diseases,  Osaka University,  5Virology Division,   Department of Infectious Diseases,  Osaka Prefectural Institute of Public Health, Osaka,  6Pathogenic  Risk Evaluation, Graduate School of Veterinary Medicine, Rakuno Gakuen University, Hokkaido, JapanAbstract: Influenza viruses A/H1N1, A/H3N2, and B are known seasonal viruses that undergo  annual mutation.",Non-OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
"Although VN is considered a more significant functional marker than HI, the fluctuation of VN Mikihiro Yunoki Research and Development Division, Japan Blood Products Organization, 7F World Trade Center Building, 2-4-1, Hamamatsu-cho, Minato-ku, Tokyo 105-6107, JapanEmail Yunoki-mikihiro@jbpo.or.jp Ritsuko Kubota-Koketsu Research and Development Division, The Research Foundation for Microbial Diseases of Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, JapanEmail rkoketsu@mail.biken.or.jpJournal name: Biologics: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 11Running head verso: Onodera et alRunning head recto: Neutralizing activities against seasonal influenza viruses in IVIGDOI: http://dx.doi.org/10.2147/BTT.S123831",Non-OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
Available from: http://www.nih.go.jp/niid/ja/typhi-m/iasr-reference/230-iasr-data/5492-iasr-table-v-p.html.,OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
"Biologics: Targets and Therapy 2017:11submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 30 Onodera et al,Non-OADS,/arxiv_data1/oa_pdf/43/7f/btt-11-023.PMC5354529.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/ijn-12-1941.PMC5354530.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1941–1958International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1941OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12557 3 Cyclic RGD peptide-modified liposomal drug  delivery system for targeted oral apatinib  administration: enhanced cellular uptake and  improved therapeutic effects Zhiwang Song Yun lin Xia Zhang Chan Feng Y onglin Lu Y ong Gao Chunyan Dong Department of Oncology, Shanghai  East Hospital, Tongji University  School of Medicine, Shanghai, People’s  Republic of ChinaAbstract:  Apatinib is an oral tyrosine kinase inhibitor, which selectively targets vascular  endothelial growth factor receptor 2 and has the potential to treat many tumors therapeutically.",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/ijn-12-1941.PMC5354530.pdf
"VEGFR inhibitors have also been recently developed.4 Apatinib is an orally administered TKI, which selectively targets VEGFR-2, simi - larly to vatalanib, but with a higher binding affinity and greater efficacy than either  vatalanib or sorafenib.5,6 It was found to inhibit the efflux function of the multiple  ATP-binding cassette transporter.7 Clinical trials have confirmed the efficacy and safety Correspondence: Chunyan Dong Department of Oncology, Shanghai  East Hospital, Tongji University School  of Medicine, 150 Jimo Road, Shanghai  200120, People’s Republic of China Tel +86 133 7002 9736 email cydong_tongji@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Song et al Running head recto: Cyclic RGD peptide-modified liposomes for oral apatinib in CRC DOI: http://dx.doi.org/10.2147/IJN.S125573",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/ijn-12-1941.PMC5354530.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/ijn-12-1941.PMC5354530.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/c7/ijn-12-1941.PMC5354530.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2017:5 1–9Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 1 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S130526Induction of erythropoiesis by hypoxia-inducible  factor prolyl hydroxylase inhibitors without  promotion of tumor initiation, progression,  or metastasis in a VEGF-sensitive model of spontaneous breast cancer T odd W Seeley Mark D Sternlicht Stephen J Klaus Thomas B NeffDavid Y Liu Therapeutics R&D, FibroGen, Inc., San  Francisco, CA, USAAbstract:  The effects of pharmacological hypoxia-inducible factor (HIF) stabilization were  investigated in the MMTV -Neundl-YD5 (NeuYD) mouse model of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
"6,7 Mutations in HIF pathway genes underlie specific familial polycythemias,8 includ- ing mutation of the von Hippel–Lindau protein (pVHL) in Chuvash polycythemia and erythrocytoses associated with mutations in HIF-2α (e.g., EP AS1 [HIF2A] G537W , G537R, I533V) 9,10 and PHD2 (EGLN1 [PHD2] P317R, R371H).11,12 These provide  genetic evidence that modulation of HIF pathway genes can be used to increase RBC Correspondence: Todd W Seeley Therapeutics R&D, FibroGen, Inc., 409 Illinois Street, San Francisco, CA 94158, USATel +1 415 978 1494Email tseeley@fibrogen.comJournal name: Hypoxia Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 5Running head verso: Seeley et alRunning head recto: Erythropoiesis by HIF-PHIs without tumor promotionDOI: http://dx.doi.org/10.2147/HP .S130526",Non-OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
"Hypoxia 2017:5submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 9 Erythropoiesis by HIF-PHIs without tumor promotion  39.,Non-OADS,/arxiv_data1/oa_pdf/5b/c0/hp-5-001.PMC5354531.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 421–430Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  421OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11594 5 Dementia and delirium, the outcomes in elderly  hip fracture patients Christina A Mosk1 Marnix Mus1 Jos PAM Vroemen1 Tjeerd van der Ploeg2 Dagmar I Vos1 leon hgJ elmans3 lijckle van der laan1 1Department of surgery, Amphia  hospital, Breda, 2Department of  Public health, erasmus MC–University  Medical Center, rotterdam,   3Department of Orthopedic  surgery, Amphia hospital, Breda,   the netherlandsBackground:  Delirium in hip fractured patients is a frequent complication.",Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
"The number of  persons aged 70 will double within the next three decades, which will result in an  increase in the incidence of hip fractures.1 More than any other type of fracture, a hip fracture in elderly is associated with loss  of independence, high morbidity and mortality (36%), and high health care costs.2 A major complication in elderly hip fracture patients is delirium, with an incidence  rate varying from 13% to 70%.3–6 Postoperative delirium is associated with poor out - comes, such as impaired functional and cognitive recovery, increased hospital length  of stay, higher costs, and increased mortality.3–12Correspondence: Christina A Mosk Department of surgery, Amphia  hospital, 90518, 4800 rK Breda,  the netherlands Tel +31 76 595 2653 email amosk@amphia.n l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Mosk et al Running head recto: Hip fracture patients, delirium and dementia DOI: http://dx.doi.org/10.2147/CIA.S115945",Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs404/en/ 201 5.,Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0a/a3/cia-12-421.PMC5354532.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care 2017:9 63–75HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 63 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S120576Can the HIV-1 splicing machinery be targeted for  drug discovery?",Non-OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
"The 2 kb completely spliced the transcripts, 4 kb partially spliced the transcripts, and 9 kb unspliced the Correspondence: Zodwa Dlamini Research, Innovation & Engagements Portfolio, Mangosuthu University of Technology, 511 Griffiths Mxenge Highway, Umlazi, Durban 4031, South AfricaEmail dlaminiz@mut.ac.zaJournal name: HIV/AIDS - Research and Palliative Care Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Dlamini and HullRunning head recto: Can HIV -1 splicing machinery be targeted for drug discovery?DOI: http://dx.doi.org/10.2147/HIV .S120576",Non-OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
"HIV/AIDS - Research and Palliative Care 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 75 Can HIV-1 splicing machinery be targeted for drug discovery?,Non-OADS,/arxiv_data1/oa_pdf/2f/75/hiv-9-063.PMC5354533.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/e9/copd-12-839.PMC5354536.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 839–848International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  839OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12714 6 Colds as predictors of the onset and severity of  COPD exacerbations neil W Johnston1 Marita Olsson2 staffan edsbäcker3 Maria gerhardsson de  Verdier4 Per gustafson5 Christopher McCrae3 Peter V Coyle6 r andrew McIvor1 1Department of Medicine, Firestone  Institute for respiratory health,  McMaster University, hamilton, On ,  Canada; 2early Clinical Development  Biometrics, 3Respiratory, Inflammation &   autoimmunity Unit, Innovative  Medicines & Early Development,  4Medical evidence and Observational  research Centre, 5respiratory,  Inflammation & Autoimmunity  Translational Medicine Unit, early  Clinical Development, Innovative  Medicines & Early Development,  astraZeneca research and  Development, gothenburg, Molndal,  sweden; 6regional Virology laboratory,  Belfast hsC Trust, Belfast, UKRationale:  Common colds are associated with acute respiratory symptom exacerbations in  COPD patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/e9/copd-12-839.PMC5354536.pdf
"COPD exacerbations associated with symptoms  of a cold have been shown to have longer recovery times and more sudden onset11,12 than  those without cold symptoms, and COPD patients having more frequent exacerbations  experience nearly double the number of colds compared to patients experiencing fewer  exacerbations.13 The frequent exacerbator phenotype has been suggested to be related Correspondence: neil W Johnston Department of Medicine, Firestone  Institute for respiratory health,  McMaster University, 50 Charlton  avenue east, hamilton, On l8n 4a6,  Canada  Tel +1 905 537 6911 email njohnsto@mcmaster.c a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Johnston et al Running head recto: Colds as predictors of onset and severity of COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S127146",Non-OADS,/arxiv_data1/oa_pdf/a0/e9/copd-12-839.PMC5354536.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a0/e9/copd-12-839.PMC5354536.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/e9/copd-12-839.PMC5354536.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 769–774Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  769OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12756 7 Preliminary evaluation of a “formulation-driven  cognitive behavioral guided self-help (fcBT -gsh)”  for crisis and transitional case management clients Farooq Naeem1,2 rupinder K Johal1 claire Mckenna1 Olivia calancie1 Tariq Munshi1,2 Tariq hassan1 amina Nasar3 Muhammad ayub1 1Department of Psychiatry, Queen’s  University, Kingston, ON, canada;   2addiction and Mental health  services  – Kingston, Frontenac,   lennox & addington (aM hs-KFla),   Kingston, ON, canada; 3services  institute of Medical sciences,   lahore,  PakistanBackground:  Cognitive behavioral therapy (CBT) is found to be effective for common mental  disorders and has been delivered in self-help and guided self-help formats.",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
"Crisis intervention also reduced correspondence: Tariq Munshi  addiction and Mental health  services – Kingston, Frontenac,  lennox & addington (aMhs-KFla),  385 Princess street, Kingston,  ON, K7l, canada email munshit@providence.car e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Naeem et al Running head recto: Preliminary evaluation of fCBT-GSH DOI: http://dx.doi.org/10.2147/NDT.S127567",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
"Available from: http://onlinelibrary.wiley.com.proxy.queensu.ca/ doi/10.1002/14651858.CD011698/abstrac t. Accessed October 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
"Available from:  http://www.schres-journal.com/article/S0920996415001206/abstrac t.  Accessed October 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d1/4d/ndt-13-769.PMC5354537.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2017:9 37–53Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 37 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S87828 Management of systemic lupus erythematosus  during pregnancy: challenges and solutions Caroline L Knight Catherine Nelson-Piercy Division of women’s Health, women’s  Health Academic Centre, King’s  College London and King’s Health Partners, St Thomas’ Hospital,  London, UKAbstract:  Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease  predominantly affecting women, particularly those of childbearing age.",Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
"The incidence of SLE in women is six times higher than in men in the UK (8.34 vs 1.44/100,000 person-years); 1 in premenopausal adults,  the female-to-male ratio is 15:1.4 There are also marked variations in incidence in Correspondence: Catherine  Nelson-PiercyDivision of women’s Health, women’s Health Academic Centre, King’s College London and King’s Health Partners, St Thomas’ Hospital, westminster Bridge Road, London Se1 7eH, UKTel +44 20 7188 7905email catherine.nelson-piercy@gstt.nhs.ukJournal name: Open Access Rheumatology: Research and Reviews Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Knight and Nelson-PiercyRunning head recto: Management of systemic lupus erythematosus during pregnancyDOI: http://dx.doi.org/10.2147/OARRR.S87828",Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
2016. http://www.medicinesinpregnancy.org/bumps/monographs/USE-OF-MYCOPHENOLATE-MOFETIL-IN-PREGNANCY/.,Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
2016. http://www.medicinesinpregnancy.org/bumps/monographs/USE-OF-METHOTREXATE-IN-PREGNANCY/.,Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
"Open Access Rheumatology: Research and Reviews 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 53 Management of systemic lupus erythematosus during pregnancy,Non-OADS,/arxiv_data1/oa_pdf/b5/19/oarrr-9-037.PMC5354538.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 81–95Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  81 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S120048Retrospective, nonrandomized controlled study  on autoadjusting, dual-pressure positive airway  pressure therapy for a consecutive series of  complex insomnia disorder patients Barry Krakow1–3 Natalia D McIver1,2 Victor A Ulibarri1,2 Michael R Nadorff4,5 1Sleep & Human Health Institute,   2Maimonides Sleep Arts & Sciences,   Ltd, Albuquerque, 3Los Alamos  Medical Center, Los Alamos,   NM, 4Department of Psychology,   Mississippi State University,   Mississippi, MS, 5Department of  Psychiatry and Behavioral Sciences,  Baylor College of Medicine,  Houston,  TX, USAPurpose: Emerging evidence shows that positive airway pressure (PAP) treatment of obstructive  sleep apnea (OSA) and upper airway resistance syndrome (UARS) in chronic insomnia patients  (proposed “complex insomnia” disorder) leads to substantial decreases in insomnia severity.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
"Keywords: insomnia, obstructive sleep apnea, upper airway resistance syndrome, CPAP failure,  autobilevel, adaptive servoventilation Introduction Chronic insomnia is noted to be the “most prevalent sleep disorder worldwide”.1  Extensive research has evaluated the etiology and assessment of insomnia,2–7 eco- nomic impact,1,5,8,9 and evidence-based pharmacological and nonpharmacological Correspondence: Barry Krakow Sleep & Human Health Institute, 6739 Academy Rd NE, Ste 380, Albuquerque, NM 87109, USATel +1 505 998 7204Fax +1 505 998 7220Email bkrakow@sleeptreatment.comJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Krakow et alRunning head recto: Advanced PAP therapy for complex insomnia disorder patientsDOI: http://dx.doi.org/10.2147/NSS.S120048 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
Or use: http://youtu.be/5TkbK2JkLs8,Non-OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal Nature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/nss-9-081.PMC5354540.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 133–140Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 133 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S126003 Silicone-induced granuloma of breast implant  capsule (SIGBIC): similarities and differences   with anaplastic large cell lymphoma (ALCL)   and their differential diagnosis Eduardo de Faria Castro  Fleury1 Milena Morais Rêgo1 Luciana Costa Ramalho1 Veronica Jorge Ayres1 Rodrigo Oliveira Seleti2 Carlos Alberto Pecci Ferreira 2 Decio Roveda Jr2 1Radiology Department, IBCC –  Instituto Brasileiro de Controle  do Câncer, 2Irmandade Santa Casa  de Misericórdia de São Paulo,  São Paulo,  BrazilAbstract:  Primary breast lymphoma is a rare disease and accounts for 0.5% of cases of breast  cancer.",Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
"4Correspondence: Eduardo de Faria  Castro FleuryRua Maestro Chiaffarelli, 409, Jardim Paulista – São Paulo 01432-030, BrazilTel +55 11 98148 1188Email edufleury@hotmail.com Journal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Fleury et alRunning head recto: Silicone-induced granuloma of breast implant capsule (SIGBIC)DOI: http://dx.doi.org/10.2147/BCTT.S126003",Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 140 Fleury et al Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
Available from: http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/mama.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm241090.htm.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm064348.htm.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/bctt-9-133.PMC5354541.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/dddt-11-725.PMC5354542.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 725–731Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  725Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13112 3 an open-label, two-period comparative study  on pharmacokinetics and safety of a combined  ethinylestradiol/gestodene transdermal  contraceptive patch chao Zhang1 haiyan li2 Xin Xiong1 suodi Zhai1 Yudong Wei2 shuang Zhang2 Yuanyuan Zhang1 lin Xu2 li liu1 1Department of Pharmacy, 2institute  of clinical Trial, Peking University  Third hospital, Beijing, People’s  republic of chinaAbstract:  We investigated the pharmacokinetics and safety profiles of a newly developed  combined ethinylestradiol (EE)/gestodene (GSD) transdermal contraceptive patch after a  single-dose administration and compared with the market available tablet formulation in healthy  adult subjects.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/dddt-11-725.PMC5354542.pdf
"Concerns about using COCs focus on their safety and large fluctuations in  serum hormone concentration.2–4 The risk of venous thromboembolism (VTE) and  cardiovascular events is dose related with estrogen and progestogen.5 Meanwhile,  it is recognized that poor compliance is common with daily COCs and can greatly  reduce contraceptive efficacy.6,7 Therefore, over the years, the development of  innovative, safe contraceptives associated with improved compliance has been  important.correspondence: chao Zhang Department of Pharmacy, Peking  University Third hospital, 49 huayuan  north road, haidian District, Beijing,  People’s republic of china Tel/fax +86 10 8226 5740 email laural.zhang@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Zhang et al Running head recto: Combined EE/GE transdermal contraceptive patch DOI: http://dx.doi.org/10.2147/DDDT.S131123",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/dddt-11-725.PMC5354542.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/dddt-11-725.PMC5354542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/dddt-11-725.PMC5354542.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/62/ott-10-1513.PMC5354543.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1513–1518OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1513Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12368 5 adverse prognostic impact of TGFB1  T869c  polymorphism in non-small-cell lung cancer Yulan sang1 Xin Bi1 Yan liu2 Wei Zhang1 Dongjie Wang1 1Department of respiratory,   The First affiliated hospital  of harbin Medical University,   2Department of respiratory,   The Fourth hospital of harbin,   harbin, People’s republic of chinaAbstract:  Previously, several polymorphisms in TGFB1  have been identified in non-small-cell  lung cancer (NSCLC), and the variants, C-509T, T869C, and G915C, have been demonstrated to  associate with higher circulating levels of TGF- β1.",Non-OADS,/arxiv_data1/oa_pdf/12/62/ott-10-1513.PMC5354543.pdf
"Emerging evidence has  demonstrated that SNPs affect gene expression and further increase the potential risk  of cancer.7,8 Meanwhile, the prognostic value of SNPs has been revealed in multiple  human cancers, including NSCLC.9–11 TGF-β1 is a multifunctional cytokine that regulates many aspects of cellular function,  including cellular proliferation, differentiation, migration, apoptosis, and immune  surveillance.12 In cancers, it has been reported that TGF- β1 acts as a tumor suppressor  at early stages by inhibiting cell proliferation and as a tumor promoter at enhanced  stages by facilitating tumor progression and metastasis.13 In lung cancer, several poly - morphisms in the TGFB1  gene have been reported previously, including rs1800469, correspondence: Wei Zhang Department of respiratory, The First  Affiliated Hospital of Harbin Medical  University, #23, Youzheng street,  nangang District, harbin 150086,  heilongjiang Province, People’s  republic of china Tel/fax +86 451 8555 6000 email drzhanghuge@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Sang et al Running head recto: The prognostic impact of TGFB1  T869C in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S123685",Non-OADS,/arxiv_data1/oa_pdf/12/62/ott-10-1513.PMC5354543.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/62/ott-10-1513.PMC5354543.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/62/ott-10-1513.PMC5354543.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/da/40/opth-11-493.PMC5354544.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 493–501Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  493Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12770 0 Preoperative subconjunctival combined injection  of bevacizumab and mitomycin C before the  surgical excision of primary pterygium: clinical and  histological results alahmady hamad alsmman1 gamal radwan1 Mortada ahmed abozaid1 Usama ali Mohammed1 nesreen gamal abd  elhaleim2 1Department of Ophthalmology,   2Department of histology, sohag  Faculty of Medicine, sohag University,   sohag, egyptPurpose:  The aim of this study was to detect the clinical and histological effects of preoperative  subconjunctival injection of both bevacizumab and mitomycin C (MMC) 1 month before the  surgical excision of primary pterygium using a bare sclera technique.",Non-OADS,/arxiv_data1/oa_pdf/da/40/opth-11-493.PMC5354544.pdf
"In advanced cases,  the pterygium may affect vision through obscuring the optical center and inducing  astigmatism and corneal scarring.3Correspondence: alahmady hamad  alsmman Department of Ophthalmology, Faculty  of Medicine, sohag University, elmhafza  street, sohag 82524, egypt Tel +20 1 1111 02698 email alahmady20@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Alsmman et al Running head recto: Preoperative subconjunctival combined injection of bevacizumab and MMC DOI: http://dx.doi.org/10.2147/OPTH.S127700",Non-OADS,/arxiv_data1/oa_pdf/da/40/opth-11-493.PMC5354544.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/da/40/opth-11-493.PMC5354544.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/40/opth-11-493.PMC5354544.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/df/ott-10-1519.PMC5354545.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1519OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/df/ott-10-1519.PMC5354545.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 1519ReTRacTiO nopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13638 2 MTA1 promotes proliferation and invasion in human gastric cancer cells  [Retraction] Y ao Y, Feng S, Xiao M, et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/df/ott-10-1519.PMC5354545.pdf
A case of image Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2017 Volume: 10 Running head verso: Dove Medical Press Running head recto: MTA1 promotes proliferation and invasion in human gastric cancer cells DOI: http://dx.doi.org/10.2147/OTT.S13638 2 duplication in Figure 5 was brought to the attention of the  Editorial team.,Non-OADS,/arxiv_data1/oa_pdf/ad/df/ott-10-1519.PMC5354545.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 153–161Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 153 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S125783 The effects of turmeric (curcumin) on tumor  suppressor protein (p53) and estrogen receptor  (ERα) in breast cancer cells Kelly Hallman Katie Aleck Brigitte Dwyer Victoria LloydMeghan QuigleyNada Sitto Amy E Siebert Sumi Dinda School of Health Sciences, Prevention  Research Center, Oakland University,  Rochester, MI, USAAbstract:  Curcumin (CUR) is a compound that has antibacterial, antiviral, anti-inflammatory,  and anticancer properties.",Non-OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
"4–6 It is also  considered to have valuable potential with regards to the targeting of various cancers.6Correspondence: Sumi Dinda Biomedical Diagnostic and Therapeutic Sciences, 3164 HHB, School of Health Sciences, 433 Meadow Brook Road, Oakland University, Rochester, MI 48309, USATel +1 248 364 8676Fax +1 248 364 8657Email sdinda@oakland.eduJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Hallman et alRunning head recto: Effects of turmeric on p53 and ERαDOI: http://dx.doi.org/10.2147/BCTT.S125783",Non-OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 161 Effects of turmeric on p53 and ER α31.,Non-OADS,/arxiv_data1/oa_pdf/e6/ac/bctt-9-153.PMC5354546.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 87–94International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 87 OrIGInal research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S129235Utilization and prescribing patterns of direct   oral anticoagulants Maegan M Whitworth1 Krystal K haase1 David s Fike1 ravindra M Bharadwaj2 rodney B Y oung3 eric J Maclaughlin1,4 1Department of Pharmacy Practice,   T exas T ech University health  sciences center (TTUhsc) school  of Pharmacy, 2Department of  Internal Medicine, 3Department of  Family and community Medicine,   4Departments of Family Medicine and  Internal Medicine, TTUhsc school of  Medicine, amarillo, TX, UsaBackground: Scant literature exists evaluating utilization patterns for direct oral anticoagu- lants (DOACs).",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"4 The health care costs associated with VTE are considerable,  exceeding $1.5 billion annually in the US.5,6correspondence:  eric J Maclaughlin Department of Pharmacy Practice, Texas  Tech University health sciences center (TTUhsc) school of Pharmacy, 1300 s. coulter street, suite 203, amarillo, TX 79106, UsaTel +1 806 414 9302Fax +1 806 356 4018email eric.Maclaughlin@TTUhsc.eDUJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Whitworth et alRunning head recto: Direct oral anticoagulantsDOI: http://dx.doi.org/10.2147/IJGM.S129235 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
Or use: http://youtu.be/OQnFa0ta114,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK44178/.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 94 Whitworth et al Table S1  adapted  medication appropriateness indexa Criteria Category Instructions Indication A Valid indication exists B DOAC used as a last resort or indication does not fit within reimbursement criteria C Off-label use Choice A DOac preferred choice: labile Inr with VKa, cI to VKa, patient preference, recurrent  stroke/VTe on VKa, resistance to VKa B no contraindication, not yet tested, no recurrent stroke/VTe on VKa C Not preferred choice: severe renal insufficiency, poor compliance, need for drug monitoring, severe hepatic impairment, recurrent VTe/stroke on current DOac Dosage A receives daily dose as recommended C Inappropriate daily dose (too low or too high) Correct administration A correct modalities of DOac intake B limited clinical relevance for modalities of DOac intake (rivaroxaban taken in evening, dabigatran taken c/o meals) C Inappropriate modalities of DOac intake (once-daily dabigatran, variable times of intake, rivaroxaban taken without meals) Practical administration A No difficult taking dosage form C Difficulties taking the drug (dabigatran BID in patients with poor compliance, dabigatran in patients with swallowing difficulties [capsules cannot be opened]) Drug-drug interactions A no DDI B Potential DDI (caution or warning) without s/sx adverse event C DDI contraindication with adverse consequence Drug-disease interactions A no drug-disease interactions B Potential interaction (caution or warning) without s/sx of worsening disease C contraindicated with disease, presents high risk, or DOac used with caution and positive s/sx of worsening disease Therapeutic duplication A DOac is the only antithrombotic B concomitant anticoagulant when switching therapy (DOac to VKa) C Duplication of antithrombotic Duration of therapy A Duration in accordance with manufacturer indications C Duration not appropriate based on recommendations Notes: a = appropriate, B = inappropriate with limited clinical importance, c = inappropriate.",Non-OADS,/arxiv_data1/oa_pdf/1f/cd/ijgm-10-087.PMC5354547.pdf
"2, December 2016           109        This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/f6/AIPM-14-103.PMC5354619.pdf
Available at: http://www.biomedcentral.com /1471-2261/15/5 6.Sarnat HB.,Non-OADS,/arxiv_data1/oa_pdf/b9/6e/AIPM-14-110.PMC5354620.pdf
"2, December 2016            113        This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License         (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.and practice 5th ed.",Non-OADS,/arxiv_data1/oa_pdf/b9/6e/AIPM-14-110.PMC5354620.pdf
20.Guidelines for Community noise; WHO Expert Task Force 1999.   http://apps.who.int/iris/ handle/10665/66217 (accessed on 27/121/2014).,OADS,/arxiv_data1/oa_pdf/46/5a/AIPM-14-58.PMC5354622.pdf
Sound Meter V2.7 http://trajkovski.net  (accessed 12/1/2014).,Non-OADS,/arxiv_data1/oa_pdf/46/5a/AIPM-14-58.PMC5354622.pdf
"2, December 2016              64          This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/5a/AIPM-14-58.PMC5354622.pdf
The raw data for this study may be accessed through: https://drive.google.com/file/d/0BxDI- mGBDiH1RkttVFJkbjh1M2M/view  .The London School of Hygiene and Tropical Medicine Research Ethics Committee (No: 011/415) and the University of Ibadan/University College Hospital Ethics Committee (NHREC/05/01/2008a) provided ethical clearance for this study.,Non-OADS,/arxiv_data1/oa_pdf/8d/5f/AIPM-14-65.PMC5354623.pdf
"2, December 2016              73           This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/5f/AIPM-14-65.PMC5354623.pdf
"2, December 2016              80           This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/e4/AIPM-14-74.PMC5354624.pdf
"2, December 2016             84         This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/a8/AIPM-14-81.PMC5354625.pdf
"2, December 2016             91 This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/bb/AIPM-14-85.PMC5354626.pdf
Jul21st]; Available from: http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/04/bb/AIPM-14-85.PMC5354626.pdf
[cited 2011 Aug 6th]; Available from: <http://www.globalissues.org/article/26/ poverty-facts-and-stats>.,Non-OADS,/arxiv_data1/oa_pdf/04/bb/AIPM-14-85.PMC5354626.pdf
"2, December 2016             98        This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/01/AIPM-14-92.PMC5354627.pdf
"2, December 2016           102       This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (<uri xlink:href=""http://creativecommons.org/licenses/by-nc/3.0/"">http://creativecommons.org/licenses/by-nc/3.0</uri>)  which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/AIPM-14-99.PMC5354628.pdf
We have previously reported the spectrum of DNA mutations in the LuCaP PDX series using whole exome sequencing [38] (http://trace.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/0f/f8/PROS-77-654.PMC5354949.pdf
"Received:  June 18, 2015    Revised:  February 6, 2016 Accepted:  March 30, 2016    Available online:  September 9, 2016  Correspondence:  Ji Y oung Song, MD Department of Psychiatry, Kyung Hee University School of Medicine, 23 Kyung - heedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea Tel: +82-2-958-8550, Fax: +82-2-957-1997, E-mail:  jysongnp@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.111",Non-OADS,/arxiv_data1/oa_pdf/9a/9d/pi-14-111.PMC5355007.pdf
"Received:  July 7, 2016    Revised:  July 7, 2016 Accepted:  July 15, 2016    Available online:  March 6, 2017  Correspondence:  Y eunhee Joyce Kim, PhD  Department of Social Welfare, Daegu University, Center for Multiculturalism  and Social Policy, 200 Daegudae-ro, Jillyang-eup, Gyeongsan 38453, Republic  of Korea Tel: +82-53-850-6317, Fax: +82-53-850-6319, E-mail:  yeunheekim@daegu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.118",Non-OADS,/arxiv_data1/oa_pdf/0a/c6/pi-14-118.PMC5355008.pdf
Available  at http://www.unikorea.go.kr/content.do?cmsid=1440.,Non-OADS,/arxiv_data1/oa_pdf/0a/c6/pi-14-118.PMC5355008.pdf
"Received:  December 25, 2015    Revised:  February 24, 2016 Accepted:  March 31, 2016    Available online:  October 13, 2016  Correspondence:  Sung Man Chang, MD, PhD Department of Psychiatry, Kyungpook National University School of Medi - cine, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Republic of Korea Tel: +82-53-420-5753, Fax: +82-53-426-5361, E-mail:  psyjang@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.126",Non-OADS,/arxiv_data1/oa_pdf/3e/13/pi-14-126.PMC5355009.pdf
"Received:  March 15, 2016    Revised:  June 25, 2016 Accepted:  July 10, 2016    Available online:  January 6, 2017  Correspondence:  Y oung-Min Park, MD, PhD Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medi - cine, 170 Juhwa-ro, Ilsansu-gu, Goyang 10380, Republic of Korea Tel: +82-31-910-7260, Fax: +82-31-910-7268, E-mail:  medipark@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.136",Non-OADS,/arxiv_data1/oa_pdf/14/a2/pi-14-136.PMC5355010.pdf
"Received:  May 13, 2016    Accepted:  July 23, 2016 Available online:  October 24, 2016  Correspondence:  Do-Un Jung, MD, PhD  Department of Psychiatry, Busan Paik Hospital, Inje University College of  Medicine, 75 Bokji-ro, Busanjin-gu, Busan 47392, Republic of Korea Tel: +82-51-890-6189, Fax: +82-51-894-2532, E-mail:  gabriel.jdu@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS https://doi.org/10.4306/pi.2017.14.2.141ORIGINAL ARTICLE   Copyright © 2017 Korean Neuropsychiatric Association   141",Non-OADS,/arxiv_data1/oa_pdf/8d/02/pi-14-141.PMC5355011.pdf
"Received:  June 27, 2016    Revised:  August 3, 2016 Accepted:  August 29, 2016    Available online:  November 2, 2016  Correspondence:  Jae-Min Kim, MD, PhD Department of Psychiatry, Chonnam National University Medical School, 160  Baekseo-ro, Dong-gu, Gwangju 61469, Republic of Korea Tel: +82-62-220-6143, Fax: +82-62-225-2351, E-mail:  jmkim@chonnam.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.150",Non-OADS,/arxiv_data1/oa_pdf/e5/4a/pi-14-150.PMC5355012.pdf
"Received:  February 12, 2016    Revised:  February 24, 2016    Accepted:  March 17, 2016    Available online:  November 2, 2016  Correspondence:  Jun-Won Hwang, MD Department of Psychiatry, Kangwon National University School of Medicine, 156 Baengnyeong-ro, Chuncheon 24289, Republic of Korea Tel: +82-33-258-9410, Fax: +82-33-254-1376, E-mail:  huangjw@daum.net cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 ) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.158",Non-OADS,/arxiv_data1/oa_pdf/bf/35/pi-14-158.PMC5355013.pdf
Available  at: http://www.koreatimes.co.kr/www/news/nation/2015/03/116_175007.,Non-OADS,/arxiv_data1/oa_pdf/bf/35/pi-14-158.PMC5355013.pdf
"Received:  October 31, 2015    Revised:  April 2, 2016 Accepted:  April 11, 2016    Available online:  November 2, 2016  Correspondence:  Myung Ho Lim, MD, PhD  Department of Psychology, College of Social Science, Dankook University,  119 Dandae-ro, Cheonan 31116, Republic of Korea Tel: +82-41-550-3263, Fax: +82-41-550-3260, E-mail:  paperose@dku.edu cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.166",Non-OADS,/arxiv_data1/oa_pdf/0f/ba/pi-14-166.PMC5355014.pdf
"Received:  January 5, 2016    Revised:  April 11, 2016 Accepted:  April 20, 2016    Available online:  January 6, 2017  Correspondence:  Hasan Bozkurt, MD Department of Child and Adolescent Psychiatry, Faculty of Medicine, Gazios - manpasa University Medical Faculty Hospital, Kaleardı District, Muhittin  Fisunoğlu Street, Ali Şevki Erek Campus, Tokat 60100, Turkey Tel: +90-356-2129500, Fax: +90-356-2133179, E-mail:  drhasan33@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.172 172  Copyright © 2017 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/98/16/pi-14-172.PMC5355015.pdf
"Received:  June 8, 2016    Revised:  August 2, 2016 Accepted:  August 4, 2016    Available online:  October 13, 2016  Correspondence:  Chul-Hyun Cho, MD, PhD  Department of Psychiatry, Korea University College of Medicine, 73 Inchon- ro, Seongbuk-gu, Seoul 02841, Republic of Korea Tel: +82-2-920-5815, Fax: +82-2-927-2836, E-mail:  david0203@gmail.com  Correspondence:  Leen Kim, MD, PhD  Department of Psychiatry, Korea University College of Medicine, 73 Inchon- ro, Seongbuk-gu, Seoul 02841, Republic of Korea Tel: +82-2-920-5815, Fax: +82-2-927-2836, E-mail:  leen54@chol.com  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.179",Non-OADS,/arxiv_data1/oa_pdf/56/1f/pi-14-179.PMC5355016.pdf
"The Fitbit Charge HR  (Fitbit Inc., San Francisco, CA, USA; https://www.fitbit.com/)  that was used in this study has a three-axis acceleration sen - sor, altimeter, vibration motor, and optical heart rate monitor.",Non-OADS,/arxiv_data1/oa_pdf/56/1f/pi-14-179.PMC5355016.pdf
"Received:  May 31, 2016    Revised:  August 1, 2016 Accepted:  August 3, 2016    Available online:  October 13, 2016  Correspondence:  Suk Kyoon An, MD, PhD Department of Psychiatry, Y onsei University College of Medicine, Severance  Hospital, Y onsei University Health System, 50-1 Y onsei-ro, Seodaemun-gu,  Seoul 03722, Republic of Korea Tel: +82-2-2228-1585, Fax: +82-2-313-0891, E-mail:  ansk@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.186",Non-OADS,/arxiv_data1/oa_pdf/0b/76/pi-14-186.PMC5355017.pdf
"Received:  January 19, 2016    Revised:  May 7, 2016 Accepted:  July 1, 2016    Available online:  October 19, 2016  Correspondence:  Wan Seok Seo, MD, PhD Department of Neuropsychiatry, College of Medicine, Y eungnam University,  170 Hyeonchung-ro, Daegu 42415, Republic of Korea Tel: +82-53-620-3344, Fax: +82-53-629-0256, E-mail:  sws3901@ynu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.193",Non-OADS,/arxiv_data1/oa_pdf/47/19/pi-14-193.PMC5355018.pdf
"Received:  January 17, 2016    Revised:  April 1, 2016 Accepted:  September 1, 2016    Available online:  January 10, 2017  Correspondence:  Heejune Ahn, MD Deptartment of Electrical and Information Engineering, Seoul National Univer - sity of Science and Technology, 232 Gongneung-ro, Nowon-gu, Seoul 01811, Re - public of Korea  Tel: +82-2-970-6543, Fax: +82-2-949-2654, E-mail:  heejune@seoultech.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.198",Non-OADS,/arxiv_data1/oa_pdf/7a/5f/pi-14-198.PMC5355019.pdf
"Received:  October 11, 2015    Revised:  May 15, 2016 Accepted:  June 1, 2016    Available online:  February 4, 2017  Correspondence:  IL Han Choo, MD, PhD Department of Neuropsychiatry, School of Medicine, ChosunUniversity, Chosun  University Hospital, 365 Pilmun-daero, Dong-gu, Gwangju 61452, Republic of  Korea  Tel: +82-62-220-3104, Fax: +82-62-225-3659, E-mail:  ilhan.choo@chosun.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.205",Non-OADS,/arxiv_data1/oa_pdf/2c/e3/pi-14-205.PMC5355020.pdf
"When the data were reported as sensitivity and specificity,  Hedges’s g was calculated by the Comprehensive Meta-Analy - sis program (http://meta-analysis.com).",OADS,/arxiv_data1/oa_pdf/2c/e3/pi-14-205.PMC5355020.pdf
Supplementary Materials The online-only Data Supplement is available with this ar - ticle at https://doi.org/10.4306/pi.2017.14.2.205.,OADS,/arxiv_data1/oa_pdf/2c/e3/pi-14-205.PMC5355020.pdf
"Received:  April 5, 2016    Revised:  July 27, 2016 Accepted:  July 27, 2016    Available online:  October 19, 2016  Correspondence:  Soo-Y oung Bhang, MD, PhD, MPH Department of Psychiatry, Eulji University School of Medicine, Eulji Univer - sity Eulji Hospital, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, Republic of  Korea Tel: +82-2-970-8303, Fax: +82-2-970-8429, E-mail:  dresme@dreamwiz.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.216",Non-OADS,/arxiv_data1/oa_pdf/06/83/pi-14-216.PMC5355021.pdf
"Received:  June 14, 2016    Revised:  August 7, 2016 Accepted:  August 12, 2016    Available online:  October 13, 2016  Correspondence:  Yu Jin Lee, MD, PhD  Department of Psychiatry, Seoul National University College of Medicine,  101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea Tel: +82-2-2072-2456, Fax: +82-2-744-7241, E-mail:  leeyj1203@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS https://doi.org/10.4306/pi.2017.14.2.219BRIEF REPORT   Copyright © 2017 Korean Neuropsychiatric Association   219",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/pi-14-219.PMC5355022.pdf
"Received:  January 24, 2016    Revised:  February 26, 2016 Accepted:  April 4, 2016    Available online:  October 13, 2016  Correspondence:  Chi-Un Pae, MD, PhD Department of Psychiatry, Bucheon St. Mary’s Hospital, College of Medicine,  The Catholic University of Korea, 327 Sosa-ro, Wonmi-gu, Bucheon 14647, Re - public of Korea Tel: +82-32-340-7067, Fax: +82-32-340-2544, E-mail:  pae@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.https://doi.org/10.4306/pi.2017.14.2.226",Non-OADS,/arxiv_data1/oa_pdf/3b/79/pi-14-226.PMC5355023.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.cmet.2017.01.008,Non-OADS,/arxiv_data1/oa_pdf/29/90/main.PMC5355363.pdf
"http://dx.doi.org/10.1016/j.cmet.2017.01.008 SUMMARY Low-grade systemic inﬂammation associated to obesity leads to cardiovascular complications,caused partly by inﬁltration of adipose and vasculartissue by effector T cells.",Non-OADS,/arxiv_data1/oa_pdf/29/90/main.PMC5355363.pdf
Published by Elsevier Inc. 593 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/90/main.PMC5355363.pdf
This cohort wasdivided by BMI in accordance to the World Health Organization deﬁnition(lean for BMI < 25 Kg/m 2; overweight for 25 Kg/m2%BMI < 30 Kg/m2; and obese for BMI R30 Kg/m2;http://www.who.int/en) .,Non-OADS,/arxiv_data1/oa_pdf/29/90/main.PMC5355363.pdf
"Three videos were initially produced, including a general radiotherapy process video (URL: http://vimeo.com/tamworthnwcc/rt) and two disease-site speciﬁc (breastand prostate) videos.",Non-OADS,/arxiv_data1/oa_pdf/a4/a6/JMRS-64-35.PMC5355370.pdf
Available from: http://www.arpansa.gov.au/pubs/rps/ rps4.pdf (accessed 1 November 2016).,OADS,/arxiv_data1/oa_pdf/d2/3e/JMRS-64-52.PMC5355374.pdf
"6231.5031533    E-mail: cindysadikin@yahoo.com.sgThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/9f/ni-12-1.PMC5355455.pdf
"Editorial Summary of 12th Asian Australasian  Federation of Interventional and  Therapeutic Neuroradiology (AAFITN 2016) Prijo Sidipratomo1, Cindy Sadikin2Neurointervention 2017;12:1-2 https://doi.org/10.5469/neuroint.2017.12.1.1ISSN (Print): 2093-9043 ISSN (Online): 2233-6273 Fig.",Non-OADS,/arxiv_data1/oa_pdf/aa/9f/ni-12-1.PMC5355455.pdf
"852.29903276    E-mail: neeraj.mahboobani@gmail.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/b0/ni-12-11.PMC5355456.pdf
Key Words : Intracranial aneurysm; stents; flow diversion; flow diverters; FRED;  Flow Re-direction Endoluminal DeviceNeurointervention 2017;12:11-19 https://doi.org/10.5469/neuroint.2017.12.1.11ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/e4/b0/ni-12-11.PMC5355456.pdf
"82.2.440.6932    E-mail: md.cwryu@gmail.comThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/53/ni-12-20.PMC5355457.pdf
Key Words : ASPECTS score; Stroke; Thrombectomy; Reperfusion therapyNeurointervention 2017;12:20-30 https://doi.org/10.5469/neuroint.2017.12.1.20ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/b4/53/ni-12-20.PMC5355457.pdf
"82.2.476.0090    E-mail: dhlee@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/72/ni-12-3.PMC5355458.pdf
Key Words : Onyx; Liquid embolic material; Brain arteriovenous malformations; EmbolizationNeurointervention 2017;12:3-10 https://doi.org/10.5469/neuroint.2017.12.1.3ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/e2/72/ni-12-3.PMC5355458.pdf
"interest (ROI) using Image J (NIH; Bethesda, Maryland; http://imagej.nih.gov/ij/) by an experiencedradiology technician.",Non-OADS,/arxiv_data1/oa_pdf/e2/72/ni-12-3.PMC5355458.pdf
"82.2.476.0090    E-mail: dhlee@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/5e/ni-12-31.PMC5355459.pdf
Key Words : Intracranial aneurysm; Self-expandable stents; Endovascular treatment; Neurovascular stentNeurointervention 2017;12:31-39 https://doi.org/10.5469/neuroint.2017.12.1.31ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/0d/5e/ni-12-31.PMC5355459.pdf
"82.53.423.0504    E-mail: kdhdock@hotmail.comThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/be/ni-12-40.PMC5355460.pdf
Key Words : Blood blister-like aneurysm; Flow diversion; Pipeline Embolization Device;  Fetal circulation; Coil embolization Neurointervention 2017;12:40-44 https://doi.org/10.5469/neuroint.2017.12.1.40ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/a4/be/ni-12-40.PMC5355460.pdf
"82.53.422.4265    E-mail: yw.kim23@gmail.com This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d9/ni-12-45.PMC5355461.pdf
Key Words : Acute ischemic stroke; Mechanical thrombectomy;  Forced arterial suction thrombectomy; Aspiration thrombectomy; Distal access catheterNeurointervention 2017;12:45-49 https://doi.org/10.5469/neuroint.2017.12.1.45ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/03/d9/ni-12-45.PMC5355461.pdf
"82.2.3462.5904    E-mail: kzoo@yuhs.acThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/c4/ni-12-50.PMC5355462.pdf
Key Words : Dural arteriovenous fistula; Dementia; Therapeutic embolizationNeurointervention 2017;12:50-53 https://doi.org/10.5469/neuroint.2017.12.1.50ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/f2/c4/ni-12-50.PMC5355462.pdf
"82.2.3010.0090E-mail: dcsuh@amc.seoul.krThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/07/ni-12-54.PMC5355463.pdf
"Letter to Editor Cortical versus Pial Venous Drainage in  Dural Arteriovenous Fistula Sang Hun Lee, MD, Dae Chul Suh, MDNeurointervention 2017;12:54-56 https://doi.org/10.5469/neuroint.2017.12.1.54ISSN (Print): 2093-9043 ISSN (Online): 2233-6273 Key Words : Dural arteriovenous fistula; Pial venous drainage; Pial venous reflux; Cortical venousdrainage; Cortical venous reflux",Non-OADS,/arxiv_data1/oa_pdf/e0/07/ni-12-54.PMC5355463.pdf
"82.2.2045.4127    E-mail: dcsuh@amc.seoul.krThis is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/a1/ni-12-57.PMC5355464.pdf
"Letter to Editor Transdural Segment of the Radicular Vein in  Spinal Dural Arteriovenous Fistula Su Hee Cho, MD, Dae Chul Suh, MDNeurointervention 2017;12:57-58 https://doi.org/10.5469/neuroint.2017.12.1.57ISSN (Print): 2093-9043 ISSN (Online): 2233-6273",Non-OADS,/arxiv_data1/oa_pdf/f4/a1/ni-12-57.PMC5355464.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/05/f3/40291_2017_Article_256.PMC5355524.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/f3/main.PMC5355527.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/f3/main.PMC5355527.pdf
http://dx.doi.org/10.1016/j.shaw.2016.07.002Safety and Health at Work 8 (2017) 67 e71,Non-OADS,/arxiv_data1/oa_pdf/42/f3/main.PMC5355527.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/00/main.PMC5355528.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/00/main.PMC5355528.pdf
http://dx.doi.org/10.1016/j.shaw.2016.07.003Safety and Health at Work 8 (2017) 11 e18,Non-OADS,/arxiv_data1/oa_pdf/0f/00/main.PMC5355528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/a3/main.PMC5355529.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/a3/main.PMC5355529.pdf
http://dx.doi.org/10.1016/j.shaw.2016.06.005Safety and Health at Work 8 (2017) 42 e48,Non-OADS,/arxiv_data1/oa_pdf/18/a3/main.PMC5355529.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
http://dx.doi.org/10.1016/j.shaw.2016.07.004Safety and Health at Work 8 (2017) 36 e41,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
Avail- able from: http://www.ci.avondale.az.us/DocumentCenter/Home/View/29697 .,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
Available from: https://www.cooperinstitute.org/pub/products.cfm?,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
Available from: http://www.criminaljustice.ny.,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
Available from: https://www.fbi.gov/about-us/cjis/ucr/crime-in-the-u.s/2011/crime-in-the-u.,Non-OADS,/arxiv_data1/oa_pdf/d4/27/main.PMC5355530.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/89/main.PMC5355531.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/89/main.PMC5355531.pdf
http://dx.doi.org/10.1016/j.shaw.2016.06.003Safety and Health at Work 8 (2017) 19 e28,Non-OADS,/arxiv_data1/oa_pdf/26/89/main.PMC5355531.pdf
Available from: http://www.quantpsy.org/sobel/sobel.htm .,Non-OADS,/arxiv_data1/oa_pdf/26/89/main.PMC5355531.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
http://dx.doi.org/10.1016/j.shaw.2016.07.001Safety and Health at Work 8 (2017) 29 e35,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.occupationalcancer.ca/2011/burden-of-occupational-cancer/ .,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.carexcanada.ca/en/diesel_engine_exhaust/ occupational_estimate/ .,OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.carexcanada.ca/en/asbestos/ occupational_estimate/ .,OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.carexcanada.ca/en/shiftwork/ .,OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.labour.gov.on.ca/english/hs/ topics/oels.php .,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.labour.gc.ca/eng/home.,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: https://www.policyalternatives.ca/publications/ commentary/federal-government-undermining-workplace-safety .,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.cancer.ca/en/about-us/ for-media/media-releases/saskatchewan/2013/saskatchewan-legislature- makes-history/?region ¼sk.,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from:http://www.iwh.on.ca/plenaries/2009 .,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: https://www.tc.,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.cdc.gov/ niosh/topics/hierarchy/ .,OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: https://www.cdph.ca.gov/programs/ hesis/Documents/diesel.pdf .,OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://www.apha.org/policies-and-advocacy/public-health- policy-statements/policy-database/2015/01/28/12/14/preventing-health- effects-of-diesel-exhaust .,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Available from: http://healthycanadians.gc.ca/healthy-living-vie- saine/environment-environnement/air/contaminants/asbestos-amiante-eng.,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
Availablefrom: http://www.ncchpp.ca/172/Publications.ccnpps?id_article ¼827.A.,Non-OADS,/arxiv_data1/oa_pdf/7a/34/main.PMC5355532.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
http://dx.doi.org/10.1016/j.shaw.2016.08.004Safety and Health at Work 8 (2017) 94 e98,Non-OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
Available from: http://www.mhlw.go.jp/ ﬁle/ 06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
Available from: http://www.mhlw.go.jp/ ﬁle/04-Houdouhappyou-10904750- Kenkoukyoku-Gantaisakukenkouzoushinka/0000106547.pdf [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
Tokyo (Japan); 2013 [cited 2015 Dec 9].Available from: http://www.mhlw.go.jp/stf/houdou/2r9852000002xple-att/ 2r9852000002xpqt.pdf [In Japanese].,OADS,/arxiv_data1/oa_pdf/1b/3f/main.PMC5355533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/39/main.PMC5355534.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/39/main.PMC5355534.pdf
http://dx.doi.org/10.1016/j.shaw.2016.04.002Safety and Health at Work 8 (2017) 84 e88,Non-OADS,/arxiv_data1/oa_pdf/b3/39/main.PMC5355534.pdf
"*Correspondence: ike@tsurumi.yokohama-cu.ac.jp Editor: Hiroyuki Noji Biophysical Journal 112, 911–920, March 14, 2017 911http://dx.doi.org/10.1016/j.bpj.2017.01.029 /C2112017 Biophysical Society.",OADS,/arxiv_data1/oa_pdf/c2/29/main.PMC5355535.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
http://dx.doi.org/10.1016/j.shaw.2016.05.005Safety and Health at Work 8 (2017) 89 e93,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.cdc.gov/nchs/ data/databriefs/db82.pdf .,OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.health.govt.nz/our-work/diseases-and-conditions/obesity/obesity- key-facts-and-statistics .,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.nhlbi.nih.gov/health/health-topics/ topics/obe/risks.html .,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.abs.,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by þSubject/4125.,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.abs.gov.au/AUSSTATS/abs@.,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/4363.0.55.,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
Available from:http://www.health.qld.gov.au/epidemsiology/documents/srhs2010centralqld.,Non-OADS,/arxiv_data1/oa_pdf/5d/63/main.PMC5355536.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
http://dx.doi.org/10.1016/j.shaw.2016.05.007Safety and Health at Work 8 (2017) 1 e10,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: http://www.ada.org/ w/media/ADA/Member%20Center/FIles/safety.pdf .,OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: http://www.who.int/ oral_health/publications/dental_material_2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: http://www.fdiworldental.org/media/11271/Mercury- hygiene-guidance-2007.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: http://www.fda.gov/downloads/.../ medicaldevices/.../ucm236379.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: https://www.unisa.edu.au/Global/Health/Sansom/Documents/iCAHE/ CATs/McMasters_Quantitative%20review.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
Available from: https://www.cda-adc.ca/_ ﬁles/position_ statements/amalgam.pdf .,OADS,/arxiv_data1/oa_pdf/41/ad/main.PMC5355537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/84/main.PMC5355538.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/84/main.PMC5355538.pdf
http://dx.doi.org/10.1016/j.shaw.2016.09.003Safety and Health at Work 8 (2017) 77 e83,Non-OADS,/arxiv_data1/oa_pdf/03/84/main.PMC5355538.pdf
Avail- able from: http://laborsta.ilo.org/applv8/data/EAPEP/eapep_E.html .,OADS,/arxiv_data1/oa_pdf/03/84/main.PMC5355538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
http://dx.doi.org/10.1016/j.shaw.2016.08.002Safety and Health at Work 8 (2017) 49 e58,Non-OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
"Data management and statistical analysis Data were summarized using Microsoft Excel 2013 and analyzed using Open Source Epidemiologic Statistics for Public Health (OpenEpi), version 3.03a ( http://www.openepi.com/Menu/OE_ Menu.htm , updated 2015/05/04).",OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
Ranking of priority pathogens according to risk group and select agent status was done according to the United States Department of Agriculture and CDC criteria (available on the American Biological Safety Association website: https://my.absa.org/tiki-index.php?page ¼Riskgroups ).,OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
Available from: http://emergency.cdc.gov/agent/agentlist.asp .,OADS,/arxiv_data1/oa_pdf/88/b3/main.PMC5355539.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
http://dx.doi.org/10.1016/j.shaw.2016.09.002Safety and Health at Work 8 (2017) 105 e115,Non-OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
"For asbestos-related literatures, the search terms “asbestos, ”“chrysotile, ”“amosite, ”“actinolite, ”“tremolite, ” “crocidolite, ”“asbestosis, ”“lung cancer, ”and “mesothelioma ”were used singly or in combination in the Research Information Sharing Service ( http://www.riss.kr ) operated by the Korea Education and Research Information Service.",Non-OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
Available from: http://www.who.int/ipcs/assessment/public_health/ chrysotile_asbestos_summary.pdf .,OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
Available from: http://minerals.usgs.gov/minerals/ pubs/commodity/asbestos/myb1-2013-asbes.pdf .,OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
Available from:http://www.cdc.gov/niosh/docs/2003-154/pdfs/7400.pdf .Saf Health Work 2017;8:105 e115 114,Non-OADS,/arxiv_data1/oa_pdf/fb/20/main.PMC5355542.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 249–257 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.010 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/11/d0/main.PMC5355545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/d0/main.PMC5355545.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/d0/main.PMC5355545.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 280–289 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.005 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"Materials and methods All the generic products authorised through the centralised procedure (from September 2007 till February 2015) in theEU were extracted from the European Medicines Agency(EMA) database of centrally approved medicinal products for human use, see: http://www.ema.europa.eu/ema/index.",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Scientiﬁc_Discussion/human/000793/WC500042687.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Scientiﬁc_Discussion/human/000792/ WC500045948.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"<http://www.ema.europa.eu/doc s/en_GB/document_library/ EPAR_-_Public_assessment_report/human/000962/WC500035271.pdf> (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
: EMEA/507381/2008.<http://www.ema.europa.eu/doc s/en_GB/document_library/ EPAR_-_Public_assessment_report/human/000961/WC500040803.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"<http://www.ema.europa.eu/doc s/en_GB/document_library/ EPAR_-_Public_assessment_report/human/001093/WC500036108.pdf> (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Public_assessment_report/human/001085/WC500070065.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Public_assessment_report/human/ 001086/WC500070070.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
: EMEA/774092/2009.<http://www.ema.europa.eu/doc s/en_GB/document_library/ EPAR_-_Public_assessment_report/human/001088/WC500070061.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
": EMA/598319/2010 < http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Public_assessment_report/human/001195/ WC500097557.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Public_assessment_report/human/001226/WC500108104.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Public_assessment_report/human/002367/WC500109886.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Public_assessment_report/human/002198/ WC500109707.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/doc- ument_library/EPAR_-_Public_assessment_report/human/002404/WC500122417.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
< http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/docu- ment_library/EPAR_-_Public_assessment_report/human/002050/WC500145306.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Public_asse ssment_report/human/002594/ WC500143108.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Public_assessment_report/human/ 003824/WC500165292.pdf > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
< http://ec.europa.eu/ health/ﬁles/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_ 83_cons_2012_en.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
http://dx.doi.org/10.1111/j.1365- 2125.2010.03718.x .,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
< http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
"< http://www.ema.eu- ropa.eu/ema/index.jsp?curl=pages/medicines/general/general_con- tent_000433.jsp&mid=WC0b01ac058067fa25 > (accessed May 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
http://dx.doi.org/10.1377/hlthaff.2010.0270 .,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
http://dx.doi.org/10.1162/ 0034653053327694 .Changing paradigms in bioequivalence trials 289,Non-OADS,/arxiv_data1/oa_pdf/df/7b/main.PMC5355546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/6b/main.PMC5355547.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 266–274 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.007 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/02/6b/main.PMC5355547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/6b/main.PMC5355547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC5355548.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 214 –223 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.005 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC5355548.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC5355548.pdf
"In vitro evaluation of the anticancer activity Synthesized derivatives 33–49 were selected by National Cancer Institute (NCI, Bethesda USA) Developmental Thera-peutic Program (DTP) and evaluated for anticancer activity at the concentration of 10 /C05M toward a panel of approximately sixty cancer cell lines ( http://dtp.nci.nih.gov ).",Non-OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC5355548.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2016.",OADS,/arxiv_data1/oa_pdf/89/ee/main.PMC5355548.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/9c/main.PMC5355549.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 290 –293 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.01.003 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/main.PMC5355549.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/9c/main.PMC5355549.pdf
"http://dx.doi.org/ 10.1002/mds.26552 , EPub 16 Feb 2016.Erythropoietin repackaging in polypropylene syringes 293",Non-OADS,/arxiv_data1/oa_pdf/b4/9c/main.PMC5355549.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/dc/main.PMC5355550.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 275–279 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.005 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/77/dc/main.PMC5355550.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/dc/main.PMC5355550.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 231 –235 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.004 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/16/3b/main.PMC5355551.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/3b/main.PMC5355551.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/3b/main.PMC5355551.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/9d/main.PMC5355552.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 236–240 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.003 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6b/9d/main.PMC5355552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/9d/main.PMC5355552.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 184 –195 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.003 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/main.PMC5355553.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/e2/main.PMC5355553.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/e2/main.PMC5355553.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/d9/main.PMC5355554.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 206 –213 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.010 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/d9/main.PMC5355554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/d9/main.PMC5355554.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 258–265 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.009 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/32/17/main.PMC5355555.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/17/main.PMC5355555.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/17/main.PMC5355555.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 224 –230 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.009 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/cd/main.PMC5355556.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/cd/main.PMC5355556.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/cd/main.PMC5355556.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5355557.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5355557.pdf
http://dx.doi.org/10.1016/j.shaw.2016.08.005Safety and Health at Work 8 (2017) 99 e104,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5355557.pdf
Available from: http://www.globalhealthaction.net/index.php/gha/article/view/1958/2182 .,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5355557.pdf
Available from: http://www.ilocis.org/ documents/chpt42e.htm .,OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5355557.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/8f/main.PMC5355558.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 176–183 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/57/8f/main.PMC5355558.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/8f/main.PMC5355558.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/70/main.PMC5355559.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 149–164 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.04.025 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b9/70/main.PMC5355559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/70/main.PMC5355559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/32/main.PMC5355560.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 196 –205 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.05.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7b/32/main.PMC5355560.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/32/main.PMC5355560.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/16/main.PMC5355561.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 294–297 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e4/16/main.PMC5355561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/16/main.PMC5355561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/02/main.PMC5355562.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/02/main.PMC5355562.pdf
http://dx.doi.org/10.1016/j.shaw.2016.09.005Safety and Health at Work 8 (2017) 59 e66,Non-OADS,/arxiv_data1/oa_pdf/08/02/main.PMC5355562.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 241–248 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fe/8d/main.PMC5355563.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8d/main.PMC5355563.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/8d/main.PMC5355563.pdf
http://dx.doi.org/ 10.1155/2013/925804 Article number: 925804.,Non-OADS,/arxiv_data1/oa_pdf/fe/8d/main.PMC5355563.pdf
http://dx.doi.org/10.1155/2014/280120 Article number: 280120.,Non-OADS,/arxiv_data1/oa_pdf/fe/8d/main.PMC5355563.pdf
"Stem Cell Reports Article GATA6 Plays an Important Role in the Induction of Human Deﬁnitive Endoderm, Development of the Pancreas, and Functionality of PancreaticbCells Amita Tiyaboonchai,1,2Fabian L. Cardenas-Diaz,1,2Lei Ying,1Jean Ann Maguire,1Xiuli Sim,1,3 Chintan Jobaliya,1Alyssa L. Gagne,1Siddharth Kishore,1,3Diana E. Stanescu,4Nkecha Hughes,5Diva D. De Leon,4Deborah L. French,1,6and Paul Gadue1,6,* 1Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, CTRB 5012, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA 2Department of Biology, School of Arts and Sciences 3Graduate Program in Cell and Molecular Biology, Perelman School of Medicine 4Division of Endocrinology, Department of Pediatrics, Perelman School of Medicine, The Children’s Hospital of Philadelphia University of Pennsylvania, Philadelphia, PA 19104, USA 5Clinical and Translational Research Center 6Department of Pathology and Laboratory Medicine The Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA *Correspondence: gaduep@email.chop.edu http://dx.doi.org/10.1016/j.stemcr.2016.12.026 SUMMARY Induced pluripotent stem cells were created from a pancreas agenesis patient with a mutation in GATA6 .",Non-OADS,/arxiv_data1/oa_pdf/b4/e2/main.PMC5355564.pdf
589 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/e2/main.PMC5355564.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/b4/e2/main.PMC5355564.pdf
"Published online February 9, 2017. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b4/e2/main.PMC5355564.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/72/main.PMC5355565.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 165–175 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.002 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1c/72/main.PMC5355565.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/72/main.PMC5355565.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK22430/ .,Non-OADS,/arxiv_data1/oa_pdf/1c/72/main.PMC5355565.pdf
"Stem Cell Reports Article SHISA6 Confers Resistance to Differentiation-Promoting Wnt/ b-Catenin Signaling in Mouse Spermatogenic Stem Cells Moe Tokue,1,2Kanako Ikami,1,2,13Seiya Mizuno,3Chiyo Takagi,4Asuka Miyagi,4,14Ritsuko Takada,5,6 Chiyo Noda,7Yu Kitadate,1,2Kenshiro Hara,1,2,8Hiroko Mizuguchi,1Takuya Sato,9Makoto Mark Taketo,10 Fumihiro Sugiyama,3Takehiko Ogawa,9Satoru Kobayashi,2,6,7,11Naoto Ueno,2,4Satoru Takahashi,3,12 Shinji Takada,2,5,6and Shosei Yoshida1,2,* 1Division of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, Okazaki 444-8787, Japan 2Department of Basic Biology, School of Life Science, Graduate University for Advanced Studies (Sokendai), Okazaki 444-8585, Japan 3Laborarory Animal Resource Center, University of Tsukuba, Tsukuba 305-8575, Japan 4Division of Morphogenesis, National Institute for Basic Biology, National Institutes of Natural Sciences, Okazaki 444-8585, Japan 5Division of Molecular and Developmental Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, Okazaki 444-8787 , Japan 6Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, Okazaki 444-8787, Japan 7Division of Developmental Genetics, National Institute for Basic Biology, National Institutes of Natural Sciences, Okazaki 444-8787, Japan 8Laboratory of Animal Reproduction and Development, Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan 9Laboratory of Proteomics, Institute of Molecular Medicine and Life Science, Yokohama City University Association of Medical Science, Yokohama 236-0004, Japan 10Division of Experimental Therapeutics Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan 11Life Science Center of Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba 305-8577, Japan 12Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan 13Present address: Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA 14Present address: Core Biotechnology Services, Advanced Research Facilities and Services, Preeminent Medical Photonics Education and Research Ce nter, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan*Correspondence: shosei@nibb.ac.jp http://dx.doi.org/10.1016/j.stemcr.2017.01.006 SUMMARY In the seminiferous tubules of mouse testes, a population of glial cell line-derived neurotrophic factor family receptor alpha 1 (GFR a1)- positive spermatogonia harbors the stem cell functionality and supports continual spermatogenesis, likely independent of asymmetricdivision or deﬁnitive niche control.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/main.PMC5355566.pdf
561 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/aa/main.PMC5355566.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and seven ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2017.01.006 .,Non-OADS,/arxiv_data1/oa_pdf/90/aa/main.PMC5355566.pdf
"Stem Cell Reports Article Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells Johanna Bolander,1,2Wei Ji,1,2Jeroen Leijten,1,2,3Liliana Moreira Teixeira,1,2Veerle Bloemen,2,4 Dennis Lambrechts,1,2Malay Chaklader,1,2and Frank P. Luyten1,2,* 1Tissue Engineering Laboratory, Skeletal Biology and Engineering Research Center 2Prometheus, Division of Skeletal Tissue Engineering KU Leuven, O&N 1, Herestraat 49, Box 813 13, 3000 Leuven, Belgium 3Department of Developmental BioEngineering, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Drienerlola an 5, 7522NB Enschede, the Netherlands 4Materials Technology TC, Campus Group T, KU Leuven, Andreas Vesaliusstraat 13, 3000 Leuven, Belgium *Correspondence: frank.luyten@uzleuven.be http://dx.doi.org/10.1016/j.stemcr.2017.01.005 SUMMARY Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo performance where the use of sera dur- ing in vitro preparation inherently limits the efﬁcacy and reproducibility.",Non-OADS,/arxiv_data1/oa_pdf/7e/45/main.PMC5355567.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/45/main.PMC5355567.pdf
"The animals were housedaccording to the guidelines of the Animalium Leuven (KULeuven).SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Results, Supple-mental Experimental Procedures, six ﬁgures, and one table and canbe found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/7e/45/main.PMC5355567.pdf
http://www.kuleuven.be/prometheus .,Non-OADS,/arxiv_data1/oa_pdf/7e/45/main.PMC5355567.pdf
http://dx.doi.org/10.1002/term.2049 .,Non-OADS,/arxiv_data1/oa_pdf/7e/45/main.PMC5355567.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.01.010 SUMMARY In the process of generating presumably clonal human induced pluripotent stem cells (hiPSCs) from two carriers of a complex structural rearrangement, each having a psychotic disorder, we also serendipitously generated isogenic non-carrier control hiPSCs, ﬁnding that the rearrangement occurs as an extrachromosomal marker (mar) element.",OADS,/arxiv_data1/oa_pdf/1e/59/main.PMC5355568.pdf
519 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/59/main.PMC5355568.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.",Non-OADS,/arxiv_data1/oa_pdf/1e/59/main.PMC5355568.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.008 SUMMARY Zika virus (ZIKV) infection causes microcephaly in a subset of infants born to infected pregnant mothers.,Non-OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
715 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
http://dx.doi.org/10.1056/ NEJMoa1602412 .,OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
https://www.cdc.gov/ncbddd/birthdefects/ microcephaly.html .,Non-OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
http://dx.doi.org/10.1093/infdis/jw302 .,Non-OADS,/arxiv_data1/oa_pdf/95/cc/main.PMC5355569.pdf
"Senckenberg Institute of Pathology, Frankfurt University Medical School, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 60528 Frankfurt, Germany 5Cellular Neuroscience, Max Delbru ¨ck Centre for Molecular Medicine (MDC) in the Helmholtz Society, 13092 Berlin, Germany 6Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, 52074 Aachen, Germany *Correspondence: stefan.momma@kgu.de http://dx.doi.org/10.1016/j.stemcr.2017.01.009 SUMMARY Brain injuries, such as stroke or trauma, induce neural stem cells in the subventricular zone (SVZ) to a neurogenic response.",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/main.PMC5355570.pdf
701 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/main.PMC5355570.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.2017.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/main.PMC5355570.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
"37(1): 1~9 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.1 Copyright © Korean Society for Food Science of Animal Resources 1REVIEWpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human andAnimal Neonates: A Concise Review Hlaing Myat Thu1, Theingi Win Myat1, Mo Mo Win1, Kyaw Zin Thant1, Shofiqur Rah- man2, Kouji Umeda2, Sa Van Nguyen2, Faustino C. Icatlo, Jr.2, Kyoko Higo-Mori- guchi3, Koki Taniguchi3, Takao Tsuji4, Keiji Oguma5, Sang Jong Kim6, Hyun Suk Bae6, and Hyuk Joon Choi* BK bio, #2706-38, Iljudon g-ro, Gujwa-eup, Jeju-si, Jeju-do, 63359, Korea 1Department of Medical Research, No.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
"1 (2017) 2 http://www.kosfaj.org/dren less than five years old, rotavirus comprises the most important single etiologic agent of severe diarrhea world-wide.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
Anti-Rotavirus IgY for Prevention and Treatment of Neonatal Rotavirus Diarrhea http://www.kosfaj.org/ 3bacteria (Müller et al.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
1 (2017) 4 http://www.kosfaj.org/tis.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
"Anti-Rotavirus IgY for Prevention and Treatment of Neonatal Rotavirus Diarrhea http://www.kosfaj.org/ 5wed by Diraviyam et al., 2014.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
1 (2017) 6 http://www.kosfaj.org/2012 by Rahman et al.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
Anti-Rotavirus IgY for Prevention and Treatment of Neonatal Rotavirus Diarrhea http://www.kosfaj.org/ 7Asian markets (Table 1; Fig.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
"1 (2017) 8 http://www.kosfaj.org/need for more randomized, placebo controlled and dou- ble-blind trials with bigger sample sizes to further solidifyand confirm claims of efficacy and safety in controllingdiarrhea caused by rotavirus infection especially amonghuman infants with health issues such as low birth weightsor compromised immunity in whom it is most needed.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
Anti-Rotavirus IgY for Prevention and Treatment of Neonatal Rotavirus Diarrhea http://www.kosfaj.org/ 9proteins.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/kosfa-37-1.PMC5355572.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"37(1): 10~17 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.10 10 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Effects of Additions of Monascus  and Laccaic acid on the Color and Quality Properties of  Nitrite-Free Emulsion Sausage during Refrigerated Storage Pil-Nam Seong, Hoa Van Ba, Yoon-Seok Kim,  Sun-Moon Kang, Soo-Hyun Cho, Jin- Hyoung Kim, Beom-Young Park, Geun-Ho Kang, Sung-Sil Moon1, and Hyun-Woo Seo* National Ins titute of Anim al Science, RDA, Wanju 55365, Korea 1Sunjin Meat Research Center, Seoul 05372, Korea Abstract This effect of Monascus  and Laccaic acid  on the chemical composition, physical, texture and sensory properties of sausage were investigated during storage.",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"Quality Properties of Emulsion Sausage http://www.kosfaj.org/ 11was essentially eliminated, the levels of nitrite used were lowered and much tighter control of manufacturing pro-cesses was instituted (Cassens, 1997).",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"1 (2017) 12 http://www.kosfaj.org/treatment, the chopped lean meat was placed in a bowl cutter (CR-40, Spain), chopped for about 10 s at lowspeed, and then the mixture of ingredients and replacingmaterials were gradually added while chopping.",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
Quality Properties of Emulsion Sausage http://www.kosfaj.org/ 13replications.,Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"1 (2017) 14 http://www.kosfaj.org/al., 1990; Wolf et al., 1990).",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
Quality Properties of Emulsion Sausage http://www.kosfaj.org/ 15and texture.,Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"1 (2017) 16 http://www.kosfaj.org/acid added tended to have higher color scores than did the control samples, however, not significantly different.It was showed that the sausages made with Monascus  and Laccaic acid  had slight higher “ a” values, indicating more red color (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"Quality Properties of Emulsion Sausage http://www.kosfaj.org/ 17meat spoilage and pathogenic bacteria by lysozyme, nisin and EDTA in the presence of nitrite and sodium chloride at 24oC.",Non-OADS,/arxiv_data1/oa_pdf/36/79/kosfa-37-10.PMC5355573.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"37(1): 105~113 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.105 Copyright © Korean Society for Food Science of Animal Resources 105ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Effect of Fermented Spinach as Sources of Pre- Converted Nitrite on Color Development of CuredPork Loin Tae-Kyung Kim, Young-Boong Kim, Ki-Hong Jeon, Jong-Dae Park, Jung-Min Sung, Hyun-Wook Choi, Ko-Eun Hwang1, and Yun-Sang Choi* Food Processing Research Center, Korean Food Research Institute, Seongnam 13539, Korea 1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea Abstract The effect of fermented spinach extracts on color development in cured meats was investi- gated in this study.",Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"1 (2017) 106 http://www.kosfaj.org/2010) becuase the addition of synthetic nitrite in meat products has been doubted due to the potential conversionof nitrite to nitrosamine, a possible carcinogen (Bedale et al., 2016).",Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"Effect of Fermented Spinach on Color Development in Pork http://www.kosfaj.org/ 107Color instrument The internal surface color of samples were monitored with a colorimeter (Chroma meter CR-210, Minolta, Jap-an) and the measuring area had a diameter of 8-mm.",OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"1 (2017) 108 http://www.kosfaj.org/Statistical analysis The effect of different concentration of pre-converted nitrite sources from fermented spinach on pH, color,TBARS, VBN, TVC, and residual nitrite contents wasexamined using a one way analysis of variance (ANOV A),where the measured variables were set as dependent vari- ables and replicates were set as random effect.",OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"Effect of Fermented Spinach on Color Development in Pork http://www.kosfaj.org/ 109higher than those of other treatments (Djeri and Williams, 2014).",Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"1 (2017) 110 http://www.kosfaj.org/isms (Kohsaka, 1975).",Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
Effect of Fermented Spinach on Color Development in Pork http://www.kosfaj.org/ 111aerobic counts were lower in meat products treated with celery juice powder and cherry juice powder.,Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
1 (2017) 112 http://www.kosfaj.org/Planning (Republic of Korea).,Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
Effect of Fermented Spinach on Color Development in Pork http://www.kosfaj.org/ 113L.,Non-OADS,/arxiv_data1/oa_pdf/4b/94/kosfa-37-105.PMC5355574.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
"37(1): 114~122 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.114 114 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources The Application of Clove Extract Protects Chinese- style Sausages against Oxidation and Quality Det-erioration Huiyun Zhang*, Xinyan Peng1, Xinling Li, Jingjuan Wu, and Xinyu Guo Food and Bioengineering Department, Henan University of Science and Technology, Luoyang, Henan, 471003, China 1College of Food Engineering, Ludong University, Yantai, Shandong 264025, China Abstract This study was conducted to evaluate the effects of clove extract (CE) (0.25%, 0.5%, 1%, and 2%) on the oxidative stability and quality deterioration of Chinese-style sausage stored for 21 d at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
The Application of Clove Extract Protects Chinese-style Sausages against Oxidation and Quality Deterioration http://www.kosfaj.org/ 115thetic antioxidants.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
1 (2017) 116 http://www.kosfaj.org/the procedure described by Botsoglou et al.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
The Application of Clove Extract Protects Chinese-style Sausages against Oxidation and Quality Deterioration http://www.kosfaj.org/ 117as a natural antioxidant to improve the storage stability of meat products.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
"1 (2017) 118 http://www.kosfaj.org/ing metal ions, scavenging free radicals, blocking lipid oxi- dation and combining with proteins to form compounds(Maqsood et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
"The Application of Clove Extract Protects Chinese-style Sausages against Oxidation and Quality Deterioration http://www.kosfaj.org/ 119al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
1 (2017) 120 http://www.kosfaj.org/dants may maintain the integrity of muscle membranes by inhibiting lipid oxidation and thereby prevent moistureloss from muscle fibers and changes in the texture of sau-sages (Estévez et al.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
The Application of Clove Extract Protects Chinese-style Sausages against Oxidation and Quality Deterioration http://www.kosfaj.org/ 121ges were probably a result of the darker color of the clove extract itself.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
1 (2017) 122 http://www.kosfaj.org/11.,Non-OADS,/arxiv_data1/oa_pdf/72/64/kosfa-37-114.PMC5355575.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"37(1): 123~133 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.123 Copyright © Korean Society for Food Science of Animal Resources 123ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Development of Two-Step Temperature Process to  Modulate the Physicochemical Properties of β-lac- toglobulin Nanoparticles Ho-Kyung Ha, Gyeong-Won Nam1, Dongwoo Khang2, Sung Jean Park3, Mee- Ryung Lee4*, and Won-Jae Lee* Department of Animal Bioscience (Institute of Agriculture and Life Science), Gyeongsang National University, Jinju 52828, Korea 1Kawoo Commerce Co., Ltd., Goyang 10364, Korea 2Department of Physiology, School of Medicine, Gachon University, Incheon 21999, Korea 3College of Pharmacy, Gachon University, Incheon 21936, Korea 4Department of Food and Nutrition, Daegu University, Gyeongsan 38453, Korea Abstract The development of a new manufacturing process, a two-step temperature treatment, to mod- ulate the physicochemical properties of nanoparticles including the size is critical.",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"1 (2017) 124 http://www.kosfaj.org/improve the bioavailability of encapsulated bioactive com- pounds (Chen and Subirade, 2005; Chen et al., 2006; Du- chêne and Ponchel, 1997).",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"Two-Step Temperature Process for the Physicochemical Properties of β-lactoglobulin Nanoparticles http://www.kosfaj.org/ 125acid (DTNB), and resveratrol were purchased from the Sigma Chemical Company (USA).",OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
1 (2017) 126 http://www.kosfaj.org/AFM with a resolution of 128 × 128 pixels and at a scan rate of 1 Hz.,Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
Two-Step Temperature Process for the Physicochemical Properties of β-lactoglobulin Nanoparticles http://www.kosfaj.org/ 127on the surface hydrophobicity of β-lg were presented in Fig.,OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"1 (2017) 128 http://www.kosfaj.org/lg was enhanced at higher mild heat temperature (i.e., > 65°C).",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"Two-Step Temperature Process for the Physicochemical Properties of β-lactoglobulin Nanoparticles http://www.kosfaj.org/ 129like structure and/or denaturation of β-lg in its tertiary structure, can be increased with increased mild heat tem-perature (Iametti et al., 1996; Parris et al., 1991).",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
1 (2017) 130 http://www.kosfaj.org/Impacts of the first sub-ambient temperature and sec- ond mild heat temperature treatments on the morphologi-cal properties of β-lg nanoparticles were shown in Figs.,OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
Two-Step Temperature Process for the Physicochemical Properties of β-lactoglobulin Nanoparticles http://www.kosfaj.org/ 131perature (Fig.,Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"1 (2017) 132 http://www.kosfaj.org/University Fund for Professors on Sabbatical Leave, 2015 and ‘Basic Science Research Program (NRF-2014R1A1A2059497)’ through the National Research Foundation ofKorea (NRF) funded by the Ministry of Education, Rep-ublic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
Two-Step Temperature Process for the Physicochemical Properties of β-lactoglobulin Nanoparticles http://www.kosfaj.org/ 133tional changes involved in the aggregation pathways of beta- lactoglobulin.,Non-OADS,/arxiv_data1/oa_pdf/74/d7/kosfa-37-123.PMC5355576.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
"37(1): 134~138 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.134 134 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Inducible spy Transcription Acts as a Sensor for Envelope Stress of Salmonella  typhimurium Seon Mi Jeong†, Hwa Jeong Lee†, Yoon Mee Park, Jin Seok Kim1, Sang Dae Lee2, and Iel Soo Bang* Department of Microbiology and Immunology, Chosun University School of Dentistry, Gwangju 61452, Korea 1Division of Life Science, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea 2Department of Biological Sciences, Seonam University, Namwon 55724, Korea Abstract Salmonella enterica  infects a broad range of host animals, and zoonostic infection threatens both public health and the livestock and meat processing industries.",Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
"Spy Sensor for Salmonella  Envelope Stress http://www.kosfaj.org/ 135increased levels of drug tolerance, and necessitates the development of new antimicrobials (Doyle, 2015; Waleset al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
1 (2017) 136 http://www.kosfaj.org/suspended with 10 mM Tris buffer (pH 8.0) containing sucrose (0.5 M) and incubated for 10 min before the addi-tion of lysozyme (200 µg/mL).,Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
Spy Sensor for Salmonella  Envelope Stress http://www.kosfaj.org/ 137ences in the envelope architecture of two species.,Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
1 (2017) 138 http://www.kosfaj.org/chaperone and a repressor of the zinc-responsive two-com- ponent regulator ZraSR.,Non-OADS,/arxiv_data1/oa_pdf/69/f5/kosfa-37-134.PMC5355577.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
"37(1): 139~146 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.139 Copyright © Korean Society for Food Science of Animal Resources 139ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Response Surface Methodology Using a Fullest Bal- anced Model: A Re-Analysis of a Dataset in theKorean Journal for Fo od Science of Animal Resources Sungsue Rheem1*, Insoo Rheem2, and Sejong Oh* Division of Animal Science, Chonnam National University, Gwangju 61186, Korea 1Department of Applied Statistics, Korea University, Sejong 30019, Korea 2Department of Laboratory Medicine, Dankook University Hospital, Cheonan 31116, Korea Abstract Response surface methodology (RSM) is a useful set of statistical techniques for modeling and optimizing responses in research studies of food science.",Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
1 (2017) 140 http://www.kosfaj.org/tion results might not be accurate.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
Response Surface Methodology Using a Fullest Balanced Model http://www.kosfaj.org/ 141programming.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
"1 (2017) 142 http://www.kosfaj.org/consists of linear, quadratic, cubic, and two-way and three- way interaction terms, anticipating a possible improve-ment in modeling.",Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
Response Surface Methodology Using a Fullest Balanced Model http://www.kosfaj.org/ 143spherical with the radius  = 1.732.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
1 (2017) 144 http://www.kosfaj.org/ending order.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
Response Surface Methodology Using a Fullest Balanced Model http://www.kosfaj.org/ 145ded to verify the optimization results obtained by this me- thodology.Drawing 3D and contour plots of response surfaces Like in Oh et al.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
1 (2017) 146 http://www.kosfaj.org/with the vertical axis representing the predicted response and two horizontal axes representing the coded levels oftwo explanatory factors.,Non-OADS,/arxiv_data1/oa_pdf/c0/eb/kosfa-37-139.PMC5355578.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
"37(1): 147~152 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.147 Copyright © Korean Society for Food Science of Animal Resources 147ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Monitoring of Bioluminescent Lactobacillus plan- tarum  in a Complex Food Matrix Gi-Seong Moon* and Arjan Narbad1 Department of Biotechnology, Korea National University of Transportation, Jeungpyeong 27909, Korea 1Gut Health and Food Safety Programme, Institute of Food Research, Norwich NR4 7UA, UK Abstract A bioluminescent Lactobacillus plantarum  (pLuc2) strain was constructed.",Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
1 (2017) 148 http://www.kosfaj.org/tures that have potential for use in complex food matrices harboring their own indigenous microbial communitiesare more difficult to follow during the fermentation pro-cesses.,Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
Monitoring of Bioluminescent L. plantarum http://www.kosfaj.org/ 149was amplified (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
"1 (2017) 150 http://www.kosfaj.org/tains many different types of endogenous bacteria includ- ing LAB (Oguntoyinbo and Narbad, 2012).",Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
Monitoring of Bioluminescent L. plantarum http://www.kosfaj.org/ 151fermentation outcome (Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
1 (2017) 152 http://www.kosfaj.org/Microbiol.,Non-OADS,/arxiv_data1/oa_pdf/53/bb/kosfa-37-147.PMC5355579.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
"37(1): 18~28 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.18 18 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Changes in the Total Lipid, Neutral Lipid, Phospho- lipid and Fatty Acid Compo sition of Phospholipid Fractions during Pastırma Processing, a Dry-Cured Meat Product Muhammet Irfan Aksu1*, Mehmet Dogan1, and Ahmet Necdet Sirkecioglu Department of Agricultural Biotechnology, Agriculture Faculty, Atatürk University, Erzurum, Turkey 1Department of Food Engineering, Faculty of Agriculture, Ataturk University, Erzurum, Turkey Abstract Pastırma is a dry-cured meat product, produced from whole beef or water buffalo muscles.",Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
"Changes in Phospholipid Fractions during Pastırma Processing http://www.kosfaj.org/ 19and Doğruer, 2000) or between 1.41 and 24.67% (Çakıcı et al.,  2015).",OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
1 (2017) 20 http://www.kosfaj.org/muscles obtained from two different beef carcasses were used as the raw material for pastırma production.,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
Changes in Phospholipid Fractions during Pastırma Processing http://www.kosfaj.org/ 21ane was added to the tubes and then they were vortexed.,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
"1 (2017) 22 http://www.kosfaj.org/Results and Discussion Moisture content Moisture content of the raw meat, after curing, after 2nd drying and final product (pastırma), and means of the pH and colour (L*, a* and b*) values for raw meat and pas- tırma and the results of the Duncan’s Multiple Range Testare presented in Table 1.",Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
"Changes in Phospholipid Fractions during Pastırma Processing http://www.kosfaj.org/ 23meat used for pastırma, it was determined between 17.50- 23.71 in pastırma.",OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
1 (2017) 24 http://www.kosfaj.org/(p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
Changes in Phospholipid Fractions during Pastırma Processing http://www.kosfaj.org/ 25docosapentaenoic acid (22:5n-3) are other unsaturated fatty acids that are significant ( p<0.01) affected by the production stages.,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
1 (2017) 26 http://www.kosfaj.org/Σn3 (p>0.05) and Σn3/Σn6 (p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
Changes in Phospholipid Fractions during Pastırma Processing http://www.kosfaj.org/ 27rite.,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
1 (2017) 28 http://www.kosfaj.org/cured muscle phospholipids from Iberian pigs.,Non-OADS,/arxiv_data1/oa_pdf/52/e4/kosfa-37-18.PMC5355580.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
"37(1): 29~37 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.29 Copyright © Korean Society for Food Science of Animal Resources 29ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Nutritional Quality and Physicochemical Charac- teristics of Defatted Bovine Liver Treated by Super-critical Carbon Dioxide  and Organic Solvent Sung-Won Kang1†, Hye-Min Kim1†, M. Shafiur Rahman1, Ah-Na Kim1, Han-Sul Yang1, and Sung-Gil Choi* Division of Food Science and Technology (Institute of Agriculture and Life Sciences), Gyeongsang National University, Jinju 52828, Korea 1Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju 52828, Korea Abstract Defatted bovine liver (DBL) is a potential source of protein and minerals.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
1 (2017) 30 http://www.kosfaj.org/A traditional organic solvent method is widely used for the extraction of lipid from plant and animal foods(Pariser et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
Nutritional Quality and Physicochemical Characteristics of Defatted Bovine Liver http://www.kosfaj.org/ 31of extracted oil obtained from the samples.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
1 (2017) 32 http://www.kosfaj.org/min.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
"Nutritional Quality and Physicochemical Characteristics of Defatted Bovine Liver http://www.kosfaj.org/ 33ults, i.e., a higher yield of rice bran oil was observed when using SC-CO2 than when using propane as the organic solvent.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
1 (2017) 34 http://www.kosfaj.org/(1984)  postulated that peroxidase activity in corn germ flour defatted using SC-CO2 was decreased to one-tenth than that of hexane-extracted flour.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
Nutritional Quality and Physicochemical Characteristics of Defatted Bovine Liver http://www.kosfaj.org/ 35samples.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
"1 (2017) 36 http://www.kosfaj.org/tively) after homogenization, as shown in Fig.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
Nutritional Quality and Physicochemical Characteristics of Defatted Bovine Liver http://www.kosfaj.org/ 37different types of Spanish liver pâtés: A comparative study.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
Available from: http://www.rirdc.gov.au/reports/EOI/00-40.pdf.,OADS,/arxiv_data1/oa_pdf/a9/34/kosfa-37-29.PMC5355581.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
"37(1): 38~43 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.38 38 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Physical and Sensory Properties of Ice Cream Con- taining Fermented Pepper Powder Su-Jung Yeon, Ji-Han Kim, Go-Eun Hong, Woojoon Park, Soo-Ki Kim1, Han-Geuk Seo2, and Chi-Ho Lee* Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 1Department of Animal Science and Technology, Konkuk University, Seoul 05029, Korea 2Department of Stem Cell and Regenerative Biology, Konkuk University, Seoul 05029, Korea Abstract This study was conducted to investigate the physical and sensory properties of ice cream con- taining fermented pepper powder.",Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
Properties of Fermented Pepper Powder Ice Cream http://www.kosfaj.org/ 39mented soy ice cream for diabetic patients while Kim et al.,Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
"1 (2017) 40 http://www.kosfaj.org/mm, and the trigger load was 5 g.  Melting rate was determined by measuring the weight of the melting ice cream at 25oC.",Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
"Properties of Fermented Pepper Powder Ice Cream http://www.kosfaj.org/ 41al., 1998).",Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
1 (2017) 42 http://www.kosfaj.org/of functional food.,Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
Properties of Fermented Pepper Powder Ice Cream http://www.kosfaj.org/ 43(2014) Quality characteristics of ice creams using Tarak .,Non-OADS,/arxiv_data1/oa_pdf/9b/aa/kosfa-37-38.PMC5355582.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
"37(1): 44~51 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.44 44 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Experimental and Modelling Study of the Denatur- ation of Milk Protein by Heat Treatment Fang Qian1, Jiayue Sun1, Di Cao1, Yanfeng Tuo1, Shujuan Jiang1, and Guangqing Mu1,2* 1School of Food Science and Technology, Dalian Polytechnic University, Dalian, 116034, P. R .",Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
"Experimental and Modelling Study of the Denaturation of Milk Protein by Heat Treatment http://www.kosfaj.org/ 45polymerise with κ-casein and αs2-casein (Vasbinder  et al., 2003).",Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
1 (2017) 46 http://www.kosfaj.org/unt of whey protein in the supernatant fluid of heat treat- ment milk.,Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
Experimental and Modelling Study of the Denaturation of Milk Protein by Heat Treatment http://www.kosfaj.org/ 47tein.,Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
1 (2017) 48 http://www.kosfaj.org/low under different temperatures.,Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
Experimental and Modelling Study of the Denaturation of Milk Protein by Heat Treatment http://www.kosfaj.org/ 49milk under heat treatment due to the poor thermal stabil- ity of whey protein.,Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
1 (2017) 50 http://www.kosfaj.org/Y = 66.3476  − 2.12271 T + 0.017519 T2 (10 min); Y = 20.00307  − 1.065 T + 0.01267 T2 (20 min); Y = 27.32839  − 1.21571 T + 0.01408 T2 (30 min).,Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
"Experimental and Modelling Study of the Denaturation of Milk Protein by Heat Treatment http://www.kosfaj.org/ 51aublanc, A.",Non-OADS,/arxiv_data1/oa_pdf/87/88/kosfa-37-44.PMC5355583.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
"37(1): 52~61 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.52 52 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Combined Effects of Wheat Sprout and Isolated Soy Protein on Quality Prop erties of Breakfast Sau- sage Cheol-Won Lee, Tae-Kyung Kim, Ko-Eun Hwang1, Hyun-Wook Kim2, Young-Boong Kim, Cheon-Jei Kim1*, and Yun-Sang Choi* Food Processing Research Center, Korean Food Research Institute, Seongnam 13539, Korea 1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 2Meat Science and Muscle Biology Lab, Purdue University, West Lafayette, IN 47907, USA Abstract The objective of this study was to investigate the effects of different concentrations of WSP (wheat sprout powder) and ISP (isolated soy protein) on the quality of breakfast sausage.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
Breakfast Sausage Formulated with Wheat Sprout and Isolated Soy Protein http://www.kosfaj.org/ 53ing for alternative to ISP.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
"1 (2017) 54 http://www.kosfaj.org/1.5% ISP + 0.5% WSP, T3: 1.0% ISP + 1.0% WSP, T4: 0.5% ISP + 1.5% WSP, T5: 2% WSP.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
Breakfast Sausage Formulated with Wheat Sprout and Isolated Soy Protein http://www.kosfaj.org/ 55Texture profile analysis (TPA) Texture profile analysis (TPA) was followed by the me- thod of Choi et al.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
"1 (2017) 56 http://www.kosfaj.org/ding to RDA (2009), high content of protein (proximately 29%) exist in wheat sprout.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
Breakfast Sausage Formulated with Wheat Sprout and Isolated Soy Protein http://www.kosfaj.org/ 57ing loss in breakfast sausage.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
"1 (2017) 58 http://www.kosfaj.org/protein solubility could be attributed to addition of ISP, and to some degree of the protein content of WSP.",Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
Breakfast Sausage Formulated with Wheat Sprout and Isolated Soy Protein http://www.kosfaj.org/ 59determine overall acceptability.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
1 (2017) 60 http://www.kosfaj.org/all improved as the amount of WSP increased.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
Breakfast Sausage Formulated with Wheat Sprout and Isolated Soy Protein http://www.kosfaj.org/ 61apy Res .,Non-OADS,/arxiv_data1/oa_pdf/87/0e/kosfa-37-52.PMC5355584.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
"37(1): 62~70 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.62 62 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Peptide Analysis and the Bioactivity of Whey Pro- tein Hydrolysates from Cheese Whey with SeveralEnzymes Renda Kankanamge Chaturika Jeewanthi1, Myeong Hee Kim1, Na-Kyoung Lee1, Yoh Chang Yoon1, and Hyun-Dong Paik1,2* 1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul 05029, Korea 2Bio/Molecular Informatics Center, Konkuk University, Seoul 05029, Korea Abstract The aim of this study was identifying a suitable food grade enzymes to hydrolyze whey pro- tein concentrates (WPCs), to give the highest bioactivity.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
Bioactivity of Whey Protein Hydrolysates as Enzymes http://www.kosfaj.org/ 63cesses or substrates and hence have an impact on body function or condition and health.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
"1 (2017) 64 http://www.kosfaj.org/enzyme solution were collected at 0.5, 1, 2, 3, 4, and 5 h while shaking at 180 rpm.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
The peptide probability was calculated accordingto mascot probability scores (http://www.matrixscience.,OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
"Bioactivity of Whey Protein Hydrolysates as Enzymes http://www.kosfaj.org/ 65Results and Discussion General components of WPC-35 Usage of UF and spray drying methods to manufacture WPC-35 has a relatively easy scale-up, comparing to other membrane separation techniques or preparative chromat- ographic techniques.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
1 (2017) 66 http://www.kosfaj.org/2.94-2.63 ( p<0.05) at 0-5 h hydrolysis (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
"Bioactivity of Whey Protein Hydrolysates as Enzymes http://www.kosfaj.org/ 67son of protease S is a thermostable neutral protease, the WPH solution has given a favorable atmosphere to per-form enzyme activity than the other acidic or base enzy-mes.",Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
1 (2017) 68 http://www.kosfaj.org/in fragment 92-100 from β-Lg with a higher confidence levels.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
Bioactivity of Whey Protein Hydrolysates as Enzymes http://www.kosfaj.org/ 69releasing peptides that are inactive in intact WPs with the influence of enzymatic activity.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
1 (2017) 70 http://www.kosfaj.org/whey proteins.,Non-OADS,/arxiv_data1/oa_pdf/86/a1/kosfa-37-62.PMC5355585.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
"37(1): 71~78 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.71 Copyright © Korean Society for Food Science of Animal Resources 71ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Effect of Black Rice Powd er on the Quality Proper- ties of Pork Patties Sin-Young Park, Jong-Wan Lee, Gye-Woong Kim*, and Hack-Youn Kim* Department of Animal Resources Science, Kongju National University, Yesan 32439, Korea Abstract Physicochemical properties of pork patties formulated with black rice powder were investi- gated.",Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
"1 (2017) 72 http://www.kosfaj.org/antioxidant activity and neuro-protective effect was added to emulsion-type sausages, the sausages showed increa-sed pH, water holding capacity, and cooking yield.",Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
Pork Patties Added Black Rice http://www.kosfaj.org/ 73WHC (%) = [Meat area (mm2) / Total area (mm2)] × 100 Cooking yield The uncooked patties (initial weight) heat processed at 80±1°C for 30 min and then core temperature of sampleswas reached respectively at 80±1°C.,Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
1 (2017) 74 http://www.kosfaj.org/pork patties after heating according to the amount of black rice powder added are shown in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
Pork Patties Added Black Rice http://www.kosfaj.org/ 75after heating (5.55).,Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
"1 (2017) 76 http://www.kosfaj.org/balls were produced, adding legume proteins resulted in decreased rate of diameter reduction, with the samples to which black-eyed peas were added showing the lowest rate of diameter reduction (Serdaroglu et al., 2005).",Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
Pork Patties Added Black Rice http://www.kosfaj.org/ 77Sensory evaluation The results of a sensory evaluation on pork patties with black rice powder added are shown in Table 5.,Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
1 (2017) 78 http://www.kosfaj.org/tion of processed foods and the recognition for food additives of urban housewives.,Non-OADS,/arxiv_data1/oa_pdf/2a/d3/kosfa-37-71.PMC5355586.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
"37(1): 79~86 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.79 Copyright © Korean Society for Food Science of Animal Resources 79ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Determination of Aflatoxin M1 and Heavy Metals in Infant Formula Milk Bran ds Available in Pakistani Markets Saeed Akhtar1, Muhammad Arif Shahzad1, Sang-Ho Yoo2, Amir Ismail1, Aneela Hameed1, Tariq Ismail1, and Muhammad Riaz1,2* 1Institute of Food Science and Nutrition, Bahauddin Zakariya University, Multan-Pakistan 2Department of Food Science and Biotechnology, College of Life Sciences, Sejong Uni- versity, Seoul 143-747, Korea Abstract Aflatoxin M1 (AFM1) after its bioconversion from aflatoxin B1 in animal liver becomes the part of milk while heavy metals get entry into milk and milk products during handling in thesupply chain.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
1 (2017) 80 http://www.kosfaj.org/and manufactured for infants.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
Aflatoxin M1 and Heavy Metals in Infant Formulas http://www.kosfaj.org/ 81ough centrifugation (Germany) for 10 min at 2000× g. The upper layer of fat was removed carefully by using a spat-ula.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
1 (2017) 82 http://www.kosfaj.org/tion spectrophotometer for quantification of the metals.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
Aflatoxin M1 and Heavy Metals in Infant Formulas http://www.kosfaj.org/ 83turing practices by the IFM manufacturers to control these highly toxic heavy metals.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
1 (2017) 84 http://www.kosfaj.org/analysis of AFM1 in IFM samples revealed that 30.76% infant formula samples exceeded the EU maximum per-missible limit which might result in severe toxicity in inf-ants being immunity compromised group of age.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
Aflatoxin M1 and Heavy Metals in Infant Formulas http://www.kosfaj.org/ 85cinogenic risks to humans.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
1 (2017) 86 http://www.kosfaj.org/ding.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/kosfa-37-79.PMC5355587.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
"37(1): 87~97 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.87 Copyright © Korean Society for Food Science of Animal Resources 87ARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Optimization of Manufacturing Conditions for Imp- roving Storage Stability of Coffee-Supplemented Milk Beverage Using Response Surface Methodol- ogy Sung-Il Ahn, Jun-Hong Park, Jae-Hoon Kim1, Duk-Geun Oh1, Moojoong Kim2, Donghwa Chung2,3, Jin-Woo Jhoo, and Gur-Yoo Kim* Program of Animal Products and Food Science, College of Animal Life Sciences, Kang- won National University , Chuncheon 24341, Korea 1Seoul F&B Co., Ltd., Korea 2Institutes of Green Bio Science and Technology, Seoul National University, Korea 3Graduate School of International Agricultural Technology, Seoul National University, Korea Abstract This study aimed at optimizing the manufacturing conditions of a milk beverage supple- mented with coffee, and monitoring its physicochemical and sensory properties during stor-age.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
"1 (2017) 88 http://www.kosfaj.org/Coffee is one of the most popular beverages and princi- pal commodities in the world (Feria-Morales, 2002; Geelet al., 2005).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
Optimization and Properties of Coffee-Supplemented Milk Beverage http://www.kosfaj.org/ 89face in a three dimensional plane.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
"1 (2017) 90 http://www.kosfaj.org/Optimization of manufacturing conditions A total of 13 experiments were conducted (Table 3) using primary homogenization speed ( X1) and amount of emulsifier ( X2) as independent variables and particle size (Y1) as well as zeta-potential ( Y2) as responses by FCCD, and the result are indicated in Table 4.",OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
Optimization and Properties of Coffee-Supplemented Milk Beverage http://www.kosfaj.org/ 91The 3-D response surfaces and contour plots for parti- cle sizes and zeta-potentials in the coffee beverages areshown in Figs.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
1 (2017) 92 http://www.kosfaj.org/McClements (2011).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
Optimization and Properties of Coffee-Supplemented Milk Beverage http://www.kosfaj.org/ 93of the GF110.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
1 (2017) 94 http://www.kosfaj.org/10.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
Optimization and Properties of Coffee-Supplemented Milk Beverage http://www.kosfaj.org/ 95Sensory evaluation The sensory properties of the milk beverages with cof- fee during storage at 4°C for 12 d are shown in Table 6.Brownness of either the GF160 or GF110 showed no sig-nificant differences during storage ( p<0.05).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
1 (2017) 96 http://www.kosfaj.org/sucrose decreases the sensory perception of bitterness in coffee beverages.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
Optimization and Properties of Coffee-Supplemented Milk Beverage http://www.kosfaj.org/ 9713.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/kosfa-37-87.PMC5355588.pdf
"This is an open access article distributed under the terms of the Creative Commons Attribution Non-Com- mercial License (http://creativecommons.org/licences/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
"37(1): 98~104 (2017) DOI https://doi.org/10.5851/kosfa.2017.37.1.98 98 Copyright © Korean Society for Food Science of Animal ResourcesARTICLEpISSN 1225-8563 eISSN 2234-246X Korean Journal forFood Science ofAnimal Resources Effects of Short-Term Presalting and Salt Level on the Development of Pink Color in Cooked Chicken Breasts Jong Youn Jeong* School of Food Biotechnology & Nutrition, Kyungsung University, Busan 48434, Korea Abstract The objective of this study was to determine the effects of short-term presalting on pink color and pigment characteristics in ground chicken breasts after cooking.",Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
Effects of Short-Term Presalting on Pink Color of Chicken Breasts http://www.kosfaj.org/ 99Sodium chloride is one of the fundamental and com- mon ingredients used in the production of meat and poul-try products.,Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
"1 (2017) 100 http://www.kosfaj.org/chicken product was homogenized (DI 25 basic, IKA- Werke Gmbh & Co., KG, Germany) in 20 mL 0.1 M sodiumcarbonate for 15 s at 13,000 rpm.",Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
Effects of Short-Term Presalting on Pink Color of Chicken Breasts http://www.kosfaj.org/ 101NaCl products had similar ( p>0.05) cooking yields on day 0 and day 3.,Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
1 (2017) 102 http://www.kosfaj.org/products.,Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
"Effects of Short-Term Presalting on Pink Color of Chicken Breasts http://www.kosfaj.org/ 103Residual nitrite, nitrosyl hemochrome and total pig- ments contents Residual nitrite contents were significantly ( p<0.05) increased as NaCl level was increased from 0 to 3% onday 0 (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
1 (2017) 104 http://www.kosfaj.org/meat.,Non-OADS,/arxiv_data1/oa_pdf/d7/3d/kosfa-37-98.PMC5355589.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.012 SUMMARY The truncated mutant form of the charged multivesicular body protein 2B (CHMP2B) is causative for frontotemporal dementia linked to chromosome 3 (FTD3).,OADS,/arxiv_data1/oa_pdf/ae/6f/main.PMC5355623.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/6f/main.PMC5355623.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/ae/6f/main.PMC5355623.pdf
"Stem Cell Reports Report EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells Terren K. Niethamer,1,2,3Andrew R. Larson,1,2Audrey K. O’Neill,1,2Marina Bershteyn,5 Edward C. Hsiao,1,3,4,6Ophir D. Klein,1,3,4,7,8Jason H. Pomerantz,1,3,5,8,9and Jeffrey O. Bush1,2,3,4,5,* 1Program in Craniofacial Biology 2Department of Cell and Tissue Biology 3Biomedical Sciences Graduate Program 4Institute for Human Genetics 5Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research 6Department of Medicine 7Department of Pediatrics 8Department of Orofacial Sciences 9Division of Plastic and Reconstructive Surgery, Department of Surgery University of California, San Francisco, San Francisco, CA 94143, USA *Correspondence: jeffrey.bush@ucsf.edu http://dx.doi.org/10.1016/j.stemcr.2017.01.017 SUMMARY Although human induced pluripotent stem cells (hiPSCs) hold great potential for the study of human diseases affecting disparate cell types, they have been underutilized in seeking mechanistic insights into the pathogenesis of congenital craniofacial disorders.",Non-OADS,/arxiv_data1/oa_pdf/4e/d5/main.PMC5355632.pdf
529 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/d5/main.PMC5355632.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/4e/d5/main.PMC5355632.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.01.014 SUMMARY Astrocytes, due to the proximity to neuronal lineage and capability to proliferate, are ideal starting cells to regenerate neurons.",Non-OADS,/arxiv_data1/oa_pdf/d8/3c/main.PMC5355633.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/main.PMC5355633.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.01.014 .",OADS,/arxiv_data1/oa_pdf/d8/3c/main.PMC5355633.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.015 SUMMARY Hematopoietic stem cells (HSCs) are considered one of the most promising therapeutic targets for the treatment of various blood disor- ders.,Non-OADS,/arxiv_data1/oa_pdf/f2/64/main.PMC5355634.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/64/main.PMC5355634.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, one table, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/f2/64/main.PMC5355634.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.016 SUMMARY The success of stem cell-mediated gene therapy in cancer treatment largely depends on the speciﬁc homing ability of stem cells.,Non-OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC5355636.pdf
743 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC5355636.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.01.016 .",OADS,/arxiv_data1/oa_pdf/0b/04/main.PMC5355636.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.021 SUMMARY Genome editing in induced pluripotent stem cells is currently hampered by the laborious and expensive nature of identifying homology- directed repair (HDR)-modiﬁed cells.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/main.PMC5355643.pdf
491 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/dc/main.PMC5355643.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures and three tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/75/dc/main.PMC5355643.pdf
"Stem Cell Reports Article Genome T ransfer Prevents Fragmentation and Restores Developmental Potential of Developmentally Compromised Postovulatory AgedMouse Oocytes Mitsutoshi Yamada1,3and Dieter Egli1,2,* 1The New York Stem Cell Foundation Research Institute, New York, NY 10032, USA 2Department of Pediatrics, Naomi Berrie Diabetes Center, Columbia University, New York, NY 10032, USA 3Present address: Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan *Correspondence: de2220@cumc.columbia.edu http://dx.doi.org/10.1016/j.stemcr.2017.01.020 SUMMARY Changes in oocyte quality can have great impact on the developmental potential of early embryos.",Non-OADS,/arxiv_data1/oa_pdf/95/d1/main.PMC5355644.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/d1/main.PMC5355644.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/95/d1/main.PMC5355644.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.019 SUMMARY Neurons communicate by regulated secretion of chemical signals from synaptic vesicles (SVs) and dense-core vesicles (DCVs).,OADS,/arxiv_data1/oa_pdf/15/53/main.PMC5355645.pdf
659 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC5355645.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and three movies and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/15/53/main.PMC5355645.pdf
"Stem Cell Reports Article Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced PluripotentStem Cells Xiaohong Xu,1Yilin Tay,1Bernice Sim,1Su-In Yoon,2Yihui Huang,1Jolene Ooi,1Kagistia Hana Utami,1 Amin Ziaei,1Bryan Ng,1Carola Radulescu,1Donovan Low,3Alvin Yu Jin Ng,4Marie Loh,1 Byrappa Venkatesh,4,5Florent Ginhoux,3George J. Augustine,2,6and Mahmoud A. Pouladi1,7,* 1Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology and Research (A *STAR), 8A Biomedical Grove, Immunos, Level 5, Singapore 138648, Singapore 2Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 637553, Singapore 3Singapore Immunology Network (SIgN), A *STAR, Singapore 138648, Singapore 4Comparative Genomics Laboratory, Institute of Molecular and Cell Biology, A *STAR, Biopolis, Singapore 138673, Singapore 5Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore 6Institute of Molecular and Cell Biology (IMCB), Singapore 138673, Singapore 7Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore *Correspondence: map@pouladilab.org http://dx.doi.org/10.1016/j.stemcr.2017.01.022 SUMMARY Huntington disease (HD) is a dominant neurodegenerative disorder caused by a CAG repeat expansion in HTT.",Non-OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
619 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and six tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.01.022 .",OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
6.http://dx.doi.org/10.1371/ currents.hd.0242d2e7ad72225efa72f6964589369a .,OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/13/main.PMC5355646.pdf
The genes  targeted by DE -miRNAs were predicted using the miRecords  (http://c1.accurascience.com/miRecords/ ) (21) and miRWalk  (www.umm.uni -heidelberg.de /apps/zmf/mirwalk /) (22) data - bases.,OADS,/arxiv_data1/oa_pdf/a6/57/mmr-14-06-5451.PMC5355656.pdf
http://ctep.cancer.gov/protocolDevelopment/electronic_applica - tions/ctc.htm#ctc_40.,Non-OADS,/arxiv_data1/oa_pdf/03/c9/or-37-02-0695.PMC5355662.pdf
"In IPA,  canonical pathways are well characterized pathways that have been curated and hand-drawn by Ph d level scientists and the  information comes from specific journal articles, review arti - cles, text books and HumanCyc, an encyclopaedia of human genes and metabolism (http://humancyc.org).",OADS,/arxiv_data1/oa_pdf/87/c3/or-37-01-0010.PMC5355666.pdf
"World Cancer Report 2014.  International Agency for Research on Cancer (IARC) Publi - cations, lyon, france, 2014 (http://www.iarc.fr/en/publications/ books/wcr/index.php).",Non-OADS,/arxiv_data1/oa_pdf/87/c3/or-37-01-0010.PMC5355666.pdf
"Differential gene expression values  and Sanger miRNA database (Gminix -Cloud Biotechnology  Information, GCBI, http://www.gcbi.com.cn /gclib /html /index ,  Gminix Informatics Co., Ltd., Shanghai, China) interactions  were used to investigate associations between miRNAs and  genes, and to create an miRNA -gene network.",OADS,/arxiv_data1/oa_pdf/25/ba/mmr-15-01-0249.PMC5355667.pdf
"Stem Cell Reports Article In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling Kohei Yamamizu,1,*Mio Iwasaki,2Hitomi Takakubo,1Takumi Sakamoto,3Takeshi Ikuno,1Mami Miyoshi,1 Takayuki Kondo,4Yoichi Nakao,3Masato Nakagawa,2Haruhisa Inoue,4and Jun K. Yamashita1 1Laboratory of Stem Cell Differentiation, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan 2Department of Life Science Frontier, CiRA, Kyoto University, Kyoto 606-8507, Japan 3Department of Chemistry and Biochemistry, Waseda University, Tokyo 169-8555, Japan 4Laboratory of Stem Cell Medicine, Department of Cell Growth and Differentiation, CiRA, Kyoto University, Kyoto 606-8507, Japan *Correspondence: kohei@cira.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2017.01.023 SUMMARY The blood-brain barrier (BBB) is composed of four cell populations, brain endothelial cells (BECs), pericytes, neurons, and astrocytes.",OADS,/arxiv_data1/oa_pdf/4a/57/main.PMC5355679.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/57/main.PMC5355679.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2017.01.023 .",OADS,/arxiv_data1/oa_pdf/4a/57/main.PMC5355679.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.01.026 SUMMARY Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is accompanied by morphological, functional, and metabolic alterations before acquisition of full pluripotency.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/main.PMC5355680.pdf
787 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/6f/main.PMC5355680.pdf
"KLF4 Directly Regulates Tcl1 Expression by Binding to Its Regulatory Regions (A) KLF4 binding on the Tcl1 gene in mouse ESCs is shown by the red graph created by GeneProf ( http://www.geneprof.org ), based upon the published ChIP data ( Chen et al., 2008 ).",OADS,/arxiv_data1/oa_pdf/8b/6f/main.PMC5355680.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/8b/6f/main.PMC5355680.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.01.025 SUMMARY Conversion of ﬁbroblasts into functional cardiomyocytes represents a potential means of restoring cardiac function after myocardial infarction, but so far this process remains inefﬁcient and little is known about its molecular mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/8d/88/main.PMC5355682.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/88/main.PMC5355682.pdf
"Specific primers  (Sunny Biotech Co., Ltd., Shanghai, China) were designed  using Primer3 software (version, 4.0.0; http://primer3.ut.ee) for  the amplification of all exons and the exon/intron boundary  sequences of TGFβ1 (Table I).",Non-OADS,/arxiv_data1/oa_pdf/1c/22/mmr-15-01-0235.PMC5355693.pdf
"Medscape: Accessed: Apr 10, 2003 (http://www.medscape.",Non-OADS,/arxiv_data1/oa_pdf/c5/4a/mmr-14-06-5501.PMC5355698.pdf
References  1. http://www.who.int /mediacentre /factsheets /fs297 /en/.,Non-OADS,/arxiv_data1/oa_pdf/76/cd/mmr-14-06-5475.PMC5355708.pdf
"The log2 transfor - mation, background correction and data normalization were  performed using the GeneChip Robust Multi -array Analysis  (GCRMA) method within Bioconductor ( http://www.biocon - ductor.org ) (15).",OADS,/arxiv_data1/oa_pdf/c9/6b/mmr-14-06-5041.PMC5355717.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.01.027 SUMMARY Familial hypercholesterolemia (FH) causes elevation of low-density lipoprotein cholesterol (LDL-C) in blood and carries an increased risk of early-onset cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/0b/ab/main.PMC5355732.pdf
605 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/ab/main.PMC5355732.pdf
"Cell Culture and Reprogramming Urinary cells were obtained and expanded according to our pub-lished protocol ( Zhou et al., 2012 ) with approval from the Institu- tional Review Board (HKCTR-725, http://www.hkclinicaltrials.",Non-OADS,/arxiv_data1/oa_pdf/0b/ab/main.PMC5355732.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/0b/ab/main.PMC5355732.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.01.028 SUMMARY MicroRNA plays an important role in bone tissue engineering; however, its role and function in osteogenic differentiation warrant further investigation.",Non-OADS,/arxiv_data1/oa_pdf/67/df/main.PMC5355733.pdf
773 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/df/main.PMC5355733.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and two tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2017.01.028 .,Non-OADS,/arxiv_data1/oa_pdf/67/df/main.PMC5355733.pdf
Stem Cells http://dx.doi.org/10.1002/stem.2439 .,Non-OADS,/arxiv_data1/oa_pdf/67/df/main.PMC5355733.pdf
"Finally, 441 HCC and healthy samples were included  in dataset HCC , and 234 cirrhosis samples were included in  dataset C. Pretreatment of raw data was conducted with package  affy (http://www.bioconductor.org/packages/release /bioc/ html /affy.html)  (16) and probes were mapped into genes.",OADS,/arxiv_data1/oa_pdf/9b/cb/mmr-15-01-0380.PMC5355740.pdf
Data from the expression profiling  array GSE49688 (5) were downloaded from the Gene Expression  Omnibus database ( http://www.ncbi.nlm.nih.go v/geo/ ).,OADS,/arxiv_data1/oa_pdf/30/a8/mmr-15-01-0139.PMC5355747.pdf
"In addition,  their association based on function was determined using  the Database for Annotation, Visualization and Integrated  Discovery (DAVID; http://david.abcc.ncifcrf.gov ) gene clas - sification tool  (18).",OADS,/arxiv_data1/oa_pdf/30/a8/mmr-15-01-0139.PMC5355747.pdf
IQGAP1-interacting proteins were predicted based  on the online human protein-protein interaction (PPI) data - sets (http://www.hprd.org/).,OADS,/arxiv_data1/oa_pdf/67/39/or-37-02-0768.PMC5355752.pdf
The interacting proteins with IQGAP1 were analyzed based on HPRD database online (http://www.hprd.org/).,OADS,/arxiv_data1/oa_pdf/67/39/or-37-02-0768.PMC5355752.pdf
The interacting proteins with IQGAP1 analyzed based on HPRD database (http://www.hprd.org/).,OADS,/arxiv_data1/oa_pdf/67/39/or-37-02-0768.PMC5355752.pdf
"According to our bioin - formatics analysis of IQGAP1-interacting proteins based on human protein-protein interactions database (HPRD) (http://www.hprd.org/), IQGAP1 with its interacting proteins involve in oncogenesis-associated signaling pathways (Fig.",OADS,/arxiv_data1/oa_pdf/67/39/or-37-02-0768.PMC5355752.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  María-Victoria Alvarez Sánchez,  MD, Department of Gastroenterology, Complejo Hospitalario  Universitario de Pontevedra, Instituto de Inve stigación Sanitaria  Galicia Sur, Avenida de Mourente s/n, 36071 Pontevedra,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/75/43/WJGE-9-105.PMC5355758.pdf
"victoria.alvarez.sanchez@hotmail.com Telephone:  +34-986-800907 Fax: +34-986-800309 Received:  September 3, 2016 Peer-review started:  September 4, 2016 First decision:  September 29, 2016 Revised:  October 18, 2016 Accepted:  December 13, 2016 Article in press:  December 14, 2016 Published online:  March 16, 2017 Abstract Obesity is a growing problem in developed countries, Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i3.105World J Gastrointest Endosc   2017 March 16; 9(3): 105-126 ISSN 1948-5190 (online) and surgery is the most effective treatment in terms of  weight loss and improving medical comorbidity in a high  proportion of obese patients.",Non-OADS,/arxiv_data1/oa_pdf/75/43/WJGE-9-105.PMC5355758.pdf
wjgnet.com/1948-5190/full/v9/i3/105.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/43/WJGE-9-105.PMC5355758.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/75/43/WJGE-9-105.PMC5355758.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Yuji Sakai, MD,  Department of Gastroen -Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i3.127World J Gastrointest Endosc   2017 March 16; 9(3): 127-132 ISSN 1948-5190 (online) terology and Nephrology, Graduate School of Medicine, Chiba  University, Inohana 1-8-1, Chuou-ku, Chiba City 260-8670,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/ea/0d/WJGE-9-127.PMC5355759.pdf
wjgnet.com/1948-5190/full/v9/i3/127.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/0d/WJGE-9-127.PMC5355759.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ea/0d/WJGE-9-127.PMC5355759.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript  Correspondence to: Daniel Luba, MD,  Monterey Bay Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i3.133World J Gastrointest Endosc   2017 March 16; 9(3): 133-138 ISSN 1948-5190 (online) Gastroe nterology Consultants, 23 Upper Ragsdale Dr, Monterey,  Ca 93940, United States.",Non-OADS,/arxiv_data1/oa_pdf/8e/cc/WJGE-9-133.PMC5355760.pdf
World J  Gastrointest Endosc  2017; 9(3): 133-138  available from: URL:   http://www.wjgnet.com/1948-5190/full/v9/i3/133.htm  DOI:  http://dx.doi.org/10.4253/wjge.v9.i3.133 INTRODUCTION Colorectal cancer is the second leading cause of cancer  mortality in men and women in the United States with  about 132700 new cases and 49700 deaths expected  in 2015.,Non-OADS,/arxiv_data1/oa_pdf/8e/cc/WJGE-9-133.PMC5355760.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8e/cc/WJGE-9-133.PMC5355760.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dennis Y Kim, Assistant Professor  of  Surgery, Department of Surgery, Harbor-UCLA Medical Center,  1000 West Carson Street, Torrance, CA 90502,  United States.",Non-OADS,/arxiv_data1/oa_pdf/97/9a/WJGE-9-139.PMC5355761.pdf
"dekim@dhs.lacounty.go v Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i3.139World J Gastrointest Endosc   2017 March 16; 9(3): 139-144 ISSN 1948-5190 (online) Telephone:  +1-310-2222700 Fax: +1-310-5331841 Received:  April 29, 2016  Peer-review started: May 3, 2016 First decision:  May 17, 2016 Revised:  December 6, 2016 Accepted: December 27, 2016 Article in press:  December 28, 2016 Published online:  March 16, 2017 Abstract Langerhans cell histiocytosis (LCH) is a rare syndrome  characterized by unifocal, multifocal unisystem, or  disseminated/multi-system disease that commonly  involves the bone, skin, ly mph nodes, pituitary, or  sometimes lung (almost exclusively in smokers) causing  a variety of symptoms from rashes and bone lesions to  diabetes insipidus or pulmonary infiltrates.",Non-OADS,/arxiv_data1/oa_pdf/97/9a/WJGE-9-139.PMC5355761.pdf
wjgnet.com/1948-5190/full/v9/i3/139.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/9a/WJGE-9-139.PMC5355761.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/97/9a/WJGE-9-139.PMC5355761.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Xiu-Hua Zhang, MD, Medical Center for  Digestive Diseases, the Second Affiliated Hospital of Nanjing  Medical University, 121 Jiangjiayuan, Nanjing 210011, Jiangsu  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/fe/63/WJGE-9-145.PMC5355762.pdf
"1129wy@sina.co m Telephone:  +86-25-58509932 Fax: +86-25-58509931 Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4253/wjge.v9.i3.145World J Gastrointest Endosc   2017 March 16; 9(3): 145-148 ISSN 1948-5190 (online) Received:  November 13, 2016    Peer-review started:  November 15, 2016    First decision:  December 1, 2016 Revised:  December 13, 2016   Accepted: January 11, 2017 Article in press:  January 14, 2017 Published online:  March 16, 2017 Abstract A 63-year-old man presented at our hospital with right  upper abdomen pain and fever for 4 d. The patient’s  magnetic resonance cholangiopancreatography revealed  dilated common bile duct and choledocholithiasis.",Non-OADS,/arxiv_data1/oa_pdf/fe/63/WJGE-9-145.PMC5355762.pdf
wjgnet.com/1948-5190/full/v9/i3/145.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/63/WJGE-9-145.PMC5355762.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fe/63/WJGE-9-145.PMC5355762.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Guido Engelmann, MD,  Department of  Paediatrics, Lukas Hospital, Preussenstraße 84, D-41464 Neuss,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/4c/d1/WJH-9-409.PMC5355763.pdf
World J Hepatol  2017; 9(8): 409-417  Available from:  URL:  http://www.wjgnet.com/ 1948-5182 /full/v9/i8/409.htm   DOI: http://dx.doi.org/10.4254/wjh.v9.i8.,Non-OADS,/arxiv_data1/oa_pdf/4c/d1/WJH-9-409.PMC5355763.pdf
409Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i8.409World J Hepatol   2017  March 18; 9(8): 409-417 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/4c/d1/WJH-9-409.PMC5355763.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4c/d1/WJH-9-409.PMC5355763.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ana Claudia Reis Schneider, PhD,  Laboratório Experimental de Hepatologia e Gastroenterologia,  Hospital de Clínicas de Porto Alegre, 2350/sala 12214, Porto Alegre, 90035 ­903 RS, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
"schneiderac@gmail.com Telephone:  +55­51­33598847 Fax:  +55­51­33598760  Received:  July 12, 2016 Peer-review started:  July 13, 2016 First decision:  October 10, 2016 Revised:  October 28, 2016 Accepted:  January 11, 2017 Article in press:  January 14, 2017 Published online:  March 18, 2017 Abstract AIM To evaluate the effects of chronic exposure to ethanol  in the liver and the expression of inflammatory genes Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i8.418World J Hepatol   2017  March 18; 9(8): 418-426 © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
World J Hepatol  2017; 9(8): 418 ­426  Available from: URL:   http://www.wjgnet.co m/1948 ­5182 /full/v9/i8/418.,Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
"htm  DOI:  http://dx.doi.org/10.4254/wjh.v9.i8.418 INTRODUCTION Alcoholic liver disease (ALD) encompasses a wide  spectrum of injury, ranging from simple steatosis, leading  to steatohepatitis, fibrosis and finally to cirrhosis[1,2].",Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
Available from URL: http://www.pucrs.,Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e0/aa/WJH-9-418.PMC5355764.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to:  Dr. Martina Sterneck, Professor,  De- partment of Medicine I, University Medical Center Hamburg- Eppendorf, Martinistrasse 52, 20246 Hamburg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
We divided patients into groups  according to their underlying diagnosis: (1) hepatocellular Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i8.427World J Hepatol   2017  March 18; 9(8): 427-435 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
World J Hepatol   2017; 9(8): 427-435  Available from: URL:  http://www.wjgnet.com/1948-5182 /full/v9/i8/427.,Non-OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
"htm  DOI: http://dx.doi.org/10.4254/ wjh.v9.i8.427 INTRODUCTION Survival after liver transplantation has strongly improved  in the last decades, but factors associated with long- term survival have not been well defined yet.",Non-OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
This age-matched control cohort was  constructed baseding on historical data about the German healthy population (https://www.destatis.de).Pischke S  et al.,OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cd/07/WJH-9-427.PMC5355765.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to:  Daniel F C Mazo, MD, PhD, Division of  Clinical Gastroenterology and Hepatology, Hospital das Clínicas,  Department of Gastroenterology, University of São Paulo School  of Medicine, Avenida Dr. Eneas Carvalho de Aguiar, 255, sala  9159, São Paulo 05403-900, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/e2/ee/WJH-9-436.PMC5355766.pdf
Fifty-six patients (70%) were Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i8.436World J Hepatol   2017  March 18; 9(8): 436-442 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/e2/ee/WJH-9-436.PMC5355766.pdf
"Concordance of non-invasive mechanical and  serum tests for liver fibrosis evaluation in chronic hepatitis C.  World J Hepatol  2017; 9(8): 436-442  Available from: URL:   http://www.wjgnet.com/ 1948-5182 /full/v9/i8/436.htm  DOI:  http://dx.doi.org/10.4254/wjh.v9.i8.436 INTRODUCTION Hepatitis C virus (HCV) infection is one of the most fre­ quent etiologies of cirrhosis, and is therefore responsible  for most of its complications, including hepatocellular  carcinoma, which is the sixth most common cancer world­ wide[1].",Non-OADS,/arxiv_data1/oa_pdf/e2/ee/WJH-9-436.PMC5355766.pdf
"Available from:  URL: http://www.aids.gov.br / 14 Tsochatzis EA , Gurusamy KS, Ntaoula S, Cholongitas E,  Davidson BR, Burroughs AK.",Non-OADS,/arxiv_data1/oa_pdf/e2/ee/WJH-9-436.PMC5355766.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e2/ee/WJH-9-436.PMC5355766.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  James Adjaye, PhD, Professor,  Medical  Faculty, Institute for Stem Cell Research and Regenerative  Medicine, Heinrich Heine University, Moorenstrasse 5, 40225  Düsseldorf, Germany.",Non-OADS,/arxiv_data1/oa_pdf/ce/b4/WJH-9-443.PMC5355767.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4254/wjh.v9.i8.443World J Hepatol   2017  March 18; 9(8): 443-454 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/ce/b4/WJH-9-443.PMC5355767.pdf
World J Hepatol  2017; 9(8): 443-454   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/ v9/i8/443.,Non-OADS,/arxiv_data1/oa_pdf/ce/b4/WJH-9-443.PMC5355767.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i8.,OADS,/arxiv_data1/oa_pdf/ce/b4/WJH-9-443.PMC5355767.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ce/b4/WJH-9-443.PMC5355767.pdf
Available at http://www.questdiagnostics.com/home/physicians/testing-services/by-test-name/colovantage/about (accessed 16 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/56/f8/bjc201712a.PMC5355921.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Blood-based miRNAs for the diagnosis of CRC 774 www.bjcancer.com | DOI:10.1038/bjc.2017.12,Non-OADS,/arxiv_data1/oa_pdf/56/f8/bjc201712a.PMC5355921.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain;2Andalusian School of Public Health, Instituto de Investigacio ´n Biosanitaria ibs.GRANADA.",Non-OADS,/arxiv_data1/oa_pdf/7a/90/bjc201714a.PMC5355922.pdf
Available at: http://CRAN.r-project.org/web/packages/survminer.,Non-OADS,/arxiv_data1/oa_pdf/30/74/bjc201715a.PMC5355923.pdf
Available at http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/30/74/bjc201715a.PMC5355923.pdf
Available at: http://CRAN.R-project.org/package=survival.,Non-OADS,/arxiv_data1/oa_pdf/30/74/bjc201715a.PMC5355923.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) named above 2017 Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Association of asporin with prostate cancer progression 784 www.bjcancer.com | DOI:10.1038/bjc.2017.15",Non-OADS,/arxiv_data1/oa_pdf/30/74/bjc201715a.PMC5355923.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER OS in early-stage BRCA mutation pancreatic cancer 702 www.bjcancer.com | DOI:10.1038/bjc.2017.19,Non-OADS,/arxiv_data1/oa_pdf/29/42/bjc201719a.PMC5355924.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prognostic biomarkers in mesothelioma: systematic review BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2017.22 741,Non-OADS,/arxiv_data1/oa_pdf/46/de/bjc201722a.PMC5355927.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BOLERO-2 PIK3CA mutations from cfDNA 730 www.bjcancer.com | DOI:10.1038/bjc.2017.25,Non-OADS,/arxiv_data1/oa_pdf/8e/53/bjc201725a.PMC5355930.pdf
"Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/.",Non-OADS,/arxiv_data1/oa_pdf/52/aa/bjc201727a.PMC5355931.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Social dilemmas of tumour acidity and vasculature 792 www.bjcancer.com | DOI:10.1038/bjc.2017.5,Non-OADS,/arxiv_data1/oa_pdf/7a/46/bjc20175a.PMC5355932.pdf
"New Zealand Ministry of Health: Wellington, New Zealand.Available at: https://www.nsu.govt.nz/system/files/resources/ bsnzmortcohcceval_final7_8_dec.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ed/c3/bjc20176a.PMC5355933.pdf
Written informed consent was obtained from all patients and documented in accordance with the general authorisation to process personal data for scientific research purposes from ‘The Italian Data Protection Authority’ (http://www.garanteprivacy.it/ web/guest/home/docweb/-/docwebdisplay/export/2485392).,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/bjc20178a.PMC5355934.pdf
"All information regarding human material was managed using anonymous numerical codes, and all samples were handled in compliance with the Helsinki Declaration (http://www.wma.net/ en/30publications/10policies/b3/).",Non-OADS,/arxiv_data1/oa_pdf/6d/c3/bjc20178a.PMC5355934.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER NGS of cfDNA 810 www.bjcancer.com | DOI:10.1038/bjc.2017.8,Non-OADS,/arxiv_data1/oa_pdf/6d/c3/bjc20178a.PMC5355934.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DNA hypomethylation in compromised BER adenomas BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2017.9 801,Non-OADS,/arxiv_data1/oa_pdf/a8/6e/bjc20179a.PMC5355935.pdf
"44 A. Gomez-Caminero, P. Howe, M. Hughes, E. Kenyon, D. R. Lewis, M. Moore, J. Ng, A. Aitio and G. Becking,Arsenic and Arsenic compounds [Online], InternationalProgramme on Chemical Safety , WHO, Geneva, 2nd edn, 2001, Section 3.1, http://www.inchem.org/documents/ehc/ ehc/ehc224.htm#3.1 (accessed May 27, 2016).",Non-OADS,/arxiv_data1/oa_pdf/93/b3/SC-007-C6SC00490C.PMC5355942.pdf
"Association analyses of PEAR1 rs12041331 were performed using Mixed Model Analysis for Pedigrees (http://edn.som.umaryland.edu/mmap/) under an additive genetic model with adjustments for age, sex, and related- ness among study participants.",Non-OADS,/arxiv_data1/oa_pdf/fa/dc/CTS-10-102.PMC5355965.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.cts-journal.com,Non-OADS,/arxiv_data1/oa_pdf/fa/dc/CTS-10-102.PMC5355965.pdf
"All rights reserved EDITORIAL Advancing Clinical and Translational Science JA Wagner∗ The vision for the 2015–2020 American Society for Clinical Pharmacology and Therapeutics (ASCPT) strategic plan is that ASCPT’s influence and leadership make it the authority on the science and practice of translational medicine, build- ing on a foundation of clinical pharmacology and therapeu- tics (http://www.ascpt.org/About-ASCPT/ASCPT-Strategic- Plan).",Non-OADS,/arxiv_data1/oa_pdf/43/bb/CTS-10-53.PMC5355966.pdf
"Also in January 2017, the inaugural CTSwebinar, “Driving Patient-Centered Trans- lational Medicine,” was broadcast (https://www.youtube.",Non-OADS,/arxiv_data1/oa_pdf/43/bb/CTS-10-53.PMC5355966.pdf
"Just as with -omes in the endome, in all -omes of the ectome there are opportunities for sci- entists to innovate better measures than those that exist today.Wewelcomethescientificcommunitytocontributeto sharing and advancing the common language of -omes and -omicsathttps://omecentral.org,whichwehavedesignedto serve as a dynamic reference source going forward.",OADS,/arxiv_data1/oa_pdf/a2/6e/CTS-10-64.PMC5355967.pdf
Available at: https://www.whitehouse.gov/the- press-ofﬁce/2015/01/30/fact-sheet-president-obama-s-precision-medicine-initiative.,Non-OADS,/arxiv_data1/oa_pdf/a2/6e/CTS-10-64.PMC5355967.pdf
Available at: https://www.nih.gov/precision-medicine-initiative-cohort- program-frequently-asked-questions.,Non-OADS,/arxiv_data1/oa_pdf/a2/6e/CTS-10-64.PMC5355967.pdf
Available at: https://www.nih.gov/news- events/news-releases/nih-awards-55-million-build-million-person-precision-medicine- study.,Non-OADS,/arxiv_data1/oa_pdf/a2/6e/CTS-10-64.PMC5355967.pdf
Available at: https://www.huffpost.com/us/entry/190650.,Non-OADS,/arxiv_data1/oa_pdf/a2/6e/CTS-10-64.PMC5355967.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.cts-journal.com,Non-OADS,/arxiv_data1/oa_pdf/44/6c/CTS-10-93.PMC5355968.pdf
"In 2015 the FDA approved the first complemen- tary diagnostic using the PD-L1 IHC 28-8 PharmDx assay (http://www.agilent.com/en-us/products/pharmdx/pd-l1- ihc-28-8-pharmdx/pd-l1-ihc-28-8-pharmdx-for-autostainer- link-48-1) for the cancer immunotherapy nivolumab (OPDIVO) based on a phase III trial in second-line non-small cell lung cancer (NSCLC).11Separately, positive PD-L1 sta- tusasdeterminedbyPD-L1IHC28-8PharmDxinmelanoma is correlated with the magnitude of the treatment effect on progression-free survival (PFS) from nivolumab (OPDIVO).",Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
"In 2016 the FDA approved complementary diagnostic status for the VENTANA PD-L1 (SP142) assay based on successful pivotal trials with atezolizumab (TECENTRIQ) in NSCLC12and blad- der cancer.5The SP142 IHC assay is a qualitative immuno- histochemical assay intended for use in formalin-fixed, paraffin-embedded (FFPE) urothelial carcinoma and NSCLC tissue (http://www.ventana.com/product/1827?type =2357).",Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
"CE marking (Conformité Européene) indi- cates that the product had been assessed and meets Euro- peanUnion(EU)safety,health,andenvironmentalprotection requirements (http://ec.europa.eu/growth/single-market/ce- marking/).",Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
"Additionally, analytical concordance studiescanenablecross-referencingofCEmarkingbetween assays for the same therapy, such as for the Ventana SP263 PD-L1 IHC assay (http://www.ventana.com/ventana-pd-l1- sp263-assay-2/) to nivolumab (OPDIVO) following a concor- dance study with the 28-8 IHC assay.",Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5250lbl.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
Available from: http://www.pharmtech.com/regulation-medical-devices-and-companion-diagnostics.,Non-OADS,/arxiv_data1/oa_pdf/eb/1e/CTS-10-84.PMC5355969.pdf
http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/PromotingSafe andEffectiveDrugsfor100Years/.,Non-OADS,/arxiv_data1/oa_pdf/b8/36/CTS-10-78.PMC5355972.pdf
Accessed from http://www.fda.gov/downloads/scienceresearch/specialtopics/personal izedmedicine/ucm372421.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/36/CTS-10-78.PMC5355972.pdf
Available at http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/36/CTS-10-78.PMC5355972.pdf
Accessed from http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205494Orig1s000TOC.cfm.,OADS,/arxiv_data1/oa_pdf/b8/36/CTS-10-78.PMC5355972.pdf
"Genomic variants across individuals Large-scale high-throughput sequencing studies, such as the 1000 Genomes and NHLBI GO Exome Sequencing Projects, have already identified millions of genetic vari- ants among individuals from different populations and have established a comprehensive resource on human genetic variation.1,2The genetic variants are cataloged in pub- lic databases, such as dbSNP (https://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/19/a1/CTS-10-67.PMC5355973.pdf
gov/snp/) and dbVAR (https://www.ncbi.nlm.nih.gov/dbvar/) (Table 1).,OADS,/arxiv_data1/oa_pdf/19/a1/CTS-10-67.PMC5355973.pdf
"68 Table 1 Databases that catalog human genetic variation and phenotypic relationships Databases Description Link 1000 Genomes Project Comprehensive catalog of human genetic variation http://browser.1000genomes.org/index.html ClinVar Information about genomic variation and its relationship to human health https://www.ncbi.nlm.nih.gov/clinvar/ Catalog of somatic mutations in cancer (COSMIC)Comprehensive resource for exploring the impact of somatic mutations in human cancerhttp://cancer.sanger.ac.uk/cosmic DBASS Database of new exon boundaries induced by pathogenic mutations in human disease geneshttp://www.dbass.org.uk dbGaP NCBI’s database of genotypes and phenotypes https://www.ncbi.nlm.nih.gov/gap dbSNP NCBI’s database of single nucleotide polymorphisms (SNPs) and multiple small-scale variations (including insertions/deletions, microsatellites and nonpolymorphic variants)https://www.ncbi.nlm.nih.gov/snp dbVar NCBI’s database of genomic structural variation https://www.ncbi.nlm.nih.gov/dbvar DECIPHER Web-based database incorporating a suite of tools designed to aid the interpretation of genomic variantshttps://decipher.sanger.ac.uk Exome Aggregation ConsortiumAggregate of exome sequencing data from a variety of large-scale sequencing projectshttp://exac.broadinstitute.org GTEx Portal Data repository for genotype and tissue-specific gene expression data http://www.gtexportal.org/home/ miRBase Database of published microRNA sequences and annotation http://mirbase.org MirSNP Collection of human SNPs in predicted microRNA target sites http://bioinfo.bjmu.edu.cn/mirsnp/search/ NHGRI-EBI GWAS Catalog Catalog of published genome-wide association studies http://www.ebi.ac.uk/gwas/ NHLBI Exome Sequencing ProjectData repository for exome sequence variants related to heart, lung and blood disordershttp://evs.gs.washington.edu/EVS/ Online Mendelian Inheritance in ManCatalog of human genes and genetic disorders for relationships between phenotype and genotypehttp://omim.org/ PharmGKB Pharmacogenomics knowledge resource encompassing clinical informationhttps://www.pharmgkb.org PolymiRTS Database of naturally occurring DNA variations in microRNA seed regions and microRNA target siteshttp://compbio.uthsc.edu/miRSNP/ SPHINX – A resource of the eMERGE NetworkA web-based tool to access the pharmacogenetics gene sequence data of the eMERGE-PGx projecthttps://www.emergesphinx.org The Human Gene Mutation DatabaseCollection of published gene lesions responsible for human inherited diseasehttp://www.hgmd.cf.ac.uk/ac/index.php Figure 1 Representation of important gene regions with the number of genetic variants within a typical European or African human genome shown in brackets.",OADS,/arxiv_data1/oa_pdf/19/a1/CTS-10-67.PMC5355973.pdf
"To date, more than 3,200 GWA studies have been conducted (http://www.ebi.ac.uk/gwas) and /223c10,000 common SNPs have been associated with human traits and diseases through GWA studies.5Gusev et al.6estimated Clinical and T ranslational Science",OADS,/arxiv_data1/oa_pdf/19/a1/CTS-10-67.PMC5355973.pdf
General Secretariat of the Council to Delegations; Document number 15054/15: Personalised medicine for patients – Council conclusions (7 December 2015): http://data.consilium.europa.eu/doc/document/ST-15054-2015-INIT/en/pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
European Commission 25.10.2013 SWD(2013) 436 ﬁnal: Commission staff working document: Use of ‘-omics’ technologies in the development of personalised medicine: https://ec.europa.eu/research/health/pdf/2013-10_personalised_medicine_en.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
"Leopoldina Nationale Akademie der Wissenschaften, acatech Deutsche Akademie der Technikwissenschaften, Union der deutschen Akademien der Wissenschaften: December 2014 statement: individualised medicine - prerequisites and consequences: https://www.leopoldina.org/uploads/tx_leopublication/2014_Stellungnahme_ IndividualisierteMedizin_EN.pdf and website of the German federal ministry of edu- cation and research with information about the action plan individualised medicine: http://www.gesundheitsforschung-bmbf.de/de/4950.php 6.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
"Aviesan alliance nationale pour les siences de la vie et de la santé: Genomic medicine France 2025: http://aviesan.fr/en/aviesan/accueil/toute-l-actualite/plan-france- medecine-genomique-2025, website in French.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
"European Commission, Research and Innovation, Conferences and events: Personalised medicine conference 2016, 1–2 June Brussels: https://ec.europa.eu/research/conferences/2016/permed2016/index.cfm; presentations and video recordings from the conference are available; link to the report V. English, European Commission, Personalised Medicine Conference 2016 Report: https://ec.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
http://ec.europa.eu/research/participants/ portal/desktop/en/opportunities/index.html 9.,Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
"Aguirre M et al: PerMed, Shaping Europe’s vision for personalised medicine, strate- gic research and innovation agenda (SRIA), June 2015: http://www.permed2020.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/CTS-10-61.PMC5355974.pdf
"The clinical role for a biomarker-based test typically falls into one or more of the following categories (see US Food and Drug Administration / National Institutes of Health glos- sary at https://www.ncbi.nlm.nih.gov/books/NBK326791/): diagnostic, monitoring, pharmacodynamics/response, pre- dictive, prognostic, safety, and susceptibility/risk.",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/CTS-10-58.PMC5355975.pdf
"Use of case–control and matched study designs is fairly common in retrospective biomarker studies, and these require specialized statistical analysis methods.7,8 Analyses should additionally account for multiple testing, data distributions (e.g., nonnormal data), functional rela- tionships between biomarkers and outcomes (e.g., nonlin- ear), correlations between multiple measurements per study Table 1 Reporting guidelines particularly relevant to clinical biomarker research Acronym Reporting guideline title Website Study type BRISQ Biospecimen reporting for improved study qualityhttp://www.equator- network.org/reporting- guidelines/brisq/Studies utilizing biospecimens CONSORT Consolidated standards of reporting trialshttp://www.consort-statement.org/ Randomized clinical trials REMARK Reporting recommendations for tumor marker prognostic studieshttp://www.equator- network.org/reporting- guidelines/reporting- recommendations-for-tumour- marker-prognostic-studies-remark/Tumor marker prognostic studies (and prognostic studies more generally) STARD Standards for the reporting of diagnostic accuracy studieshttp://www.equator- network.org/reporting- guidelines/stard/Diagnostic accuracy studies STROBE Strengthening the reporting of observational studies in epidemiologyhttp://www.equator- network.org/reporting- guidelines/strobe/Observational studies in epidemiology (and more generally) www.cts-journal.com",Non-OADS,/arxiv_data1/oa_pdf/ee/b6/CTS-10-58.PMC5355975.pdf
Detailed guidance for reporting a variety of types of health research studies is available on the EQUATOR web- site (http://www.equator-network.org/reporting-guidelines/).,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/CTS-10-58.PMC5355975.pdf
http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/CTS-10-58.PMC5355975.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/ee/b6/CTS-10-58.PMC5355975.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/9a/62/CG-CGCR170011.PMC5356151.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/fb/3b/CG-CGCR170009.PMC5356152.pdf
